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Abstract
Microglia are immunocompetent cells in the central nervous system that  have many 
similarities with macrophages of peripheral tissues. Their activation protects local 
cells from foreign microbial infection in the CNS. However, “over-activated“ 
microglia become a “Double-edged sword” which show neuronal toxicity and are 
implicated in a variety of neurodegenerative diseases. Previous studies have 
suggested that potassium channels play  a role in regulating microglial activation, 
migration and proliferation. However what kinds of potassium channel subunits are 
expressed in microglia, whether their expression changes after microglial activation 
and the functional role of most potassium channels expressed in microglia are still 
not fully characterized.
To address these questions, we used the N9 mouse microglial cell line as a cell model 
for experiments in vitro. We first optimized the cell culture and lipopolysaccharide 
(LPS), the endotoxin of gram-negative bacteria, mediated stimulation of microglial 
activation that results in subsequent nitric oxide (NO) release. Using qRT-PCR, we 
analyzed mRNA expression of >80 potassium channel pore-forming subunits and 
their regulatory  subunits in both LPS-treated (1µg/ml, 24hr) and untreated microglia. 
The subunits which displayed the highest mRNA expression in resting N9 cells 
included Kcnma1 (KCa1.1), Kcnk6 (K2p6.1), Kcnc3 (Kv3.3) and Abcc8 (SUR1). In 
addition, N9 cells also expressed the mRNAs for other channel subunits previously 
reported in microglia such as Kcnn4 (KCa3.1), Kcna3 (Kv1.3) and Kcna5 (Kv1.5) 
subunits. Of these channel subunits LPS had no significant effect on mRNA 
expression except for Kcnk6 which was significantly reduced.
We then examined whether pharmacological manipulation of these channels 
controlled LPS-induced NO release. It was found out that the KCa3.1 selective 
blocker Tram34 and the Kv1.5 inhibitor propafenone (PPF) significantly decreased 
LPS-induced NO in agreement with data in primary microglia. Ba2+ that inhibits 
iv
inwardly  rectifying potassium channels as well as K2p6.1 also significantly 
attenuated LPS-induced microglial activation. Inhibition or activation of KCa1.1 
channels by paxilline and NS1619 respectively had no significant effect. However, 
paxilline significantly attenuated the effect of Tram34, PPF and Ba2+ to control LPS-
induced NO release while NS1619 significantly  facilitated the effect of Tram34 and 
PPF.
To investigate the major ionic currents expressed in N9 microglia with and without 
LPS application, we examined whole-cell ionic currents using the patch-clamp 
technique. Resting N9 cells display a small outward current at positive potentials but 
a large inwardly rectifying component at negative potentials in physiological 
potassium gradients. The outward current was dramatically  increased by  LPS 
application that  was dependent upon the intracellular free calcium concentration. 
Paxilline or Tram34 was then applied to acutely  block this apparent  outward KCa 
current. The result indicated that the LPS triggered KCa current was mainly paxilline 
sensitive supporting a role for an LPS-induced increase in KCa1.1 channel current. In 
addition, by using current clamp the mean resting membrane potential of N9 cells 
was -50.6±6.6mV (N=7) determined in the presence of 1µM  [Ca2+]i and 
-59.4±8.5mV (N=10) with 10nM [Ca2+]i. N9 cells did not display any spontaneous 
action potentials and the resting membrane potential was not significantly affected by 
LPS.
To conclude, the work presented in this thesis extends the current knowledge 
regarding potassium channel mRNA expression in microglia and their function in 
microglial NO release. What is more, it was found that KCa1.1 current expression 
was increased in LPS-activated N9 cells and revealed KCa1.1 channels as a 
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1.1 The central nervous system
The nervous system is composed of the peripheral nervous system (PNS) and the 
central nervous system (CNS). The CNS is of ectodermal origin and it exists in all 
bilateral animals. It consists of the brain and the spinal cord which are covered by 
meninges and contained in the dorsal cavity (Maton, 1993). CNS receives signals 
from the body and sends out major commands to control animal behavior. However, 
neurons are not the main cell type in the CNS (Allen & Barres, 2009; Azevedo et al., 
2009; Hawkins & Olszewski, 1957; Pfrieger & Barres, 1995). In the human brain, 
there are about 86.1±8.1 billion neurons (Azevedo et al., 2009) and the remainder are 
84.6±9.8 billion nonneuronal cells described in the following paragraphs. The 
number of neurons or nonneuronal cells is location-dependent. There is about 
69.0±6.7 billion neurons and about 16.0±2.2 billion nonneuronal cells in the 
cerebellum while about 16.3±2.2 billion neurons and about 60.8±7.0 billion 
nonneuronal cells in the cerebral cortex (including white matter and grey matter). In 
the rest  of the brain (including basal ganglia, diencephalon, mesencephalon and 
pons) there are 0.7±0.1 billion neurons and 7.7±1.5 billion nonneuronal cells 
(Azevedo et al., 2009).
1.1.1 Neuroglia
There are several types of nonneuronal cells which regulate the chemical 
environment or give physical support to neurons. These cells are called neuroglia, or 
glia in short (Hawkins & Olszewski, 1957; Pfrieger & Barres, 1995). Neuroglia are 
classified into two types, microglia and macroglia. Macroglia are composed of 
astrocytes (CNS), oligodendrocytes (CNS), ependymal cells (CNS), radial glia 
(CNS), Schwann cells (PNS), satellite cells (PNS) and enteric glial cells (PNS) 
(Table 1-1). Each of them have specific functions in either the CNS or the PNS. In 
different animals, the ratio between neurons and neuroglia in the brain is associated 
with the size of the brain (Allen & Barres, 2009). For example, there are 25% 
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regulate chemical environment of 
neurons
Oligodendrocytes form myelin sheath
Ependymal cells form walls of ventricles and secrete cerebrospinal fluid
Radial glia neuronal progenitors and the scaffold for newborn neurons to migrate
Schwann cells
PNS
form myelination in PNS
Satellite cells regulate chemical environment in PNS
Enteric glial cells play roles in digestive processes
Microglia CNS immune cells in CNS
Table 1-1. Members of glial family and their general functions. Glia 
include two groups: macroglia and microglia. There are totally  eight types of 
cells in either CNS or PNS. CNS: central nervous system; PNS: peripheral 
nervous system.
neuroglia in the fruit fly brain, 65% neuroglia in the mouse brain and 97% neuroglia 
in the elephant brain (Allen & Barres, 2009). For the human brain, it is not less than 
50% (Azevedo et al., 2009; Allen & Barres, 2009). In the human cerebral cortex, the 
neuroglia are composed of 75.6% oligodendrocytes, 17.3% astrocytes and 6.5% 
microglia (Pelvig et al., 2008). However, compared to other primates, the human 
brain is considered unique (Jerison, 1973; Marino, 1998) as other primates have less 
neuroglia in the brain (Doetsch, 2003; Nishiyama et al., 2005; Ullian et al., 2001).
1.1.1.1 Astrocytes
Astrocytes are star shaped cells in the CNS. The identification of astrocytes is often 
approached by staining for glial fibrillary acidic protein (GFAP). GFAP is expressed 
almost exclusively by astrocytes and it is commonly used in vitro for glial cell 
identification (Conrad et al., 2009; Jiang et al., 2008; Paintlia et al., 2008; Calderón-
Garcidueñas et al., 2009). However, it was pointed out that GFAP is also expressed 
by other glial cells like ependymal cells (Roessmann et al., 1980) and radial glial 
cells (Shapiro et al., 2005; Middeldorp et al., 2010) in the CNS. Astrocytes provide 
structural support to the neurons with their processes enveloping synapses. Previous 
consideration was that astrocytes only offer physical support to neurons in the CNS. 
However, astrocytes are actually very important in maintaining the environment of 
the CNS as they play  roles in secretion of nutrients for neurons, the promotion of 
myelination and forming of the glial scar during injury of the CNS. Recent 
discoveries indicate that astrocytes communicate with neurons by secreting 
glutamate (Santello & Volterra, 2009; Fiacco et al., 2009) and adenosine triphosphate 
(ATP) (Santello & Volterra, 2009). The release of neurotransmitter by astrocytes is 
calcium (Ca2+)-dependent (Santello & Volterra, 2009) except for astrocytes in the 
hippocampus (Agulhon et al., 2010). Another mechanism that astrocytes regulate is 
the uptake of neural transmitters (Tan et al., 1997; Chatton et al., 2003) and 
potassium (K+) in the CNS as astrocytes express K+ channels and transporters for 
several neurotransmitters (Kettenmann & Ransom, 2005), such as ATP, γ-
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aminobutyric acid (GABA) and glutamate on the membrane. In addition, astrocytes 
also propagate intracellular Ca2+ for a long distance (Ca2+ wave) (Newman, 2001) in 
response to stimulation of the presynaptic cell, the postsynaptic cell and the 
astrocytes at the site of synapses (Araque et al., 1999). The Ca2+ wave generated in 
astrocytes may transfer to neighbouring neurons through gap junction channels 
during the developing but not mature CNS (Scemes & Giaume, 2006). Ca2+ wave 
induced gliotransmitter release and regulate the activity of synapse (Fellin & 
Carmignoto, 2004; Haydon, 2001; Volterra & Meldolesi, 2005). Besides 
communication between astrocytes and neurons, the processes of astrocytes are also 
connected to the endothelial cells at the blood brain barrier (BBB) and blood vessels. 
Astrocytes are important for maintaining the BBB and regulating neurovascular 
coupling in the brain (Haydon & Carmignoto, 2006; Parri & Crunelli, 2003).
1.1.1.2 Oligodendrocyte
In some vertebrates, the main function of oligodendrocytes is the formation of the 
myelin sheath and this process is called myelination. Because neurons propagate 
electrical signals along axons, the myelin sheath can offer insulation of axons. It 
prevents ion leakage and increases the propagation speed due to the nodes of Ranvier 
between different myelin sheath (Baumann & Pham-Dinh, 2001). Every 
oligodendrocyte can provide myelin sheath to about 50 axons. This is different from 
the Schwann cells which form the myelin sheath in the PNS as each Schwann cell 
can only  envelope one axon. In addition, there is another kind of oligodendrocyte 
called satellite oligodendrocytes that do not form a sheath but regulate the neural 
environment (Baumann & Pham-Dinh, 2001).
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1.1.1.3 Ependymal cells and radial glia
Ependymal cells are a kind of neuroglia and cuboidal shaped cells which form the 
ependyma lining along the wall of ventricles in the CNS. Ependyma together with 
capillaries constitute the choroid plexus which filters the blood to produce 
cerebrospinal fluid (CSF) for the ventricles. Cilia on the apical surfaces of 
ependymal cells facilitate the flow of the CSF. What is more, with their microvilli on 
the membrane surface ependymal cells can also absorb CSF. Radial glial cells play a 
pivotal role during the development of the CNS. They  are precursors for neurons, 
and they  also regulate the migration of neurons (Noctor et al., 2001; Campbell & 
Götz, 2002; Merkle et al., 2004). In the mature brain, they exist in the cerebellum 
and retina maintaining synapses and facilitate the signal transduction of neurons.
1.1.1.4 Microglia
Microglia are macrophage-like immune cells in the CNS which protect the CNS 
from infection and regulate the neuronal environment. The detail of microglia is 
introduced in Chapter 1.2.
1.1.2 The blood brain barrier
The CNS is isolated from the blood circulation by the BBB which protects neurons 
and neuroglia by preventing large size molecules, including peptides, to enter into 
the CNS. The BBB was first observed by Paul Ehrlich and his student Edwin 
Goldmann. When they tried to stain organs of animals, they  observed a 
compartmentalization between the brain and the rest of the body  which prevented 
dyes to pass through. The compartmentalization was in fact the BBB. Later in 1921, 
the concept of the BBB was formally  introduced by Lina Stern. The BBB is formed 
by the tight junctions of endothelial cells along the capillaries. The layer of 
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endothelial cells is covered by the basement membrane and connected by the end-
feet of astrocytes. In this case, the BBB separates the brain extracellular fluid 
(BECF) of the CNS from the the blood circulation. Due the existence of the BBB, it 
is not easy for external microbes such as bacteria, large molecules and hydrophilic 
molecules to get into the CNS, but not for the smaller hydrophobic molecules like 
oxygen (O2), carbon dioxide (CO2) and small peptides (Kastin et al., 1999; Banks & 
Kastin, 1996), which can pass through the BBB. Endothelial cells can form such 
tight junction because they express proteins which bind as dimers expressed by 
another endothelial cell, for example claudins (Furuse et al., 1998), occludin (Furuse 
et al., 1993) and junctional adhesion molecule (Martìn-Padura et al., 1998). A 
healthy BBB is required for preventing bacterial infections. However, during 
pathological conditions, like meningitis, which can be caused by lipopolysaccharide 
(LPS) (Beam & Allen, 1977), the BBB becomes more permeable as the junction 
becomes less tight when exposed to molecules like tumor necrosis factor alfa 
(TNFα), interleukin (IL)-1β, interferon gamma (IFN-γ), or LPS. This allows bacteria, 
viruses and phagocytes in the PNS to pass through. For example during the CNS 
disease experimental autoimmune encephalomyelitis (EAE), the circulating 




1.2.1 History of microglia
Microglia were first stained together with other CNS cells in 1880s by Franz Nissl 
using Nissl staining. The concept of microglia was formally developed by Pio del 
Rio-Hortega in the seminal work “Section X - Microglia” of the book “Cytology and 
Cellular Pathology of the Nervous System” in 1932 before which other synonyms of 
microglia were used, for example mesoglia (microglia & oligodendrocyte) (Rezaie & 
Male, 2002) or Hortegaglia. Later, after the “Second World War” the term microglia 
was accepted and confirmed in “Neuroglia Morphology and Function” by Paul Glees 
1955 and the book “Biology of Neuroglia” by William Frederick Windle in 1958 
(Kettenmann et al., 2011). Most of the properties and concepts of microglia 
postulated by Pio del Rio-Hortega in the beginning of the 20th century are still 
agreed by scientists nowadays (Kettenmann et al., 2011). For example, microglia 
originate from the mesoderm and display amoeboid morphology during 
development. Under resting conditions, microglia present a typical ramified 
morphology. Under pathological conditions, microglia transform into an amoeboid 
morphology and display phagocytosis and antigen presenting abilities.
1.2.2 Origin of microglia
During embryonic development, most macroglia cells are derived from ectoderm. 
The origin of microglia had been a debate for a long time until the most accepted 
consensus that microglia, during development, are derived from hematopoietic stem 
cells (HSCs) in the bone marrow (Vitry et al., 2003; Eglitis & Mezey, 1997) which is 
of mesodermal origin (Hatai, 1902; Chan et al., 2007; Kaur et al., 2001; Boya et al., 
1979). HSCs are located in the bone marrow and are the source of all types of blood 
cells. During proliferation, HSCs are able to self-renew and derive into two kinds of 
progenitor cells: common myeloid progenitor cells and common lymphoid 
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progenitor cells. The common lymphoid progenitor cells further differentiate into 
lymphocytes including natural killer (NK) cells, B lymphocytes and T lymphocytes 
(Zech, 2004) while the common myeloid progenitor cells differentiate into basophils, 
neutrophils, eosinophils, monocytes/macrophages, platelets, red blood cells and mast 
cells (Figure 1-1) (Zech, 2004). Here, the basophils, neutrophils and eosinophils are 
granulocytes while B cells, T cells and monocytes/macrophages are agranulocytes.
1.2.2.1 Relationship between microglia and macrophages
Microglia are one of the special members of leukocytes which are permanently 
resident in the CNS. Besides microglia (CNS), other location specific members 
include langerhans cells (epidermis), osteoclasts (bone) and kuppfer cells (liver). All 
of these cell types arise from monocyte/macrophage migration. The view that 
microglia originated from bone marrow derived cells was first published in 1988 
(Hickey  & Kimura, 1988; Eglitis & Mezey, 1997; Priller et al., 2001; Block et al., 
2007; Ritter et al., 2006). Several pieces of evidence show that microglia have a 
close relationship to macrophages. Both microglia and macrophages share a number 
of markers, for example cluster of differentiation molecule (CD)11b (Tanaka et al., 
2003), CD14, EGF-like module-containing mucin-like hormone receptor-like 1 
(EMR1) and colony stimulating factor 1 receptor (CSF1R) (Beers et al., 2006; Saijo 
& Glass, 2011; Kettenmann et al., 2011). They also express similar ion channels like 
K+, sodium (Na+), proton (H+), Ca2+ and chloride (Cl-) channels on the plasma 
membrane (Färber & Kettenmann, 2005; Eder, 2005). In addition, the differentiation 
factor of lymphoid and myeloid cells, PU.1, is required for the generation of 
microglia (Beers et al., 2006) and bone marrow transplants into PU.1-/- mice results 
in the recovery of microglial expression (Beers et al., 2006). By using genome-wide 
microarray  analysis on different  primary hematopoietic cell lineages and microglia 
from wild type mice, microglia were discovered to have a close relationship  with 
bone marrow derived and thioglycollate elicited macrophages (Figure 1-2) (Saijo & 

















Figure 1-1. Origin of microglia during haematopoiesis. The diagram 
displays the differentiation of blood cell from hematopoietic stem cells. During 
development, monocytes/macrophages migrate into the CNS and 
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Cerebral cortex-derived cells
Figure 1-2. Relationship between microglia and other cells.  Genome-
wide microarray analysis of primary cells isolated from C57BL/6 mice 
revealed that microglia displayed a close gene expression pattern to bone 
marrow macrophages. Figure is adapted from (Saijo & Glass, 2011). The 
microarray data cluster analysis were from BioGPS data set of the Genomics 
Institute of the Novartis Research Foundation.
immune system while microglia belong to both the innate and adaptive immune 
systems.
1.2.2.2 Origin of fetal and adult microglia is controversial
The origins of microglia in the CNS remains controversial. The previous observation 
indicated that the peripheral macrophages and microglia were observed at embryonic 
day (E)9.5 in the fetal yolk sac of mouse (Ginhoux et al., 2010; Saijo & Glass, 2011). 
The macrophage progenitors begin to migrate into the CNS between E8.5 to E9.5 
through the embryo vascular system, and microglial migration into the CNS was 
observed at E10.5 (Saijo & Glass, 2011; Ginhoux et al., 2010). However, during the 
postnatal period microglial homeostasis was not significantly  regulated by peripheral 
hematopoietic derived cells (Ginhoux et al., 2010). During development, in the 
healthy mature brain, hematopoietic cells from bone marrow are able to cross the 
BBB and then these cells contribute to the microglial and other glial transformations 
(Eglitis & Mezey, 1997; Priller et al., 2001; Hickey & Kimura, 1988). Under 
pathological conditions of mature brain, like ischemia and Alzheimer’s Disease 
(AD), bone marrow derived microglia/macrophages were observed migrating into 
the CNS, and this process was facilitated by brain irradiation (Tanaka et al., 2003; 
Mildner et al., 2011). In addition, under ischemic conditions, myeloid progenitors 
transform into microglia by migrating into the retina through the blood system (Ritter 
et al., 2006). However, recent reports based on parabiosis experiments indicated that 
in adult brain during neurodegenerative diseases, the population of microglia are 
mainly increased by self-renewal (Ransohoff, 2007; Ajami et al., 2007; Mildner et 
al., 2007).
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1.2.3 Types of microglia
Microglia are categorized into seven types: amoeboid microglia, ramified microglia, 
activated non-phagocytic microglia, activated phagocytic microglia, gitter cells, 
perivascular and juxtavascular. These types are classified due to either microglial 
morphology, microglial location or microglial activation status (Figure 1-3).
1.2.3.1 Amoeboid microglia
Amoeboid microglia are considered precursors of mature microglia (Penfield, 1965; 
Imamoto & Leblond, 1978; Tseng et al., 1983). They exist during the development of 
the CNS which was first described by  Del Rio-Hortega (Penfield, 1965). They  can be 
selectively stained by  the silver carbonate method compared to other types of 
neuroglia. Amoeboid microglia present a large soma which is either a round or 
flattened shape with short processes. In rats, amoeboid microglia can be found in the 
forebrain from E11 (Ashwell, 1991). From E13 to E17 amoeboid microglia 
concentrate at the site of the diencephalic vesicle and the telencephalic vesicle. From 
E15 amoeboid microglia locate at the site of the future hippocampus until the 
development of the corpus callosum which happens after E19 (Ashwell, 1991). This 
kind of microglia display the mobility and phagocytosis, but they do not have antigen 
presenting and other inflammatory  abilities which are properties of activated 
microglia (Gehrmann et al., 1995; Christensen et al., 2006; Ferrer et al., 1990).
1.2.3.2 Ramified microglia
Ramified microglia, also called “resting microglia”, are microglia in the quiescent 
state. They  mainly localize throughout the healthy CNS in the absence of infection or 
cellular death (Christensen et al., 2006; Aloisi, 2001). Microglia constitute about 










Figure 1-3. The morphology of different types of microglia. The figure 
illustrates microglia cell of types: amoeboid microglia, ramified, activated 
microglia (phagocytic and non-phagocytic microglia). Amoeboid microglia 
display mobility, phagocytosis but no antigen presenting and other 
inflammatory abilities. Ramified microglia display  several primary  processes 
without having phagocytosis, antigen presenting or inflammatory abilities. 
Activated microglia have the ability of antigen presenting, pro-inflammatory 
cytokines release.They first transform into a non-phagocytic type after which 
they transform into phagocytic microglia with intracellular phagosomes. 
Figure was adapted from (Kreutzberg, 1996). In addition, microglia have 
three more special types. Gitter cells: microglia reached limit amount of 
phagocytosis. Perivascular: microglia specifically inside the basement 
membrane under the endothelium. Juxtavascular: microglia connecting to the 
basement membrane on the endothelium.
microglia is 3.5×106 (Lawson et al., 1990) and the density varies over five fold 
depending on brain region (Lawson et al., 1990). Microglia mainly concentrate in the 
hippocampal region, the substantia nigra, the basal ganglia and the olfactory 
telencephalon of both rodent (Lawson et al., 1990) and adult human (Block et al., 
2007). In contrast, the cerebellum, fibre tracts and brainstem have low density  of 
microglia (Lawson et al., 1990).
Resting microglial morphology has been investigated in vitro using isolated primary 
rat microglia and N9 murine microglial cell line (Xiang et al., 2006). Microglia in in 
vitro culture display a small and round soma whose diameter is about 20~50µm with 
zero to five primary processes and these processes can further branch up  to 6 times 
(Xiang et al., 2006). Microglia begin to form their processes 30min after plating 
(Xiang et al., 2006) and their length reaches a plateau after 24~48hr (Xiang et al., 
2006) and can reach to 150µm in length and 0.2~1.5µm in diameter. Between 
16~24hr, N9 microglia form a network of processes (Xiang et al., 2006). There is no 
difference in length of processes between N9 microglia and cultured rat microglia 
under the same culture period. Using dye coupling assays (Lucifer Yellow injection) 
there appeared to be no direct communication between microglia through their 
processes (Xiang et al., 2006). 
Ramified microglia do not display either phagocytosis, inflammation or antigen 
presenting abilities (Gehrmann et al., 1995), but  that actually does not mean they are 
dormant in the brain. Although their cell bodies are not motive their long branching 
processes are randomly and constantly scanning the microenvironment for any 
physiological changes (Hanisch & Kettenmann, 2007). The normal role of ramified 
microglia is to detect  and prepare rapid responses to external invading infection or 
neuronal cell death (Hanisch & Kettenmann, 2007). Microglia achieve this 
sensitivity through a variety of ions channels, neurotransmitter receptors, chemokine 
receptors, pattern recognition receptors (PRRs) and purinoreceptors (Kettenmann et 
al., 2011; Hanisch & Kettenmann, 2007).
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1.2.3.3 Activated microglia
One pivotal property of microglia is that they  are highly  plastic and possess many 
structural changes associated with the status of their activation (Xiang et al., 2006). 
Under pathological conditions, resting microglia can be rapidly activated and 
undergo morphological change (Aloisi, 2001). Compared to resting microglia 
activated microglia display a higher proliferation rate (Streit et al., 1999), more 
mobility, inflammatory and antigen presenting abilities. Activated microglia release 
reactive nitrogen species (RNS), reactive oxygen species (ROS), pro-inflammatory 
cytokines like TNFα, transforming growth factor beta (TGFβ), IL-1, IL-6 and 
chemokines like monocyte chemotactic protein-1 (MCP-1). They also present 
cytokine receptors and major histocompatibility  complex (MHC) proteins on the 
membrane.
Microglial activation involves two steps. They  first  become non-phagocytic 
microglia which represent a transitive status before become fully activated into 
phagocytic microglia (Figure 1-3) (Gehrmann et al., 1995; Kreutzberg, 1996) which 
can be induced by conditions like cell death or neuronal terminal degeneration. The 
morphology  between activated microglia and amoeboid microglia are similar except 
that fully activated phagocytic microglia display a larger round cell-body with 
phagosomes (Kreutzberg, 1996; Streit & Kreutzberg, 1988; Rieske et al., 1989). The 
functional difference between non-phagocytic microglia and phagocytic microglia is 
indicated by  their names. Phagocytic microglia are able to phagocytose external 
microbes while non-phagocytic microglia do not. There is also cooperation between 
activated microglia and other neuroglia, for example astrocytes cooperate with 
microglia in defending against external infection in the CNS (Gehrmann et al., 1995; 
Aloisi, 2001).
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1.2.3.4 Gitter cells, perivascular microglia and juxtavascular microglia
Besides the categorization by the activation status, there are three specific types of 
microglia which were categorized depending on their location or whether reaching 
the limit of phagocytosis. Gitter cells are a type of phagocytic microglia that have 
reached their limit amount of phagocytosis. Perivascular microglia are microglia 
specifically located inside the basement membrane under the endothelium, which 
facilitate the maintenance of the BBB. Juxtavascular microglia are microglia 
connecting to the basement membrane under the endothelium. Both perivascular and 
juxtavascular microglia express MHCII proteins which are required for antigen 
presentation. Different from all other types of microglia, perivascular microglia are 
regularly replaced by myeloid precursor cells (Gehrmann et al., 1995).
1.2.3.5 Microglial cell lines used in in vitro studies
Studies on microglia in vitro use either isolated primary cells or immortalised cell 
lines. These two methods have their pros and cons. It is often considered that isolated 
primary microglia may represent more similar properties to microglia in vivo 
compared to cell line. However, microglial cell lines can avoid the difficulties of 
purifying primary microglia and offer large amount of cells. They also offer 100% 
purity  of cells which is important for molecular approaches, like PCR. Among 
several microglial cell lines, BV-2 and N9 are the two most well characterized and 
commonly used murine microglial cell lines in the last dozen of years.
The N9 microglial cell line was derived from the brain of outbred ICR/CD1 mice 
(E13), using the v-myc oncogene of 3RV retrovirus (Righi et al., 1989). The BV-2 
microglial cell line was derived from newborn inbred C57BL/6 mice, using the J2 
retrovirus containing the v-raf and v-myc oncogenes (Blasi et al., 1990).
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N9 microglial cells express similar membrane clusters to primary microglia such as 
Mac-1, Mac-2, vimentin, EMR1, Fc receptor (FcR) (Corradin et al., 1993) and have 
been commonly applied in the investigation of microglial activation and microglial 
neurotoxicity (Zhang et al., 2010). Similar to primary microglia, N9 cells respond to 
stimuli like IFN-γ, LPS or TNFα with nitric oxide (NO) release, chemokine release, 
activation of the nuclear factor kappa-light-chain-enhancer of activated B cells 
(NFκB) pathway, activation of the intracellular mitogen-activated protein kinases 
(MAPKs) family  (Liu et al., 2010; Zhao et al., 2011; Chang et al., 2008; Meng et al., 
2008; Wu et al., 2007; Hou et al., 2006; Bi et al., 2005; Suuronen et al., 2006; 
Nuutinen et al., 2005; Suuronen et al., 2003; Meda et al., 1995; Bonaiuto et al., 
1997). In addition, N9 microglial phagocytosis is similar to primary microglia, 
including the phagocytosis of latex beads (Bruce-Keller et al., 2001), E. coli 
bioparticles (Stefano et al., 2009). BV-2 microglia show similar morphology and 
function to primary microglia such as the response to IFN-γ. This cell line also 
represents similar gene upregulation to primary microglia in response to LPS 
stimulation although normally the upregulation is less pronounced to primary 
microglia (Lund et al., 2006). In addition, BV-2 cells were used in the in vitro 
electrophysiological investigations while little electrophysiological work was done 
using N9 cells. However, a recent investigation compared both primary microglia 
and immortalised cell lines from outbred ICR/CD1 mice (N9 cell line) and inbred 
C57Bl/6 mice (BV-2 cell line) in response to LPS stimulation. Under the same LPS 
stimulation, N9 or microglia from ICR/CD1 mice had a stronger response, including 
iNOS, than BV-2 and microglia from C57Bl/6 mice. This process was not due to 
expression change of toll-like receptor (TLR) 4/CD14 or proliferation change of cells 
but may be due to inbreeding depression (Nikodemova & Watters, 2011).
The use of immortalised cell lines provide a convenient way for studies in vitro. 
However, it is hard to conclude which cell line better than the other one as no 
evidence that either of them 100% represents the properties of microglia in vivo. 
Both of these cell lines were commonly used in the investigation of microglial NO 
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release, as little is known about the electrophysiological properties of N9 cell line 
while it is a well established model for investigations on LPS-induced NO release. 
N9 murine microglial cell line will be used in this thesis.
1.2.4 PAMPs and DAMPs
Microglia can be activated by multiple signals from either external infection or cell 
damage because microglia express PRRs on their membrane which recognize 
pathogen-associated molecular patterns (PAMPs) (Aloisi, 2001) and damage 
associated molecular patterns (DAMPs) (Gehrmann et al., 1991; Morioka et al., 
1992). PAMPs are small molecules associated with pathogens (Medzhitov & 
Janeway, 2000) such as LPS. DAMPs are intracellular components released by 
damaged cells such as ATP (Ciccarelli et al., 2001).
DAMPs- or PAMPs-induced activation can lead to different microglial responses. 
ATP is able to activate microglia (Xiang et al., 2006; Inoue, 2002) through binding to 
purinoceptors (Bianco et al., 2005; Xiang & Burnstock, 2005) like P2Y (Honda et al., 
2001; Davalos et al., 2005) or P2X (Monif et al., 2009) receptors. Microglia activated 
by ATP increased the intracellular concentration of Ca2+ (McLarnon et al., 1999) and 
became amoeboid with retracted processes which become bulbs near the roots of the 
processes (Inoue, 2002). Longer treatment made the soma smaller, the processes 
shorter and bulbs larger until all the microglia finally  floated in the supernatant. 
However the floating microglia were proven still alive since it was a reversible 
process after the ATP was removed (Xiang et al., 2006). On the other hand, microglia 
activated by LPS underwent morphological change as well but did not float (Meng et 
al., 2008; Wu et al., 2007; Hou et al., 2006; Bi et al., 2005; Cavaliere et al., 2005; 
Nuutinen et al., 2005; Suuronen et al., 2003; Chang et al., 2008; Bianco et al., 2005; 
McKimmie & Fazakerley, 2005).
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Microglial receptors for PAMPs play a pivotal role in immune defence in the CNS. 
They  are proteins on the membrane belonging to the innate immune system and their 
expression is increased in the activated microglia (Aloisi, 2001). The PRRs elevated 
in microglia for PAMPs include TLR2, TLR4, TLR9, CD14, the mannose receptor, 
FcR and complement receptors. TLR2 recognizes peptidoglycans and lipoteichoic 
acids of the gram-positive bacteria (Schwandner et al., 1999; Yoshimura et al., 1999; 
Block et al., 2007). TLR4 and CD14 is specific for recognizing LPS (Horvath et al., 
2008; Poltorak et al., 1998; Qureshi et al., 1999; Wright et al., 1990; Haziot et al., 
1996), and they are implicated in microglial activation in response to endotoxemia. 
TLR9 recognizes bacterial DNA (Hemmi et al., 2000). Mannose receptor recognies 
pathogen-specific oligosaccharides (Linehan et al., 2000). FcR (Aloisi, 2001) and 
complement receptors (Aloisi, 2001; Ehlers, 2000) recognise pathogens mediated by 
immunoglobulins or complement.
LPS, an endotoxin of gram-negative bacteria such as Escherichia coli (E. coli), is the 
prototypical member of PAMPs (Henderson et al., 1996). It has been regularly used 
as a microglial activator in vivo and in vitro (Horvath et al., 2008; Kaushal & 
Schlichter, 2008; Suuronen et al., 2006; Suuronen et al., 2005; Jianmin Zhang et al., 
2003; Khanna et al., 2001; Fischer et al., 1995; Nörenberg et al., 1994; Corradin et 
al., 1993). LPS exists on the outer membrane of bacteria (Rietschel et al., 1994) and 
there is several nanograms of LPS in every  million gram-negative bacteria (Troelstra 
et al., 1999). LPS consists of O polysaccharide, core oligosaccharide, and lipid A 
(Figure 1-4) (Rietschel et al., 1994). The lipid A plays a key role in activating 
microglia, but  it is not exposed on E. coli (Sivagnanam et al., 2010; Rietschel et al., 
1994) unless the bacterium is phagocytosed or lysed. Once LPS is fully  exposed, it 
can stimulate microglial phagocytosis (Rietschel et al., 1994) and stimulate release 
of pro-inflammatory cytokines, RNS, ROS or protease (Colton et al., 1993). In 
addition, LPS also modulates the expression of ion channels including K+ channels 
(Stock et al., 2006). LPS is not directly toxic to neurons only when microglia are 












Figure 1-4. The structure of LPS. Lipopolysaccharide (LPS) is constituted 
of lipid A, core oligosaccharide (inner core/outer core) and O antigen (O 
polysaccharide). O antigen is the target of antibodies and it varies among 
different strains. LPS with full length O chains is smooth LPS, with reduction 
of O chains or no O chains is rough LPS. Bacteria with rough LPS display 
less tolerance to hydrophobic antibiotics (Tsujimoto et al., 1999). The core 
oligosaccharide contains sugars, keto-deoxyoctulosonate (KDO) or other 
components like phosphate. Core oligosaccharide directly connects to the 
lipid A. Lipid A is toxic to the host cells.
Dragunow, 2006). Over-activated microglia rarely  return to the ramified state unless 
they  are treated with de-activating molecules (Block et al., 2007), for example TGFβ, 
astrocytes conditioned medium (ACM), IL-10, IL-4 and IL-13. 
To activate microglia, LPS binds to the TLR4 receptor (Poltorak et al., 1998; Qureshi 
et al., 1999) in association with CD14 (Wright et al., 1990; Haziot et al., 1996), 
lymphocyte antigen 96 (MD2) protein (Shimazu et al., 1999) and LPS-binding 
protein (LBP) (Tobias et al., 1989; Schumann et al., 1990). The TLR4 signal is 
mediated by either myeloid differentiation primary response gene 88 (MyD88) or 
TIR domain-containing adaptor (TRIF) dependent pathways. The adaptors that  link 
MyD88 or TRIF to TLR4 receptor are TIR domain-containing adaptor protein 
(TIRAP) and TRIF-related adaptor molecule (TRAM) separately. Both the MyD88-
dependent and TRIF-dependent pathway stimulate the activation of NFκB and 
activator protein 1 (AP-1) through the activation of MAPKs and IκB kinases (IKKs) 
(Oh et al., 2010; Lu et al., 2008). Specifically the MyD88-dependent pathway 
regulates the activation of IκB and interferon regulatory factor (IRF)5 which regulate 
the expression of IL-6, TNFα, IL-12 (Yamamoto et al., 2004) while the TRIF-
dependent pathway  regulates the activity  of IRF3 (Lu et al., 2008). Besides the 
activation of MAPKs and several transcription factors, the LPS-stimulated pathway 
also involves the activation of protein kinase C (PKC), protein kinase A (PKA), Ca2+/
calmodulin-dependent protein kinase II (CaMKII) (Regenhard et al., 2001) and 
calcineurin (Figure 1-5) (Suzuki et al., 2007).
1.2.5 The release profile of microglia
Microglia regulate the CNS environment by releasing pro-inflammatory cytokines 
(Prinz & Hanisch, 1999; Suzumura et al., 1998; Chen & Goeddel, 2002; Conti et al., 
1999; S. C. Lee et al., 1993; Becher et al., 1996), anti-inflammatory molecules 
(Kitamura et al., 2000; Constam et al., 1992; Hanisch et al., 1997), chemokines 
(Aloisi, 2001; Hanisch, 2002), Fas ligand (FasL) (Spanaus et al., 1998; White et al., 
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Figure 1-5. Schematic of LPS-activated TRL4/CD14 pathway.  LPS 
activates microglia by binding to the TLR4/CD14 receptor under facilitation of 
LBP and MD2. The downstream mainly distributes into MyD88-dependent 
and MyD88-independent (TRIF-dependent) pathways. These pathways 
regulate transcription factors activity through a complex mechanism involving 
the activity of MAPKs. Several other pathways are implicated as well such as 
CaMKII, calcineurin, PKC and PKA. Figure is adapted from (Lu et al., 2008). 
LBP: LPS-binding protein; TLR4: Toll-like receptor 4; CD14: Cluster of 
differentiation molecule 14; MD2: lymphocyte antigen 96; TIRAP: TIR 
domain-containing adaptor protein; TRAM: TRIF-related adaptor molecule; 
MyD88: Myeloid differentiation primary response gene 88; TRIF: TIR domain-
containing adaptor; ERK: extracellular-signal-regulated kinase; JNK: c-Jun N-
terminal kinases; PKC: Protein kinase C; PKA: Protein kinase A; MAPK: 
Mitogen-activated protein kinase; IKKs: IκB kinases; NFκB: nuclear factor 
kappa-light-chain-enhancer of activated B cells; IRF: interferon regulatory 
factor; AP-1: activator protein 1.
Transcription factor
NFκB, AP-1, etc.






1998; Terrazzino et al., 2002; Dowling et al., 1996; Bechmann et al., 1999; Frigerio 
et al., 2000; Taylor et al., 2005), glutamate, prostanoids (Minghetti & Levi, 1995; 
Giulian et al., 1996; Hoozemans et al., 2002; Mohri et al., 2006; Jian Zhang et al., 
2006; Kim et al., 2008), cathepsins, matrix metalloproteinase (MMP) (Petanceska et 
al., 1996; Liuzzo et al., 1999; Kingham & Pocock, 2001; Gan et al., 2004; Kim et 
al., 2007; Sakamoto et al., 2008; Cross & Woodroofe, 1999; Kauppinen & Swanson, 
2005; Liuzzi et al., 2007; Milner et al., 2007; Crocker et al., 2008), ROS and RNS. 
Some of these molecules allow microglia to kill and phagocytose external microbes 
to clear the infection and resultant inflammation. However, they are also toxic to 
neurons which paradoxically make microglia a “Double-edged sword”. The 
following paragraphs introduce RNS and ROS, two important molecular groups 
participating in microglia-induced defence and neurotoxicity.
1.2.5.1 NO and NOS
NO release has been routinely  used as a marker of microglial activation. NO reacts 
with ROS forming the peroxynitrites which kill the phagocytosed microbes. 
Although controversial, NO was observed to recover the tight junction between 
endothelial cells after exposure to cytokines like TNFa, IL-1β (Wong et al., 2004). 
However, over-accumulated NO can disturb normal DNA formation by  activating the 
DNA damage p53 pathway, inhibit the respiratory mechanism by  influencing 
mitochondrial function which leads to apoptosis and facilitate bacteria to cross the 
BBB by weakening the junction of endothelial cells (Buster et al., 1995; Thiel & 
Audus, 2001). High levels of NO can also inhibit indoleamine 2,3-dioxygenase 
(IDO) which is a modulator of the proliferation of both tumor and immune cells 
(Wang et al., 2010). It was reported that in p53-deficient microglia, NO release also 
activates the endoplasmic reticulum (ER) stress response which is normally activated 
during cellular stress to protect the cell (Kawahara et al., 2001).
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NO is catalyzed from L-arginine by NO synthase (NOS) (Moncada et al., 1989). 
NOS is a group of enzymes with three isoforms, neuronal NOS (nNOS), inducible 
NOS (iNOS) and endothelial NOS (eNOS). iNOS is specifically implicated in the 
immune response and is primarily expressed by astrocytes and microglia (Wen et al., 
2011). iNOS can be induced by LPS which is mediated by the MAPKs signaling 
pathways. During hypoxia, iNOS/NO release is regulated by the PI3-kinase/Akt/
mTOR pathway, activation of hypoxia inducible factor 1alfa (HIF-1α) (Lu et al., 
2006), N-methyl D-aspartate receptor (NMDAR) and NFκB (Murugan et al., 2011). 
iNOS has been implicated in the pathogenesis of Parkinson Disease (Broom et al., 
2011).
1.2.5.2 Reactive oxygen species
ROS is another important molecule released by activated microglia and their highly 
reactive property  is due to the unpaired valence electrons (Devasagayam et al., 
2004). During the redox reaction ROS are in the intermediate state and can either be 
oxidant or reducing agents depending on what the other reactant is. Examples 
include singlet oxygen, hydrogen peroxide, hydroxyl radical, superoxide anion, 
peroxides and hypochlorous acid. They  help  to clear invading microbes but also 
threaten the survival of host  cells (Rada & Leto, 2008; Conner et al., 2002). During 
biological metabolism, ROS are produced by two main mechanisms: (1) They  are by 
products during cellular respiration (Benzie, 2003). (2) They  are produced by 
specific enzymes, such as nicotinamide adenine dinucleotide phosphate (NADP+) 
oxidase. In all phagocytic cells including activated microglia, NADPH oxidase 
regulates ROS production (El-Benna et al., 2008), except for neutrophils which have 
additional myeloperoxidase to produce ROS. In addition, exogenous mechanism, 
such as ionizing radiation, can produce ROS as well.
The core reaction sites of the NADPH oxidase complex include p22phox and 
gp91phox/NOX2. These two proteins are the only parts anchored on the cell 
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membrane. The complex of p22phox and gp91phox is called cytochrome b558 as 
their characteristic absorption is at 558nm. NAPDH also includes three cytosolic 
proteins p48phox, p67phox, p40phox and one small GTPase (either Rac1 or Rac2). 
Rac1 is expressed in monocytes while Rac2 is mainly expressed in neutrophils. 
These cytosolic components bind to the b558 during cell activation (El-Benna et al., 
2008). NADPH oxidase is an electron pump. During activation gp91phox binds to 
the electron acceptor flavin adenine dinucleotide (FAD), NADPH and two hemes 
(El-Benna et al., 2008). Electrons are removed from NADPH by the catalytic process 
and forwarded to the oxygen forming molecules of superoxide anion (O2-) which are 
the precursor of other ROS. The process of NADPH oxidase activation includes: (1) 
The phosphorylation of p47phox. (2) GTPase activation. (3) The binding of the 
cytosolic components with the cytochrome b558 after phosphorylation (Quinn & 
Gauss, 2004; Groemping & Rittinger, 2005; El-Benna et al., 2008).
NADPH has three states of activity: resting status, priming status and activated status 
which depends on the status of microglia. Under normal circumstances, host cells 
including microglia have tolerance to ROS with the help  of enzymes and 
antioxidants, for example superoxide dismutase (SOD) and vitamin C (Rada & Leto, 
2008; Conner et al., 2002). SOD exists in almost all types of cells. There are three 
types of SOD including SOD1 (cytoplasmic), SOD2 (mitochondrial) and SOD3 
(extracellular). The superoxide is catalyzed into hydrogen peroxide and oxygen by 
SOD. Hydrogen peroxide can be further catalyzed into water by catalase, glutathione 
peroxidase and peroxiredoxins. In over-activated microglia, hyperactivated NADPH 
oxidase damages host cells because large amounts of toxic ROS are produced (El-
Benna et al., 2008).
1.2.6 Microglia and disease
Due to the variety  of potential cytotoxic molecules released by microglia, microglia 
play  an important role in neurodegenerative diseases in the CNS like AD (Mrak & 
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Griffin, 2005), Parkinson’s disease (PD) and multiple sclerosis (MS) (Dheen et al., 
2007). For example, one hallmark of AD is the accumulation of amyloid beta (Aβ) 
which activates microglia (Schilling & Eder, 2011). Activated microglia during AD 
release abundant cytokines including IL-1 which further induce more neural injury 
(Mrak & Griffin, 2005). In addition, microglia activated by LPS caused the loss of 
dopamine (DA) neurons which is the hallmark of PD (Block et al., 2007). Microglia 
also have a role following viral, bacterial and parasitic infections (Rock et al., 2004). 
For example, during the streptococcus infection-induced meningitis, microglia are 
activated by streptococcus through the activation of TLR2 receptor. The activated 
microglia response to the infection by releasing pro-inflammatory  cytokines and NO 
which is toxic to neurons and may induce intracerebral edema (Rock et al., 2004).
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1.3 Ion channels and microglia
Ion channels are protein pores which allow ions to pass down their electrochemical 
gradient. Microglia express a variety of ion channels including sodium (Na+) 
channels, Ca2+ channels, K+ channels, chloride (Cl-) channels and proton (H+) 
channels (Färber & Kettenmann, 2005; Eder, 2005; Kettenmann et al., 2011). 
Channels play a pivotal role in regulating microglial properties including membrane 
potential, intracellular homeostasis, RNS and ROS release, cytokine release, cellular 
migration and proliferation. The activities of microglial K+ channels are tightly 
related to the maintenance of ionic homeostasis for many cellular processes 
including regulating membrane currents, microglial resting membrane potential, 
intracellular ion homeostasis, cell migration, change in morphology, proliferation and 
pro-inflammatory cytokine release. Investigation of the function of K+ channels in 
microglia may reveal a potential therapeutic approach to treat microglial-related CNS 
diseases.
1.3.1 Introduction to K+ channels
K+ channels are one of the largest families of ion channels with more than 80 genes 
in the human genome. K+ channels can be found in most types of cells. In excitable 
cells, such as neurons, and cardiac muscle, they contribute to the falling phase of the 
action potential. In pathological conditions, K+ channels are implicated in 
neurological disorders, the control of cardio vascular tone, blood pressure and 
hormone release, etc. For non-excitable cells, K+ channels control the resting 
membrane potential. For example, the transfection of Kv1.3 channels reset the 
membrane potential of Chinese hamster ovary cells (Defarias et al., 1995).
K+ channels are categorized into four main types: Ca2+-activated K+ channel (KCa), 
inwardly  rectifying K+ channel (Kir), tandem pore domain K+ channel (K2p) and 
voltage-gated K+ channel (Kv) (Figure 1-6).
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Figure 1-6. The family of K+ channels. Potassium (K+) channel family is 
composed of four groups: voltage-gated K+ channel (Kv), inwardly rectifying K
+ channel (Kir), tandem pore domain K+ channel (K2p), Ca2+-activated K+ 
channel (KCa). (1) The Kv channels have six transmembrane domains and 
one pore-forming loop. They are sensitive to voltage across the membrane. 
(2) The Kir channels have two transmembrane domains and one pore-
forming loop. (3) The K2p channels have four transmembrane domains and 
two pore-forming loops. They are constitutively opened channels which allow 
K+ ions to diffuse into the extracellular compartment and facilitate keeping the 
negative intracellular potential. (4) KCa channels have six transmembrane 
domains, one pore-forming loop and are regulated by intracellular cations. 
The only exception is large conductance Ca2+-activated K+ channels (KCa1.1) 
channels which have seven transmembrane domains and are sensitive to 
both intracellular Ca2+ and membrane depolarization.
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1.3.2 K+ channel expression and function in microglia
K+ channels participate in microglial pro-inflammatory cytokine release, ROS and 
NO/iNOS production and proliferation. For example, the application 4-
aminopyridine (4-AP) or agitoxin-2 (AgTX-2) diminished the microglial 
proliferation rate (Kotecha & Schlichter, 1999). Ramified microglia in acute rat  brain 
slices expressed very little K+ current compared to isolated microglia (Boucsein et 
al., 2000) which is suggested as the hall mark for resting microglia. However, 
microglia in vitro displayed large inward K+ current. The evidence indicated that 
isolated rat primary microglia lacked significant outward current but expressed an 
inwardly  rectifying K+ current as determined by  blockade using barium (Ba2+) and 
tetraethylammonium (TEA) (Kettenmann et al., 1990). In addition, both resting and 
LPS-treated microglia in vitro expressed an inwardly  rectifying current while only 
LPS-activated microglia evoked a large outwardly rectifying current. After activation 
under pathological conditions, microglia in acute brain slices displayed inwardly 
rectifying K+ current followed by an outwardly  rectifying K+ current after 24hr 
(Boucsein et al., 2000). These currents reversal potential was close to K+ reversal 
potential calculated by the Nernst Equation suggesting that they were K+ currents 
(Nörenberg et al., 1992; Nörenberg et al., 1994). Thus the outward K+ currents may 
be a hallmark of activated microglia. It was further pointed out that the amplitude of 
the microglial inward rectifier currents increased after treatment by LPS (100ng/ml, 
24hr) (Nörenberg et al., 1992). 
The magnitude of resting membrane potential of microglia is still controversial 
because it may differ from microglia in brain slices or isolated primary microglia in 
vitro culture, resting or activated microglia, developing or mature microglia. This 
may relate to the expression of outward and inward K+ currents (Chung et al., 1999).
In rat: (1) Microglia in brain slices: Microglia in the rat brain slices have their 
membrane potential mainly  distributed at about -10~-20mV using the conventional 
whole-cell patch-clamp with physiological K+ gradient (Boucsein et al., 2000). This 
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type of microglia displayed little K+ current either inward or outward type (Boucsein 
et al., 2000) while mouse microglia in brain slices also had similar low K+ current 
properties (Boucsein et al., 2003). (2) Isolated microglia in vitro: Resting microglia 
displayed a potential at -26.2±4.4mV (Chung et al., 1998) while after LPS activation, 
microglial membrane potential hyperpolarized to -48.2±6.1mV (Chung et al., 1998). 
What is more, microglial membrane potential displayed a bimodal distribution 
phenomenon. Resting isolated rat microglia displayed two different membrane 
potentials at about -33mV and -73mV (Visentin et al., 1995). After LPS activation, 
these values were reported as −45mV and -70mV (Chung et al., 1999) or -35mV and 
-70mV (Nörenberg et al., 1994). In addition, whole-cell current clamp (I=0) on a 
single LPS-activated microglia indicated that the resting membrane potential 
unusually  switched between -35mV and -70mV during the recording which 
happened within 2~3mins (Nörenberg et al., 1994).
In mouse: (1) Microglia in brain slices: Microglia have been reported to have a range 
of membrane potential. One report indicated their membrane potentials were at 
-23mV and -52mV (Boucsein et al., 2003). However, such bimodal distribution was 
not observed by another report with the mean value at -38±2.2mV (Schilling & Eder, 
2007). The membrane potential changed along with the culture duration of brain 
slices. Microglial membrane potential in acute brain slices was at -38±2.2mV while 
in cultured brain slices hyperpolarized to -41.8±2.9 mV (Schilling & Eder, 2007). 
Here microglia in briefly  cultured brain slices may become activated (Schilling & 
Eder, 2007). Such hyperpolarization was similar to the one observed in isolated rat 
microglia (Chung et al., 1998). (2) Isolated microglia in vitro: Isolated microglia 
displayed two more hyperpolarized membrane potentials which were at -29mV and 
-61mV (Boucsein et al., 2003) compared to -23mV and -52mV of microglia in brain 
slices. What is more, isolated microglia displayed extra inward current which does 
not exist in the resting microglia in brain slices (Boucsein et al., 2003; Kettenmann et 
al., 1990). (3) Microglia in brain slices of different age animals: Microglia from 6~8 
weeks old mice display -23mV and -52mV of membrane potential (Boucsein et al., 
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2003) while microglia from postnatal day (P)6~P9 have membrane potentials at 
-10mV and -70mV (Brockhaus et al., 1993).
Thus, in rat compared to in mice: (1) Microglia in brain slices: Due to limited 
evidence, microglia displaying single membrane potential was compared. The 
membrane potential of rat microglia was -15mV (Boucsein et al., 2000) while the 
one of mice microglia was more hyperpolarized -38±2.2mV (Schilling & Eder, 
2007). However, there is not enough data to conclude whether this is a common 
difference between rat and mice microglia. (2) Isolated microglia: Rat microglia have 
membrane potentials at  -33mV and -73mV (Visentin et al., 1995) while it was 
-29mV and -61mV of mice microglia (Boucsein et al., 2003).
1.3.2.1 Inward rectifier K+ channels in microglia
Inward rectifier K+ currents were first found in isolated primary rat microglia 
through the discovery of a 30pS conductance channel (Kettenmann et al., 1990) and 
this was followed by reports suggesting similar microglial currents in different 
species (Eder, 1998; McLarnon et al., 1995; Visentin et al., 2006). Inward rectifier K
+ currents have been observed in almost every microglial preparation studied, 
including primary rat microglia (Kettenmann et al., 1990; Korotzer & Cotman, 1992; 
Schlichter et al., 1996; Nörenberg et al., 1993; Nörenberg et al., 1992; Nörenberg et 
al., 1994; Sievers et al., 1994; Schmidtmayer et al., 1994; Visentin et al., 1995; 
Visentin & Levi, 1997), primary  murine microglia (Eder et al., 1995; Fischer et al., 
1995; Ilschner et al., 1996; Ilschner et al., 1995), BV-2 murine microglia cell line 
(Bocchini et al., 1992), bovine microglia (McLarnon et al., 1995) and human 
microglia (McLarnon et al., 1997). They can be elicited by hyperpolarization and 
blocked by extracellular Ba2+, Cs+, TEA or quinine in microglia (Nörenberg et al., 
1994). It  has been suggested that the inward K+ currents are a pre-marker of 
microglial activation (Kettenmann et al., 1993). For example, the inward K+ current 
is present in microglia under pathological conditions like stroke (Lyons et al., 2000). 
32
In brain slices, microglia exhibited an inward rectifier current after axotomy and 
after a short period of time this current disappeared (Boucsein et al., 2000; Schilling 
& Eder, 2007). They are also expressed in cultured microglia in vitro. However, the 
inward K+ current may not be a marker for activated microglia cultured in vitro. 
TGFβ, which can deactivate microglia, did not influence the inward rectifier K+ 
current (Schilling et al., 2000). The maintenance of microglial resting membrane 
potential is related to this type of current. As indicated previously, isolated rat 
microglia had membrane potentials mainly at either around -35mV or -70mV. Cells 
with resting membrane potential at -70mV were depolarized to -45mV by 
extracellular Ba2+ (Chung et al., 1999). The inward rectifier currents were also 
suggested to contribute to microglial [Ca2+]i modulation. Current blockade using 
external Ba2+ caused a decrease of [Ca2+]i in primary rat microglia (Franchini et al., 
2004).
It was postulated that the inward K+ currents are composed of Kir2.1 channels 
(Schilling et al., 2000) because their characteristic properties are similar to the ones 
in macrophages (Kubo et al., 1993) and monocytes (DeCoursey et al., 1996) and 
Kir2.1 mRNA was discovered in mouse microglia (Schilling et al., 2000). However, 
due to the lack of a Kir2.1 channel selective blocker there is still no direct 
pharmacological evidence supporting this assumption.
The finding of Kir2.1, several other Kir channels were found expressing in microglia 
as well. Adenosine A2a-receptor activation, using CGS 21680, enhanced mRNA 
expression of Kir1.1 and increased cyclic adenosine monophosphate (cAMP) in 
isolated rat primary microglia (Küst et al., 1999). This effect was in turn inhibited by 
adenosine A2a-receptor antagonists. However, elevation of cAMP decreased 
expression of Kir1.1 gene levels rather than increased it (Küst et al., 1999). Thus, it 
was postulated that  the A2a-receptor regulates Kir1.1 expression through the 
activation of PKC rather than cAMP pathway (Küst et al., 1999).
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Outward current generated by G protein-coupled inwardly-rectifying K+ channels 
(GIRKs) was reported in primary  mouse microglia (Ilschner et al., 1996; Ilschner et 
al., 1995). By activating metabotropic receptors, which leads to activation of G 
proteins, the K+ current was observed (Ilschner et al., 1995). The current was elicited 
by intracellular guanosine 5’-O-(3-thiotriphosphate) (GTPγS), or extracellular ATP, 
TNFα, epidermal growth factor (EGF) or complement factor C5a (Ilschner et al., 
1996; Ilschner et al., 1995). Forty percent of these current amplitudes was reduced 
by 4-AP (Ilschner et al., 1995) and blocked by pretreatment with pertussis toxin 
(PTX). Previous studies suggested GIRKs are composed of the pore-forming 
subunits from Kir3.x members which include Kcnj3 (Kir3.1), Kcnj6 (Kir3.2), Kcnj9 
(Kir3.3) and Kcnj5 (Kir3.4). For example, the GIRK family IKACh channels, which 
generate >60% of outward current in heart (Shi et al., 2004), are composed of two 
Kcnj3 (Kir3.1) subunits and two Kcnj9 (Kir3.3) subunits (Krapivinsky et al., 1995; 
Corey et al., 1998). However, it has not been clarified yet what subunits form G 
protein-gated outward K+ currents in microglia.
In addition, ATP-sensitive K+ channel (KATP) channels were also found in murine 
microglia (Ortega et al., 2012). These channels consist of pore-forming subunits 
including Kcnj8 (Kir6.1) and Kcnj11 (Kir6.2) with regulatory subunits, SUR1 and 
SUR2. Expression of both mRNA and protein of Kir6.1, Kir6.2 and SUR1 but not 
SUR2 were detected in BV-2 microglia and their expression was elevated by LPS
+IFN-γ treatment (Ortega et al., 2012). Protein expression of SUR1, SUR2B and 
Kir6.2 was detected in rat brain slices during stroke (Ortega et al., 2012). The 
blockade of KATP channels using glibenclamide (GBC) facilitated LPS+IFN-γ 
mediated BV-2 microglial activation, phagocytosis and TNFα release and it also 
protected neurons against stroke in the brain slices (Ortega et al., 2012). 
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1.3.2.2 The delayed outwardly rectifying K+ channels
The delayed outwardly  rectifying K+ channels (KDR) belong to Kv family. Most of 
the channels display a slow inactivation or non-inactivation property. This group of 
K+ channels include members from Kv1.x, Kv2.x, Kv3.x, Kv7.x and Kv10.x.
The KDR current is one of most studied K+ currents in microglia which was observed 
in activated microglia in 1992 (Nörenberg et al., 1992). It can be elevated by 
stimulation with the cell wall of gram-positive bacteria (Draheim et al., 1999), LPS, 
IFN-γ, hydrophobic teflon or pathological conditions like ischemia and is eliminated 
by the protein synthesis blocker, cycloheximide (Nörenberg et al., 1992). The 
elevation of KDR current differs between different  microglia activators. For example, 
gram-positive bacterial cell wall only triggered KDR in mature microglia while LPS 
elevated KDR expression in both amoeboid and postnatal microglia (Draheim et al., 
1999). However, microglia conditioned by astrocyte conditioned medium (ACM), a 
solution used for microglial de-activation (Shih et al., 2006) also express KDR 
currents (Eder, 1998). What is more, the KDR current is regulated by extracellular pH. 
In an alkaline environment the threshold of KDR currents became more 
hyperpolarized (Eder & Heinemann, 1996).
Similar to Kir currents, KDR currents also participate in setting microglial membrane 
potential. It was reported that 4-AP, a blocker of the outward K+ current, depolarized 
the resting membrane potential. For example, 2mM of 4-AP depolarized the resting 
potential of LPS-activated rat microglia from about -45mV to -25mV within 30s 
(Chung et al., 1998). In addition, study on cultured primary microglia of newborn 
(P1 to P3) rats indicated that LPS-activated microglia hyperpolarized the higher 
value of resting membrane potential from -32.2mV to -44.3mV while inward K+ 
current blocker, Ba2+, was not able to reverse this process (Chung et al., 1999). The 
membrane potential KDR also regulated microglial NO release (Pyo et al., 1997) and 
IL-1 synthesis (Sanz & Di Virgilio, 2000).
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To date, members of the KDR channels found in microglia include Kv1.1 (Wu et al., 
2009), Kv1.2 (Li et al., 2008a; Fordyce et al., 2005; Kotecha & Schlichter, 1999), 
Kv1.3 (Kotecha & Schlichter, 1999; Fordyce et al., 2005; Khanna et al., 2001; 
Pannasch et al., 2006; Küst et al., 1999; Schilling et al., 2000), Kv1.5 (Pannasch et 
al., 2006; Khanna et al., 2001) and Kv1.6 (Kotecha & Schlichter, 1999) which are 
introduced below.
Kv1.1 channels were expressed in amoeboid microglia at early  postnatal days and 
their expression was gradually reduced during maturation of the brain. Using rat 
brain slices from P1 to P10, Kv1.1 channels were found in the cytoplasm excluding 
the nucleus of amoeboid microglia using immunohistological staining approaches 
and after microglia transformation into mature ramified microglia, the expression 
progressively  decreased and became completely undetectable at P14 and P21 (Wu et 
al., 2009). However, different result  indicated that the mRNA expression of Kv1.1 
was not detected in isolated primary microglia from rat of P5 to P14 (Kotecha & 
Schlichter, 1999). Expression of Kv1.1 was elevated in activated microglia. Hypoxia 
exposure recovered the Kv1.1 expression in the mature (P21) brain slices (Wu et al., 
2009) and longer exposure led to more Kv1.1 being expressed. Using the BV-2 
microglial cell line, LPS treatment or hypoxia increased both the mRNA and protein 
expression of Kv1.1 channels while it was decreased by dexamethasone, an 
immunosuppressant steroid (Wu et al., 2009). In addition, Kv1.1 regulated LPS-
activated microglial pro-inflammatory mediator. Neutralization of Kv1.1 using a 
Kv1.1 antibody suppressed the release of TNFα, IL-1β and NO in the BV-2 cell line 
(Wu et al., 2009). Thus Kv1.1 channels may play a role in the microglial immune 
response and regulate the activated microglial release profile.
In previous studies, expression of Kv1.1 in the brain was closely associated with the 
expression of Kv1.2 sharing similar localization and distribution (Wang et al., 1994; 
Chung et al., 2001b; Yang et al., 2007). Kv1.2 together with Kv1.1 is expressed in 
microglia as well. Similar to Kv1.1, protein of Kv1.2 channels is expressed in rat 
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brain slices during development of microglia until P14 while at P21 it was not 
detectable (Li et al., 2008a). The absence of Kv1.2 channels was recovered by 
hypoxia exposure. Using BV-2 cells, similar results indicated that  mRNA of Kv1.2 
was detected which was upregulated by hypoxia exposure, extracellular ATP or LPS 
application (Li et al., 2008a). In cultured primary microglia from rat of P2 to P3 
(Fordyce et al., 2005) or P5 to P14 (Kotecha & Schlichter, 1999), either the mRNA 
or protein of Kv1.2 was detected but their expression was not changed using phorbol 
12-myristate 13-acetate (PMA) and LPS stimulation (Fordyce et al., 2005). This is 
different with Kv1.1. The reason may be due to different  age, different cell culture 
conditions or the different activation method applied to the cells (Li et al., 2008a; 
Fordyce et al., 2005; Kotecha & Schlichter, 1999). Similar to Kv1.1, blocking Kv1.2 
suppressed the release of IL-1β, TNFα and ROS.
Kv1.3 is the most studied Kv channel in microglia (Kotecha & Schlichter, 1999; 
Fordyce et al., 2005; Khanna et al., 2001; Pannasch et al., 2006; Küst et al., 1999; 
Schilling et al., 2000; Jou et al., 1998; Schilling & Eder, 2007; Chung et al., 2001a; 
Visentin et al., 2001; Cayabyab et al., 2000; Koeberle & Schlichter, 2010). However, 
the expression of Kv1.3 in microglia and whether their expression is elevated after 
microglial activation are still under debate. It  was reported that Kv1.3 protein was 
hardly  detectable in rat brain slices and injection of LPS near the hippocampal region 
did not elevate its expression (Jou et al., 1998). TGFβ increased gene expression of 
Kv1.3 in the BV-2 cell line (Schilling et al., 2000). Different  results indicated that 
Kv1.3 mRNA was increased in cultured primary rat microglia after LPS or PMA 
stimulation (Fordyce et al., 2005). Elevation of cAMP, which is downstream of LPS, 
increased the mRNA expression of Kv1.3 channels and activation of the A2a-receptor 
also enhanced Kv1.3 mRNA and protein expression (Küst et al., 1999). In addition, 
Kv1.3-like currents in activated microglia in brain slices was over five times larger in 
amplitude than those in resting microglia (Schilling & Eder, 2007). LPS treatment 
enhanced Kv1.3 current in cultured primary mouse microglia (Pannasch et al., 2006). 
Aβ, a marker of AD, induced the expression of Kv1.3-type current in isolated rat 
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primary microglia (Chung et al., 2001a). Activation of cultured primary rat microglia 
using Tat, a HIV-1 regulatory protein, also increased the expression of Kv1.3 current 
and this pathway was confirmed to be mediated through the NFκB transcription 
factor (Visentin et al., 2001). Although the Kv1.3 current expression is associated 
with microglial activation, this may not involve changes in protein expression. For 
example, LPS and PMA treatment did not influence protein expression of Kv1.3 
channels in cultured primary  rat microglia (Fordyce et al., 2005). The reason may be 
the translation of Kv1.3 protein in cells is not associated with their mRNA expression 
level. Finally, as various activation methods induced different Kv1.3 expression, the 
expression of Kv1.3 may be regulated by several different pathways. Functionally, 
the Kv1.3 selective blocker AgTX-2 diminished neuronal cell death evoked by LPS-
activated microglia (Fordyce et al., 2005). The effect of Kv1.3 was not through the 
NO release. Deletion of Kv1.3 by antisense oligonucleotides (Pannasch et al., 2006), 
or blockade of Kv1.3 channels using AgTX-2 (Fordyce et al., 2005), did not change 
microglial NO release. This process was proposed to be through ROS regulation. 
Blocking Kv1.3 using margatoxin (MgTX) attenuated Aβ-induced ROS release 
(Schilling & Eder, 2011) and reduced LPS- (Fordyce et al., 2005) or PMA- (Khanna 
et al., 2001) induced microglial respiratory burst. Although how Kv1.3 regulates 
ROS release is not fully  clarified yet, blockade of Kv1.3 channels did not influence 
p38 MAPK activation (Fordyce et al., 2005). In turn, accumulation of oxidative 
products may decrease the expression of Kv1.3 through phosphorylation by protein 
tyrosine kinase (Cayabyab et al., 2000). In addition, Kv1.3 channel expression was 
associated with microglial proliferation. During the proliferation of rat primary 
microglia, Kv1.3 replaced Kv1.5 on the plasma membrane as determined by patch-
clamping and immunostaining methods (Kotecha & Schlichter, 1999).
Like Kv1.3 channels, the mRNA (Pannasch et al., 2006; Fordyce et al., 2005), 
protein (Fordyce et al., 2005) or current (Pannasch et al., 2006) expression of Kv1.5 
channels have been reported in microglia (Jou et al., 1998; Khanna et al., 2001; 
Kotecha & Schlichter, 1999). The protein and current expression of Kv1.5 were 
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enhanced during microglial activation. For example, Kv1.5 protein found in the rat 
brain in vivo was elevated by LPS injection near the hippocampus (Jou et al., 1998). 
In addition, Aβ triggered an outward current in cultured rat primary microglia and 
this current was removed by antisense deoxyoligonucleotides against Kv1.5 (Chung 
et al., 2001a). BV-2 microglia treated by TGFβ did not express Kv1.5 channels 
(Schilling et al., 2000). The expression of Kv1.5, especially  current expression, may 
be cell species dependent. For instance, the transcripts and protein of Kv1.5 channels 
were detected, but their current  expression was not detectable in cultured primary rat 
microglia (Fordyce et al., 2005) while the current was found in cultured primary 
mouse microglia and upregulated by  LPS (100ng/ml, 24hr) stimulation (Pannasch et 
al., 2006). One more reason for different current expression may be that the culture 
condition led to different distribution of channels (Kotecha & Schlichter, 1999) 
during which the proteins of Kv1.5 were subcellular localized so that their current 
was not expressed (Khanna et al., 2001). However, unlike the protein and current 
expression, mRNA expression of Kv1.5 in primary cultured mouse microglia 
displayed a decrease after LPS treatment (Pannasch et al., 2006). Functionally, Kv1.5 
regulated microglial NO release. In Kv1.5 knockout mice (Pannasch et al., 2006), or 
deletion of Kv1.5 using antisense oligonucleotides (AO) in rat microglia, LPS-
induced microglial NO release was reduced (Pannasch et al., 2006).
In addition, Kv1.6 mRNA was reported at a very low level in cultured primary  rat 
microglia (Kotecha & Schlichter, 1999) but little is known about its function in 
microglia.
1.3.2.3 HERG channels
This channel, also known as Kv11.1, is encoded by human ether-a-go-go-related gene 
(HERG). They can be opened under high [K+]o with hyperpolarization from 0mV 
and are sensitive to external E-4031 but less sensitive to the universal K+ current 
blockers Ba2+ and Cs+ (Eder, 1998). The current of HERG channels was discovered 
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in rat MSL-9 microglia cell line (Zhou et al., 1998). Little is known about their 
distribution in situ and function in microglia.
1.3.2.4 The Ca2+-dependent K+ channels
Ca2+-dependent K+ channels found in microglia include large conductance Ca2+-
sensitive and voltage-activated K+ channels (BK) channels (McLarnon et al., 1995; 
McLarnon et al., 1997; Schilling et al., 2002; Schilling & Eder, 2007), intermediate 
conductance Ca2+-activated K+ channels (IK) channels (Kaushal et al., 2007; 
Schlichter et al., 2010), small conductance Ca2+-activated K+ channels (SK)2 and 
SK3 channels (Schlichter et al., 2010). BK-type currents have been reported in 
microglia from adult bovine, human and mice. Using inside-out patches with a 
symmetrical K+ solution in bovine microglia, a Ca2+-activated K+ current was 
detected whose conductance was 240pS (McLarnon et al., 1995). In microglia from a 
human fetus using physiological ion gradients, a single channel current  with 
conductance of 106pS was detected (McLarnon et al., 1997). In addition, both of 
these single channel currents increased their mean open times in response to 
depolarization which is predicted for BK channels. In microglia from juvenile mouse 
hippocampal slices, a BK-type current was elicited with conductance about 164pS 
(Schilling & Eder, 2007). Recent studies indicated that blocking BK current using 
paxilline did not attenuate Aβ-induced ROS release (Schilling & Eder, 2011). Further 
investigation on the function of BK channels is still required.
It was reported the expression of SK2 (Khanna et al., 2001), SK3 (Khanna et al., 
2001) and IK (Kaushal et al., 2007) were detected in rodent microglia. Respiratory 
burst, a key  reaction by microglia which plays an important role in killing neurons, 
was neutralized by blocking SK current using apamin (Khanna et al., 2001). A recent 
study suggested that SK3 was expressed in the rat striatum and the expression was 
elevated by LPS activation in culture microglia or hypoxia exposure in rat striatum 
(Schlichter et al., 2010). Functionally, blocking either SK3 or IK reduced microglial 
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neurotoxicity (Schlichter et al., 2010; Kaushal et al., 2007). In addition, this effect of 
IK may be through the regulation of microglial NO release and MAPKs activity  but 
not ROS synthesis as Tram34 did not influence Aβ-induced ROS release (Kaushal et 
al., 2007; Schilling & Eder, 2011).
1.3.3 K+ channels in microglia need further investigation
As introduced above, it is clear that K+ channels play  important roles in microglia. 
However, the expression and function of most K+ family members are still not 
known in microglia. The mechanisms by which K+ regulate microglial activation are 
still not fully  understood. The cross talk between microglia and other cells in the 
CNS, e.g. astrocytes, neurons, may require the activation of K+ channels. 
Importantly, there is a lack of systematic determination of K+ channel expression in 
microglia and how their expression may change during microglial activation.
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1.4 The primary aims of the thesis
Microglia play an important role in maintaining environment in the CNS, participate 
in both the native and adaptive immune response, generate acute and chronic 
neuroinflammation, and are implicated in the process of neurodegeneration. 
Microglia are either neuronal protective or neurotoxic depending on the release of 
mediators by activated microglia under acute status or chronic status.
K+ channels play important roles in microglial proliferation (Kotecha & Schlichter, 
1999), activation (Fordyce et al., 2005; Khanna et al., 2001; Schilling & Eder, 2011) 
and microglial neuronal toxicity (Fordyce et al., 2005). However, to date the 
expression of K+ channels in microglia has not been fully characterized and for those 
discovered expressions are still controversial (Küst et al., 1999; Fordyce et al., 2005; 
Pannasch et al., 2006). LPS-induced microglial NO release plays an important role in 
microglia-induced CNS defense and neuronal toxicity. K+ channels that regulate 
microglial NO release may be important for generation of new therapies for 
microglia-related CNS disease in the future (Schlichter et al., 2010; Kaushal et al., 
2007). Thus a systematic screen of K+ channels in microglia is necessary  to be 
performed and understanding of their roles in microglial activity also needs to be 
examined. In addition, K+ current expression is reported associating with microglial 
status (Boucsein et al., 2000; Kettenmann et al., 1990; Boucsein et al., 2000; 
Nörenberg et al., 1992). Thus it is important to know which K+ channel currents are 
expressed in microglia and whether LPS regulates these channels.
As described in section 1.2.3.5, N9 murine microglial cell line will be used to 
address these aims. This cell line has been widely used in the in vitro investigation of 
microglial activation. However, the culture conditions used for N9 microglia varied 
significantly among different previous experiments (Suuronen et al., 2006; Nuutinen 
et al., 2005; Suuronen et al., 2003; McKimmie & Fazakerley, 2005; Bianco et al., 
2005; Garg & Chang, 2006; Chang et al., 2008). Microglia are very sensitive to the 
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environment and this may determine the expression change of K+ channels. Thus an 
optimized maintenance and activation method needs to be confirmed.
In summary, in this thesis the overall hypothesis that N9 murine microglia express 
multiple K+ channels and that K+ channels regulate LPS-induced microglial NO 
release is tested.
Each chapter involves the following investigations:
(1) Chapter 3: Optimization of N9 microglial regular maintenance and LPS-induced 
N9 microglial activation.
(2) Chapter 4: What K+ channels are expressed in N9 microglia and how their 
mRNA expressions are changed by LPS treatment.
(3) Chapter 5: What the functional roles of K+ channels are in N9 microglia, 
including their roles in LPS-induced microglial NO release and their current 






2.1.1 Preparation of cells
2.1.1.1 N9 murine microglial cell line
N9 microglia cell line was a kind gift from Prof. Alun Williams and Dr. Clive Bate 
(the Royal Veterinary College, London, UK). It is one of the most commonly  used 
models of primary microglia in culture. The cell line is similar to primary microglia 
in morphology and offers similar response to activating stimulation (Corradin et al., 
1993; Meda et al., 1995; Bonaiuto et al., 1997; Xiang et al., 2006). Especially it 
provides pronounced NO release in response to lipopolysaccharide (LPS) stimulation 
(Nikodemova & Watters, 2011). The murine N9 microglial cell line which has been 
commonly used to investigate microglial nitric oxide (NO) release in vitro was used 
for studies of the thesis.
2.1.1.2 Regular passaging of N9 cells
The N9 cells were cultured in Iscove’s modified Dulbecco’s medium (IMDM) with 
5% fetal calf serum (FCS), 100U/ml penicillin (PEN), 100µg/ml streptomycin 
(STREP) and 50µM β-mercaptoethanol (β-MET), and maintained at 37℃ in 5% (v/
v) CO2. 
During general passaging, N9 cells were cultured in 25cm2 flasks (CELLSTAR, 
Greiner Bio-one). The supernatant was removed and cells were washed twice using 
Hanks balanced salt solution (HBSS). After which cells were incubated with 0.05% 
Trypsin-EDTA (0.5ml for 25cm2 flask) at 37℃ in 5% (v/v) CO2 for 5~10mins. Cells 
were detached by gently  tapping the flask. At this stage, 1ml growth medium was 
added to stop the reaction of Trypsin-EDTA. Cells were resuspended thoroughly and 
further diluted by adding 13ml of growth medium to every 0.5ml of cell suspension 
of which 5ml was plated into a new 25cm2 flask. Cells were harvested 2~3 times a 
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week and were typically used 48hr after seeding, over a passage ranging from 7 to 
40. Within this range, the N9 microglia gave a constant NO release to LPS 
stimulation.
2.1.1.3 N9 cell seeding density for experiments
During experimental preparation, cells were counted using a haemocytometer (#BS.
748, Hawksley) and a tally counter. Unless indicated separately, for Griess reagent 
assays (Promega) the seeding density was: 3×104 cells/well on 96 well plate, 5×104 
cells/well on 24 well plate, 2~3×105 cells/well on 6 well plate. These were within the 
range of 2.5×104~2×105 cells/well (24 well plate) which was confirmed in Chapter 3. 
For electrophysiology the seeding density was: 2~3×105 cells/well (6 well plate). For 
quantitative reverse transcription polymerase chain reaction (qRT-PCR) the seeding 
amount was 3×105 cells/well (6 well plate) (Table 2-1).
2.1.1.4 Optimization of growth medium for N9 cells
2.1.1.4.1 Components of growth medium
In previous studies growth medium used for N9 microglia varied from each other, 
thus their effect on N9 cell morphology, proliferation and even activation was 
examined. Initially three different recipes of growth medium were generated based 
on previous publications (Table 2-2) (Chang et al., 2008; Meng et al., 2008; Wu et 
al., 2007; Hou et al., 2006; Bi et al., 2005; Cavaliere et al., 2005; Wang et al., 2008; 
Garg & Chang, 2006; Nuutinen et al., 2005; Suuronen et al., 2003; Suuronen et al., 
2006; McKimmie & Fazakerley, 2005; Bianco et al., 2005), namely GM[0], GM[1] 
and GM[2]. The components of GM[0] included: Dulbecco’s Modified Eagle 
Medium (DMEM) (no glutamine (GLX)) with 5% FCS, 100U/ml PEN, 100µg/ml 
STREP, 50µM β-MET. The components of GM[1] included: IMDM (including 4mM 
GLX) with 5% FCS, 100U/ml PEN, 100µg/ml STREP, 50µM  β-MET. The 
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Table 2-1. Seeding density in each culture vessel. The density was 
confirmed based on the optimized N9 microglial activation method as 
described in Chapter 3.




total volume of 
medium (ml)
96 well plate 3×104 0.3 1×105 0.2~0.25
24 well plate 5×104 1.9 2.6×104 1
6 well plate 2~3×105 9.4 2.1~3.2×104 2~3
25 cm2 flask 2.5~7×105 25 1~2.8×104 6~10
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Table 2-2. Different growth media used for N9 microglia culture. Here 
lists recipes of growth media for N9 cells culture in vitro used in previous 
studies. Based on the these studies, components in the culture medium 
mainly  included: Iscove’s modified Dulbecco’s medium (IMDM), glutamine 
(GLX), fetal calf serum (FCS), penicillin (PEN), streptomycin (STREP) and β-
mercaptoethanol (β-MET). In addition, Roswell Park Memorial Institute 
(RPMI) medium, minimum essential media (MEM) and Dulbecco’s Modified 













IMDM 5 100 100 50 (Chang et al., 2008)
IMDM 5 2 100 100 50 (Meng et al., 2008; Wu et 
al., 2007; Hou et al., 2006; 
Bi et al., 2005; Cavaliere et 
al., 2005)
DMEM 10 2 50 (Wang et al., 2008)
MEM 5 1.4 (Garg & Chang, 2006)
IMDM 5 (Suuronen et al., 2006; 
Nuutinen et al., 2005; 
Suuronen et al., 2003)
RPMI 5 2 100 100 (McKimmie & Fazakerley, 
2005)
IMDM 5 100 10 50 (Bianco et al., 2005)
components of GM[2] included: IMDM (including 4mM  GLX) with 5% FCS, 100U/
ml PEN, 100µg/ml STREP (Table 2-3).
2.1.1.4.2 Cell imaging
N9 cells were plated at the density  of 2.5×105 cells in three 25cm2 flasks with 10ml 
of growth medium: GM[0], GM[1] or GM[2] separately and cultured for up to 120hr 
without replacing the culture medium. After each 24hr of culture, the morphology of 
cells from six different locations of each 25cm2 flask was captured using a digital 
camera (FX7, Panasonic) together with optical microscope (AE20, Motic). 10x 
eyepieces with 4x or 10x objective lens were used. The images were prepared for the 
following length measurement and cell number counting approaches.
2.1.1.4.3 Measurement of microglial morphology
At 24hr after seeding, the longest process of each microglia was obtained by 
measuring the linear length from the center of cell soma (amoeboid) to the end of the 
process. If microglial soma displayed an oval shape, radius of soma was applied as 
half of the diameter which was the average of the transverse and longitudinal axes. 
According to the study  which examined length of process and soma of primary 
microglia (Kozlowski & Weimer, 2012), the ratio between the length of process and 
the diameter of soma of resting microglia is not less than two. Thus the proportion of 
microglia with long process equal or more than twice the diameter of soma was 
calculated. Scale was obtained using a transparent flat lens with ruler engraved 




Table 2-3. Components of GM[0], GM[1] and GM[2] culture media. The 
basal medium of GM[0] was DMEM while the other two used IMDM. The 
difference between GM[1] and GM[2] was β-MET component in GM[1] while 











5 100 100 50
GM[1] IMDM
(Incl. 4mM GLX)





At 72hr after seeding, the cell number in each growth medium was counted and the 
density was obtained by normalizing cell numbers to the area (mm2).
2.1.1.4.5 Measurement of NO2- concentration in each growth medium
The microglial NO release under each growth medium condition was examined. The 
supernatant after 120hr of culture was collected and the nitrite (NO2-) concentration 
was measured using the Griess reagent assay. Procedure of Griess reagent reaction is 
described below (section 2.1.1.6).
2.1.1.5 Optimization of N9 microglial activation
2.1.1.5.1 Examination of time course and dose dependence of LPS 
treatment
LPS from the endotoxin of gram-negative bacteria Escherichia coli (E. coli) induces 
the immunoresponse of mammals and it  has been commonly used for the external 
stimulation of microglial activation in vitro. The previous dose of LPS used on 
microglia varied a lot between publications. The concentration of LPS ranged from 
1ng/ml to 10µg/ml and the LPS challenge duration ranged from 6hr to 48hr (Chang 
et al., 2008; Meng et al., 2008; Wu et al., 2007; Hou et al., 2006; Bi et al., 2005; 
Cavaliere et al., 2005; Wang et al., 2008; Garg & Chang, 2006; Nuutinen et al., 
2005; Suuronen et al., 2003; Suuronen et al., 2006; McKimmie & Fazakerley, 2005; 
Bianco et al., 2005). It  is required to confirm a proper LPS activation method before 
processing the following experiments.
To investigate the effect of different concentrations of LPS, 0.01µg/ml, 0.1µg/ml and 
1µg/ml of LPS were applied in parallel. For general procedure, five groups of N9 
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cells were cultured at the density of 5×104 cells/well on 24 well plate for totally 48hr. 
Group  one was cultured with three different concentrations of LPS for 48hr. Group 
two was challenged by LPS at 36hr after plating and cultured with LPS for 12hr. 
Group  three was challenged by LPS at 24hr after plating and cultured with LPS for 
24hr. Group four was challenged by  LPS at  12hr after plating and cultured with LPS 
for 36hr. The final group was cultured without LPS for 48hr as a negative control. 
After 48hr of culture, the supernatant of each sample was collected and used for NO 
detection by Griess reagent reaction.
2.1.1.5.2 Optimized N9 microglial activation
To stimulate N9 microglial activation, first cells were cultured for 24hr after which 
LPS was added into the supernatant to reach the final concentration of 1µg/ml and 
cells were co-cultured with LPS for another 24hr after which cells were activated and 
ready  for the following approaches. During the activation, cells without the LPS 
treatment were established in parallel as a control. This activation protocol by LPS 
(1µg/ml, 24hr) was based on the result of Chapter 3.
2.1.1.6 Griess reagent reaction
As described in section 1.2.5.2, activated microglia release NO which was produced 
from L-arginine by inducible nitric oxide synthase (iNOS) (Moncada et al., 1989). 
NO is reactive and can be oxidized to the stable form NO2-. In the culture medium, 




It was pointed out part of the NO2- in the supernatant will be further oxidized to 
nitrate (NO3-) (Marletta et al., 1988), but such effect was offset as all the samples 
including control were prepared in the same condition during microglial activation.
The detection of microglial NO release was then examined by measurement of the 
NO2- concentration in the culture medium by the Griess reagent assay (Green et al., 
1982) which was originally described by Griess in 1879. This method is based on the 
reaction of NO2-, sulfanilamide and N-1-napthylethylenediamine dihydrochloride 
(NED) (Figure 2-1) following the manual of the manufacturer (Griess Reagent 
System, Promega). The limit of detection for this assay  is 0.1µM of NO2- in the 
supernatant.
For general protocol, after the activation of microglia the supernatants were 
transferred to fresh 1.5ml Eppendorf tube and stored at -20℃ until measurement. 
During the Griess reaction, 50µl of each sample was added in a 96 well plate. 50µl of 
the sulfanilamide was following added to each sample/well by  an electronic 
multichannel pipette and the mixture at room temperature for 5~10min during which 
plates were protected from light. Finally, 50µl NED was added to each well and 
incubated the mixture at room temperature for another 5~10min, protected from 
light. A pink color will form and its absorbance was measured at  550nm within 
30min using a plate reader (PowerWave XS, BioTEK). Meanwhile, a standard curve 
was generated by dissolving sodium nitrite in culture medium at concentration 
ranging from 0~100µM in a two-fold series dilution. All samples were run in or more 
than triplicate. Data analysis was processed using KCjunior 1.41.8 (BioTEK).
2.1.1.7 Cell viability assay
To avoid the possible effect of blocking or activating K+ channels on cell viability, 
LPS-induced NO release was normalized to cell number determined by MTS assay. 
In many previous studies, such pharmacological effect on microglial proliferation has 
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Figure 2-1. Reaction of Griess reagent assay. Sulfanilamide and N-1-
napthylethylenediamine dihydrochloride (NED) react with nitrite (NO2-) 
forming Azo compound which has high absorbance at 530~550nm. Figure is 
adapted from manual of the manufacturer (Griess reagent System, 
Promega).
not been routinely examined. However, an assumption of the MTS approach to 
reliably  measure cell number is that the pharmacological manipulation does not 
dramatically affect the mitochondrial function and further work should also explore 
other cell counting methods.
To examine the pharmacological effect on cell viability, the influence of cell number 
under different culture conditions using [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) technique was 
determined. The yellow MTS reacts with dehydrogenases at the site of mitochondria 
and transfers into purple formazan (Figure 2-2). As this process only occurs in live 
cell, the amount of formazan in the supernatant is an indicator of cells numbers.
The procedure was following the manual of the manufacturer (CellTiter 96 AQueous 
One Solution Cell Proliferation Assay, Promega). For general protocol on 96 well 
plate, cells were cultured in the microplates. 100µl of growth medium was left in 
each well and then 20µl of “CellTiter 96 AQueous One Solution reagent” which 
contains MTS was added to each well. Cells were incubated under the condition of 
37°C with humidified 5% (v/v) CO2 atmosphere for 1hr. After that the plate was 
processed for absorbance measuring at 490nm using a plate reader (PowerWave XS, 
BioTEK). According to the manual, the change of cell numbers was represented by 
the direct comparison between the absorbance of sample and control. Background 
was measured and subtracted using samples without cells. Data analysis was 
processed using KCjunior (BioTEK).
2.1.2 Molecular protocols




Figure 2-2. Reaction of cell viability. Yellow MTS is converted by 
dehydrogenases at the site of cellular mitochondria into purple formazan. The 
absorbance was then measured at 490nM and used as indicator for live cell 
number. Figure is adapted from manual of the manufacturer (CellTiter 96 




The total RNA was obtained according to the manual of RNeasy  Mini Kit 
(QIAGEN) which technology  was based on the selective binding properties between 
RNA (>200 bases) and silica-based membrane. For the general protocols, cells were 
prepared in 6 well plate with cell number no more than 1×106 cells/well (6 well 
plate) in advance. Prior to lysis of cells, the bench was cleaned with RNaseZap 
(Invitrogen). Cells were first lysed by the RNeasy lysis buffer containing guanidine 
thiocyanate which inactivates the RNase. This step also aimed to release all the RNA 
of the cells by  disrupting the membranes of cells and organelles. After the lysis of 
cells, the lysates were homogenized by being passed through a needle of 0.8mm 
diameter for 30 times. This step reduced the viscosity  of the lysates aiming to 
increase the efficiency of binding of RNA to the silica-based membrane. After this 
step, same volume of 70% ethanol was added to the lysates. Total RNA of the lysates 
was bound to the membrane of the RNeasy  spin column by  centrifugation. The 
membrane was washed by centrifuging with the wash buffer provided following the 
protocol of the manufacturer. Finally, RNA was eluted by centrifuging the RNeasy 
spin column with the RNase free water.
2.1.2.2 Analysis of RNA integrity
The RNA integrity was checked by running the samples in gel electrophoresis. 
Samples were denatured by being heated at 65℃ for 10min and put on ice for 5min 
before running the gel (10% agarose). Two bands (28S and 18S) representing 
ribosomal RNA should appear (Figure 2-3A).
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Figure 2-3. Representative samples for RNA integrity and qRT-PCR. (A) 
A sample for the reproducible total RNA isolation from direct lysis of N9 
microglia. The 28S and 18S ribosomal RNA are distinguishable. Lane 1 is 
from resting microglia and lane 2 is from LPS-activated microglia. (B) A 
representative trace for qRT-PCR (Delta Rn vs. cycle number). Data 
presented is β-actin and Kcna3 (Kv1.3) (Triplicate). The baseline was set 
from cycle 3 to cycle 10 and threshold was 0.2. Rn is the ratio of 
fluorescence emission intensity of reporter dye to the passive reference dye. 
Delta Rn is Rn value subtracting the baseline. Ct is cycle number at which 
the fluorescence passes the threshold. qRT-PCR: quantitative reverse 
transcription polymerase chain reaction; Kv: voltage-gated K+ channel.
28S -
18S -





The reverse transcription was performed using the Transcriptor High Fidelity  cDNA 
Synthesis Kit (Roche). First 3~4µg of total RNA with 0.5µl anchored-oligo(dT)18 
Primer and 1µl Random Hexamer Primer were made up to 11.4µl by adding the 
appropriated volume of RNAse free H2O. The mixture was denatured by being 
heated at 65℃ for 10min in a thermocycler (#2720, Applied Biosystems) during 
which the secondary structure of RNA was diminished and immediately the 
template-primer mixture was cooled on ice to prevent the formation of secondary 
structure. The following components were added into the denatured template-primer 
mixture: 4µl Reaction buffer (5× conc.), 0.5µ RNase Inhibitor (40U/µl), 2µl 
Deoxynucleotide (10mM), 1.1µl RNase-free water and 1.1µl reverse transcriptase. 
The final volume was then 20µl. The reaction started by heating the mixture at 50℃ 
for 30min followed by the incubation at 85℃ for 5min to inactivate the reverse 
transcriptase. Finally the reaction was stopped by  putting the mixture on ice. cDNA 
was then used for following experiment or stored at  -20℃ for later use. During this 
procedure, the non-template control, which did not contain RNA, and the non-
enzyme control which did not contain the reverse transcriptase were prepared.
2.1.2.4 Quantitation of RNA and cDNA
The purity  was calculated by  the ratio of OD260/OD280. For pure cDNA the ratio is 
~1.8 while for pure RNA the ratio is ~2.0 (Barbas et al., 2007). All samples 
displayed no contamination. The RNA or cDNA was diluted with H2O by  200 times 
and the absorbance of the mixture was measured by a spectrophotometer (Biomate 3, 
Thermo Co.). The equations to calculate cDNA and RNA concentrations (Barbas et 
al., 2007) are :
Equation 2.1: 
ssDNA concentration = 33µg/ml × OD260 × dilution factor
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Equation 2.2:
RNA concentration = 40µg/ml × OD260 × dilution factor
2.1.2.5 Quantitative reverse transcription polymerase chain reaction 
The SYBR Green based qRT-PCR was carried out using ABI PRISM  7000 Sequence 
Detection System (Applied Biosystems). Over 80 K+ channel subunits were 
examined. For the general procedure, 25µl of mixture containing 1µl forward primer 
(5µM), 1µl reverse primer (5µM) of each subunits (Table 2-4 to Table 2-9), 12.5µl 
SYBR Green reagent (including the internal reference dye), 2.5µl cDNA template 
and 8µl diethylpyrocarbonate (DEPC) water was prepared for each sample. All 
samples were run in triplicate and the cycling parameter was: 50℃ for 2min (1 
cycle), 95℃ for 10min (1 cycle), 95℃ for 15sec to 60℃ for 1min (40 cycles) 
followed by the dissociation stage which was: 95℃ for 15sec to 60℃ for 20sec to 
95℃ for 15sec (1 cycle). Data was collected at step of 95℃ for 15sec to 60℃ for 
1min (40 cycles) using ABI PRISM 7000 System (Applied Biosystems). 
Representative traces are presented (Figure 2-3B). The Ct threshold was 0.2 and 
baseline was from start cycle 3 to end cycle 10. K+ channel mRNAs expression were 
normalised to the expression of β-actin. All primers were designed by SIGMA and 
validated before use.
2.1.2.6 Examination of the effect of LPS on β-actin expression
Each Ct value of β-actin was normalised to the concentration of the template 




Table 2-4. Primers for Kir channels used in qRT-PCR. Both International 
Union of Pharmacology (IUPHAR) and HUGO Gene Nomenclature 
Committee (HGNC) names of each gene are shown. Kir: inwardly rectifying K
+ channel
Name GeneBank # Primer Sequence (5’-3’)
Kir1.1 Kcnj1 NM_01965925 f: TGGTCTCCTGTGGTATGTCGTAGCr: ATCCGTAACCTATGGTCACTTGGG
Kir2.1 Kcnj2 NM_008425 f: GAGAACCAACCGCTACAGCATCGr: TCCTGCACTGTTGTCGGGTATGG
Kir2.3 Kcnj4 NM_008427 f: GCAACCGCTTTGTCAAGAAGAACGr: AGAAGAGCCAGGAAACGAGGAAGG
Kir2.4 Kcnj14 NM_145963 f: ACTGATCGCATCTTCCTCGTCTCCr: CAACCATACCTTCAAGAATGACCACCAG
Kir3.1 Kcnj3 NM_008426 f: ATCTGGCTCGCCCCTCCGTATTATGr: GAAGTGGTCACTACCTGGTAATCGTC
Kir3.2 Kcnj6 NM_001025584 f: TGTTTCCTCCTTTTCTTGTATTTTCTTCCCr: TTCACTCCATCCTGATCGCCTCTC
Kir3.3 Kcnj9 NM_008429 f: AGGAGAAACAGCAGTGTCr: GAGAAGAGTAGCCAGCAG
Kir3.4 Kcnj5 NM_010605 f: CCACTCTGCCACCGCCTCTCr: GACTCCTATCTCCATGTCTTGATTCATAGC
Kir4.1 Kcnj10 NM_001039484 f: CTCCGCTCGCCGCTCCTGr: CGTCATCTTGGCTCGAAGGTGAAG
Kir4.2 Kcnj15 NM_001039056 f: TCTGAGAAACTTGACTTCCAAAGGCr: ACTCACTCTGTAGGTCAGGAATCTTC
Kir5.1 Kcnj16 NM_010604 f: CCTCCCTGTGGAAGAGTGAATGAAGr:TCAGAGGAGTCCGATGTCAGTTAAAAG
Kir6.1 Kcnj8 NM_008428 f: TGGCCTGGAGTCCGCTGTCr: GTTGATGATCAGACCCACGATGTTC
Kir6.2 Kcnj11 NM_010602 f: GGGGCGGTGGAGGAGAGCr: GCTGGGTTCTGCTTCTCTTTATACTAC
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Table 2-5. Primers for Kv channels used in qRT-PCR (Part 1). Both 
IUPHAR and HGNC names of each gene are shown.
Name GeneBank # Primer Sequence (5’-3’)
Kv1.1 Kcna1 NM_010595 f: TTGCGTCGGACCTGACCATCTCr: TTGTCATTCAGTTCCCATCCTTGCC
Kv1.2 Kcna2 NM_008417 f: CACCCAGGAACATGGAGGCTCTGr: CGCACCACGACTTGAGGAGGAG
Kv1.3 Kcna3 NM_008418 f: ATTGTGTCAGTGCTGGTCATTCTCATCr: ACAAGGTCTCCACCACGAAGAAGG
Kv1.4 Kcna4 NM_021275 f: TGGGATGGATACTGGAGAAGGAATGCr: GGGCTGGGAACGGAAGTCAAGG
Kv1.5 Kcna5 NM_145983 f: CAAGAGCCATTGCCATCGTGTCGr: CAGGCAGAGTCTCCAAGCAGAAGG
Kv1.6 Kcna6 NM_013568 f: TCGTCTCAGTATTGGTCATCCTCATCTCr: TCATCTTCTTCCTCGTGGCTCCTG
Kv1.7 Kcna7 NM_010596 f: CCTCCCCGACAGCCCTTCAACr: GCCACCAGACGCACCAGCAG
Kv2.1 Kcnb1 NM_008420 f: CGTGCTGTGCTGAGAAGAGGAAGr: TGACAGGGCAATGGTGGAGAGG
Kv2.2 Kcnb2 NM_001098528 f: GAAACTTTGGGACTTGCTGGAGAAACr: AATGGTGGAAAGAACGATGAACAGG
Kv3.1 Kcnc1 NM_001112739 f: ACTCCCTTCCTCCCTCCCTCTTTACr: CAGGCAGGTGCGGGTCCAG
Kv3.2 Kcnc2 NM_001025581 f: ACAGAGATGGGCAAGATCGAGAGCr: TGAGGTTCAGAGGAGGCAAGAAGG
Kv3.3 Kcnc3 NM_008422 f: CACACGAGGGCTTCATCCACATCr: AGGTCAAGAAGGGTTCCGTCTCC
Kv3.4 Kcnc4 NM_145922 f: CTGGAGGTGGGATTGAGTGGTTTGr: GCCAAGAAGATGATAAGCAACAGGAAC
Kv4.1 Kcnd1 NM_008423 f: TGAGAAGGGCACGAGCAAGACCr: AGACACCGCTAAGTGAGCAGATGG
Kv4.2 Kcnd2 NM_019697 f: GCCGCAGCACCTAGTCGTTACr: TTGTCTGTCATCACCAGCCCAATG
Kv4.3 Kcnd3 NM_001039347 f: TCCGTTGTGTGCTTAACTTCTACCGr: CTGGTTGTTTTCAGAGTCATTGTCATCC
Kv5.1 Kcnf1 NM_201531 f: TCTTGGACGACCTGGGTGTTGACr: GACCACGGAGGAGACAAGGATGAG
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Table 2-6. Primers for Kv channels used in qRT-PCR (Part 2). Both 
IUPHAR and HGNC names of each gene are shown.
Name GeneBank # Primer Sequence (5’-3’)
Kv7.1 Kcnq1 NM_008434 f: ACCACTTCACCGTCTTCCTCATTGr: TCTGTCCCAAAGAACACCACAAGG
Kv7.2 Kcnq2 NM_010611 f: GTGACTATCGTGGTATTCGGTGTTGAGr: CCAGCAGCCAGCACAGCAATG
Kv7.3 Kcnq3 NM_152923 f: CACTCATCCTTTCTTCATTTCTTGTCTACCr: CTCAAACTCCTCCTTCATTTCCTCTCC
Kv7.4 Kcnq4 NM_001081142 f: AACTTGCCAACGAGTGTCTCCTTATCr: GTCCCTGCCATCCTCTGTAGCG
Kv7.5 Kcnq5 NM_023872 f: TTCTCCTTGTGTTTGGTTGCTTGATTTTGr: TCAGTCTTCCTTGCCATCCTCTATAACG
Kv8.1 Kcnv1 NM_026200 f: GCTCTGGGATATTCTGGAGAAACCTGr: GCCATGTTGACGATGGACACTGC
Kv8.2 Kcnv2 NM_183179 f: TGGACCGAGGGCAACTACAATTACTACr: TTCACTTTCAGCGTGGACATTTGGG
Kv9.1 Kcns1 NM_008435 f: TGGAGACCAATACAGTTGTAGGTAATAAGCr: GGAGTGATGGGATGGTGGGATGG
Kv9.2 Kcns2 NM_181317 f: CGAGCAGAGTGACCAGGAAAGCr: CGAACTTGGAAGCATCATTATAGAAGGC
Kv9.3 Kcns3 NM_173417 f: TGGGACCAGAAAAGCAACGATGTGr: TCAAACTTCTCCAGCTCTTTCTCAAACAG
Kv10.1 Kcnh1 NM_001038607 f: TCTACACAGCCATCTTGGTCCCTTACr: CGTCTTCAGGTAGTTCATGCGGATAAG
Kv11.1 Kcnh2 NM_013569 f: GCTTCCTGTGTCTGGTGGATGTGr: ACCATGTCCTTCTCCATCACTACTTC
Kv11.2 Kcnh6 NM_001037712 f: ACGCCCTACTCTGCTGCCTTTCr: TCGGAAGTTGATGACAATATCCACCAC
Kv11.3 Kcnh7 NM_133207 f: AAGCAGATGATACGAAAGCCTTGATACAGr: GGTCCAGAGGTCCTGATATGTTCACTAAG
Kv12.1 Kcnh8 NM_001031811 f: CCACTCGGAGCACAACGGTCAGr: ATACAGGAGGTCAAAGGGCAAGGC
Kv12.2 Kcnh3 NM_010601 f: CAATAAGGGAGTGTTTGGAGAGAAGCCr: CCACAGTGCAGCAGGATAAAGGG
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Table 2-7. Primers for K2p channels used in qRT-PCR. Both IUPHAR and 
HGNC  names of each gene are shown. K2p: tandem pore domain K+ 
channel.
Name GeneBank # Primer Sequence (5’-3’)
K2P1.1 Kcnk1 NM_008430 f: CCTCGGGAAATTGGAATTGGGACTTCr: GAGGAGGGTGAACGGGATGCC
K2P2.1 Kcnk2 NM_010607 f: GATTTTCCTGGTGGTCGTCCTCTACr: AAGGTCTGCTTCTGGATCACAATGG
K2P3.1 Kcnk3 NM_010608 f: CCATCGGCTTCGGCGACTATGr: GCAGCACCACGAGGTTGAGG
K2P4.1 Kcnk4 NM_008431 f: TGACTCTCACCACTGTAGGCTTTGr: ACTGAGGCGAAGTAGGCTAGGC
K2P5.1 Kcnk5 NM_021542 f: TCTGGTGATCCCGCCCTTTGTGr: TGGAGATGGTGATGAAGGAATAGTAGAGG
K2P6.1 Kcnk6 NM_001033525 f: CTGCTTCATCTCTCTGTCCACCATTGr: GGAAACACGGCGGAAAGTCTGC
K2P7.1 Kcnk7 NM_010609 f: ACCCCAGCCTCAGTATCAGAACATCr: CCTTGGTGCCTCCCGCTCAG
K2P9.1 Kcnk9 NM_001033876 f: TTGCTGGAAATCCAAGAAGAGTGTCTGr; CCAGGGAAGCAGAGATAGCACAGG
K2P12.1 Kcnk12 NM_199251 f: GACGCCGCCAGCTCAATTATAGGr: AGCAGGGTGAACCGTAGAGTCC
K2P13.1 Kcnk13 NM_146037 f: CCAGCCACAACGGGAGGGAAGr: AAGGTTGAAGAAGAGGATGGTACTTGC
K2P18.1 Kcnk18 NM_207261 f: AATCCCTCTAATGTTCCTGGTCCTCACr: CCGACTGTAAGCCCTGGATAAGATGG
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Table 2-8. Primers of KCa channels used in qRT-PCR. Both IUPHAR and 
HGNC names of each gene are shown. KCa: calcium-activated K+ channel.
Name GeneBank # Primer Sequence (5’-3’)
KCa1.1 Kcnma1 NM_010610 f: CTCCAATGAAATGTACACAGAATATCTCr: CTATCATCAGGAGCTTAAGCTTCACA
KCa2.1 Kcnn1 NM_032397 f: CATCAGCCTGTCCACTGTCATCTTGr: GTCGTCGGCACCATTGTCCAC
KCa2.2 Kcnn2 NM_080465 f: ATCTTCGGCATGTTCGGCATCGr: ATCGTGGAGAGACTGATAAGGCATTTC
KCa2.3 Kcnn3 NM_080466 f: GCTTGTCCATCCTGGTCTGTTGCr: ATGGCGGTAGAGTTGGCTGAAGTG
KCa3.1 Kcnn4 NM_008433 f: ATTCCGATCACATTCCTGACCATTGGr: TGTTTCTCCGCCTTGTTGAACTCC
KCa4.1 Kcnt1 NM_175462 f: CTGCCCTTCATCATCACGGTCTTCr: GCTGACTGTGTGCGTAGGATGG
KCa4.2 Kcnt2 NM_001081027 f: ATCCGTGTGTTGCTTGAGAAACCGr: CAATGCCACTGAGACCTGTAAACCC
KCa5.1 Kcnu1 NM_008432 f: AGACAAGATCAAGTTCTGGTTGGAGATGr: AATAATAAGAAATAAAGGTTGGCGGGATGG
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Table 2-9. Primers of regulatory subunits used in qRT-PCR. Both 
IUPHAR and HGNC  names of each gene are shown. SUR: sulfonylurea 
receptor.
Name GeneBank # Primer Sequence (5’-3’)
Kvβ1 Kcnab1 NM_010597 f: GCCGACCGCCTGTGTTGTGr: CGAGCGATGATAGCGACAGTGC
Kvβ2 Kcnab2 NM_010598 f: GGGGTGCTAAAGTCGCAAGGGr: GTCTGCCGCAGGGAGAGTCG
Kvβ3 Kcnab3 NM_010599 f: CTTGAGTCGCAAACACATCATTGAAGGr: CATAGGACTATTAGGATCTGAACGATTGGC
minK Kcne1 NM_008424 f: TGATGGGAGACATGGGCATGATGAGr: ACAGGGAGGATGAAGAGCACACAC
MiRP1 Kcne2 NM_134110 f: CCCACTTGTGCTTGCTCAGAAGACr: ACCCCAACAGGCTCACCTAAACC
MiRP2 Kcne3 NM_020574 f: GCCTTCCTGGTCGTAATGACAACTCr: ACATCAGATCATAGACACACGGTTCTTG
MiRP3 Kcne4 NM_021342 f: TGGAGCCTCTGAACAGCACATACCr: AGGAAAACGCCATAGAAGGACATAACG
sloβ1 Kcnmb1 NM_031169 f: GCTGTATCACACGGAAGACACTCGr: CGCTGGTCTCGTTGACTTGAGG
sloβ2 Kcnmb2 NM_028231 f: TGCCTGTCACTCCTATTGTCCTTCCr: CATTGATGTCACACCCTCGCTAACTC
sloβ3 Kcnmb3 XM_001475546 f: CCACTCGGGACAGAAAGTGCTTCr: AGGGGAAAGTTCCATTGTTGTGATCG
sloβ4 Kcnmb4 NM_021452 f: GTGCTCCTATATCCCGCCCTGTAAGr: GCAAGTGAATGGCTGGGAACCG
SUR1 Abcc8 NM_011510 f: ACTATCACAACATTGAGACCTCTAACTTCCr: TCCACCAGCAGCAGCATCCC
SUR2 Abcc9 NM_001044720 f: CTTCCTGCTGTTTATCACCTTTCCAATACr: AACGATGCCTTCCGCTATCTCAC
KChIP1 Kcnip1 NM_027398 f: CCGATTTCTTTTCAGGGGAGGGAAGr: GGGTCGCCTTTGTTTGGTCTGC
KChIP2 Kcnip2 NM_030716 f: ACAAACCAAGTTCACACGCAGAGAGr: TTGACAATTCCGCTGGGACATTCG
KChIP3 Kcnip3 NM_019789 f: GCATACCACTGAGCAAGAGGGAAAGr: CCACTTGATTAAGCAGCAACGCATC
KChIP4 Kcnip4 NM_030265 f: CGACCGAAGAGGCAAATGTGAACGr: GGTGACATGGATGCAGATTTGTAACTGG
2.1.3 Electrophysiology assays
2.1.3.1 General procedures
The voltage clamp and current clamp recording was carried out  in the conventional 
whole-cell configuration, at room temperature (15~25℃). For voltage clamp, cells 
were clamped at  -50mV and whole-cell current was evoked by steps from -140mV to 
+100mV in 10mV increment for 200ms. Current was detected at 20ms after the 
stimulation of each voltage step. For current clamp, cells were held at I=0. 
Membrane potential was recorded after cells were stabilized for 5min. During 
recordings filter was 2kHz and sampling was 100µs.
Cells were plated in 6 well plate with glass coverslips at 2~3×105 cells/well. The 
culture duration and LPS activation method were described in section 2.1.1.5.2. 
Coverslips were then transferred to the recording chamber which was attached to an 
inverted microscope (Diaphot 300, Nikon). Patching was performed using ×40 phase 
contrast objective. The fine manipulation of the pipette was operated by using the 
mechanical and hydraulic manipulators (model MHW-3, Narishige International, 
Japan) which was mounted on the microscope stage. Whole-cell signal was obtained 
using an Axopatch-200A patch clamp amplifier (Axon Instruments, USA), a digitizer 
(Digidata 1320, Axon Instruments) and a computer with pClamp (v8) installed. 
Pipettes were pulled by a Flaming/Brown type micropipette puller (P-97, SUTTER 
instrument CO.) and fire polished (home-made fire polisher) every day and 
subsequently  mounted to the headstage (CV201A, Axon instruments). To investigate 
the sensitivity  of whole-cell current to pharmacological manipulation, cells were 
incubated with bath solution containing channel modulators in the 
electrophysiological chamber for >5min before the patching.
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2.1.3.2 Solutions
Pipette and bath solutions were modified from (Pannasch et al., 2006) in which the 
physiological K+ gradient was applied. Bath solution (mM): 150 NaCl, 5.4 KCl, 2 
CaCl2, 1 MgCl2, 5 HEPES (pH=7.4) and 10 D-glucose; Pipette solution (mM): 130 
KCl, 2 MgCl2, 2 K2-ATP, 10 HEPES (pH=7.3), with intracellular free Ca2+ buffered 
to 10nM or 1µM by 1mM BAPTA. Osmolarity for each solution was adjusted at 
290~310mosM with the pipette solution normally  10 lower than bath solution using 
sucrose (Kotecha & Schlichter, 1999).
2.1.3.3 Low sealing success rate on N9 cells & glass capillaries
Before performing whole-cell patching assay, optimization of cell sealing was 
performed. The following glasses were tested:
Borosilicate glass capillaries with filament, GC150F-7.5 (Harvard Apparatus)
Borosilicate glass capillaries with filament, GC150TF-7.5 (Harvard Apparatus)
Borosilicate glass capillaries no filament, #1409250 (Hilgenberg)
Borosilicate glass capillaries no filament, #1409249 (Hilgenberg)
Borosilicate glass capillaries no filament, #EN-1 (Garner Glass Co.)
Here either Hilgenberg (#1409250) or Harvard (GC150TF-7.5) was most suitable for 
N9 microglia patching. The optimal resistance of patch electrodes was 2.7±0.3MΩ. 
However, the optimized sealing rate was not above 7.5%.
2.1.4 Data analysis
Data statistics was processed using GraphPad Prism v5 (GraphPad Software, Inc). 
Statistical analysis was carried out using either Student’s t-test or Anova with post-
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hoc comparison test as indicated in each figure legend. Significant difference was 
indicated by p values of *p<0.05, **p<0.01 and ***p<0.001.
2.2 Reagents
Cell culture reagents: DMEM  (#41965, GIBCO); IMDM  (#21980, GIBCO); FCS 
(#10270, GIBCO); HBSS (#14175, GIBCO); 0.05% Trypsin-EDTA (#25300, 
GIBCO); PEN & STREP (#15140, GIBCO); β-MET (#3135, GIBCO).
Pharmacological reagents: LPS (vehicle H2O, from E. coli 055:B5, #L6529, 
SIGMA); Tram34 (vehicle dimethyl sulfoxide (DMSO), #T6700, SIGMA); BaCl2 
(vehicle H2O; #342920, SIGMA); GBC (vehicle DMSO, #G0639, SIGMA); PPF-
hydrochloride (vehicle DMSO, #P4670, SIGMA); MgTX (vehicle DMSO, M8437, 
SIGMA); paxilline (vehicle DMSO, from Penicillium paxilli, #P2928, SIGMA); 
NS1619 (vehicle ethanol, #N170, SIGMA); NS309 (vehicle DMSO, #N8161, 
SIGMA); Griess reagent (#G2930, SIGMA); CellTiter 96 Aqueous One Solution 
Cell Proliferation Assay kit (#G3580, Promega).
Molecular reagents: RNeasy Mini Kit (#74104, QIAGEN); Transcriptor High 
Fidelity cDNA Synthesis Kit (#05081963001, Roche); RNAse Zap  (#AM9780, 
Ambion); FastStart Universal SYBR Green Master (Rox) (#04813750001, Roche); 
primers for qRT-PCR (SIGMA)





N9 Microglial Cell Line &
LPS-induced Nitric Oxide Release
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3.1 Chapter introduction
3.1.1 Microglia play an important role in the CNS
As the guardian in the central nervous system (CNS), microglia regulate their 
environment by interacting with neighboring cells like neurons and astrocytes. 
During pathological conditions like external infection, microglia undergo activation 
and protect the CNS by  releasing pro-inflammatory cytokines, recognizing and 
phagocytosing the invading material. As over-activated microglia may become 
harmful to the native cells in the CNS, they are implicated in a variety  of CNS 
diseases like Alzheimer’s disease (AD), Parkinson’s disease (PD) and multiple 
sclerosis (MS) (Mrak & Griffin, 2005; Dheen et al., 2007). Thus, microglia are an 
important cellular component for understanding CNS diseases.
3.1.2 N9 murine microglia cell line
The difficulties in purifying primary microglia and their maintenance of the resting 
state to allow systematic gene expression and functional studies led us to explore the 
N9 murine microglial cell line as a suitable model.
N9 murine microglia cell line has been used in >110 published studies in NCBI 
PubMed in the last 10 years. This cell line was constructed from the brain of 
embryonic day (E)13 CBA mice using the 3RV retrovirus containing an active v-myc 
oncogene (Righi et al., 1989). As discussed in section 1.2.3.5, N9 microglia have 
been often utilised in the investigation of microglial activation and nitric oxide (NO) 
release (Zhao et al., 2011; Chang et al., 2008; Meng et al., 2008; Wu et al., 2007; 
Hou et al., 2006; Bi et al., 2005; Suuronen et al., 2006; Nuutinen et al., 2005; 
Suuronen et al., 2003). However, to date electrophysiological analysis in ion channel 
expression in N9 microglia and their functional role have not been fully clarified.
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3.1.3 Optimizing N9 microglia culture conditions
For culture in vitro, as microglia are very sensitive to the environment, a suitable 
growth medium is important to keep them in resting status. In previous studies, 
several different media for N9 microglial growth were used (Table 2-2). However, 
whether they are all suitable for keeping N9 in the resting state or there are 
differences in N9 properties between them is not clear. The media frequently used 
included the following materials: Iscove’s modified Dulbecco’s medium (IMDM), 
fetal calf serum (FCS), glutamine (GLX), penicillin (PEN), streptomycin (STREP) 
and β-mercaptoethanol (β-MET). PEN and STREP are both bactericidal antibiotics 
used to kill bacteria in the growth medium.
To determine an optimal growth medium for the subsequent research, three different 
growth media with components based on previous studies were examined (Table 
2-3). The validation of each growth medium was determined by three steps: (1) The 
proliferation rate of microglia measured using cell counting. (2) The ramified level of 
microglia determined by comparing the length of the longest process to the diameter 
of cell soma. (3) The microglial NO release under each culture condition determined 
by the Griess reagent assay.
3.1.4 Optimizing LPS-induced activation of N9 microglia
Lipopolysaccharide (LPS) challenge has been commonly used in studies 
investigating N9 microglial activation (Or et al., 2011; Chang et al., 2008; Chang et 
al., 2008; Wang et al., 2004; Qin et al., 2005; Qin et al., 2004; Roy et al., 2008; Huo 
et al., 2011; Zhao et al., 2011; Chang et al., 2008; Meng et al., 2008; Wu et al., 2007; 
Hou et al., 2006; Bi et al., 2005; Suuronen et al., 2006; Nuutinen et al., 2005; 
Suuronen et al., 2003). However, the dose and duration of LPS exposure as well as 
N9 seeding density varied widely in previous studies (Zhao et al., 2011; Chang et al., 
2008; Meng et al., 2008; Wu et al., 2007; Hou et al., 2006; Bi et al., 2005; Suuronen 
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et al., 2006; Nuutinen et al., 2005; Suuronen et al., 2003). For example, the 
concentration LPS ranged from 1ng/ml to 10µg/ml, the duration of LPS challenge 
ranged from 6hr to 48hr and the seeding density  ranged from 4×104/cm2 to 2.7×105/
cm2 (Table 3-1). In addition, it is noteworthy  that the results under some LPS 
challenge conditions are contradictory. For example, the use of 10µg/ml LPS has 
been reported several times without causing death of microglia (Suuronen et al., 
2006; Nuutinen et al., 2005; Suuronen et al., 2003), but other studies revealed that 
this concentration was toxic to microglia (Sivagnanam et al., 2010; Zahn et al., 
1997). These findings indicate that although LPS has been usually used to trigger N9 
activation, the microglial activation by LPS is in need of systematic analysis. There 
have been a limited number of publications addressing this. For instance, 
0.001~10µg/ml of LPS has been tested on N9 for 18hr at seeding concentration of 
8×104 cells/well in 96 well plate after which only 1µg/ml and 10µg/ml stimulate 
detectable nitrite (NO2-) in the supernatant (Chang et al., 2008). N9 cells treated by 
5µg/ml LPS for 6hr, 12hr and 24hr induced about 2µM, 5µM  and 15µM NO2- in the 
supernatant (Suuronen et al., 2006) while 10µg/ml LPS treated N9 cells for 12hr and 
24hr and induced about 2µM and 18µM  NO2- (Suuronen et al., 2003). However, 
when examining the relationship between LPS treatment and NO release it  is 
necessary  to consider the cell seeding density, LPS concentration and LPS challenge 
duration at the same time. Thus the relationship between these three elements on N9 
microglial NO release was tested aiming to generate a consistent activation protocol 
for the following experiments.
3.1.5 Working hypothesis
In this chapter, the hypothesis that  microglial NO release depends on LPS 




Table 3-1. A variety of N9 microglial activation methods by LPS. The 
concentration (1ng/ml~10μg/ml), culture duration (6~48hr) and the N9 cell 
seeding density varied considerably among different in vitro studies.
Con. Time Seeding density (cells/well) References
1~10ng/ml 18hr 8×104; 96 well plate (Chang et al., 2008)
1μg/ml 24hr or 48hr 5×104; 96 well plate (Zhao et al., 2011)
1μg/ml 24hr 3×104; 96 well plate (Hou et al., 2006; Bi et al., 2005)
1μg/ml 48hr 3×104; 96 well plate (Wu et al., 2007)
1μg/ml 48hr 5×104; 96 well plate (Meng et al., 2008)
10μg/ml 6hr 12hr or 24hr 2×105; 24 well plate (Suuronen et al., 2006)
10μg/ml 12hr or 24hr 4×104 cells/cm2 (Suuronen et al., 2003)
10μg/ml 24hr 2×105; 12 well plate (Nuutinen et al., 2005)
3.1.6 Aims to be addressed in this chapter
3.1.6.1 What is the status of N9 cells in different growth media?
Based on previous studies, three growth media were created and analyzed, namely, 
GM[0], GM[1] and GM[2] (Table 2-3). The basal medium for GM[0] is Dulbecco’s 
Modified Eagle Medium (DMEM) while GM[1] and GM[2] are IMDM. In addition, 
GM[1] includes extra β-MET compared to GM[2]. The morphology of N9 cells were 
examined by comparing the length of the longest process to the diameter of soma as 
resting microglia have long process and small soma. In addition it was questioned 
whether the proliferation rate of N9 cells was different in different growth media. 
This was measured using cell counting. Besides morphology and proliferation, it  was 
investigated whether N9 cells were activated in these growth media in the absence of 
LPS. The NO released by microglia was measured as NO2- concentration in the 
supernatant using the Griess reagent assay.
3.1.6.2 What is the relationship between LPS exposure and microglial 
status?
In previous studies, LPS-induced microglial NO release was widely used as a 
microglial activation model. However, the relationship between LPS concentration, 
culture duration, microglial seeding density and NO release has not  been fully 
examined. To examine this question, a series of LPS challenge conditions was 
applied. LPS concentration ranged from 10ng/ml to 1µg/ml. LPS culture time ranged 
from 12hr to 48hr. In addition, a series of microglial seeding density was applied.
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3.2 Results
3.2.1 Cell proliferation under three different growth media
N9 cells were seeded into 25cm2 flasks at the same density (2.5×105 cells/flask) 
using different growth media of same volume: GM[0], GM[1] and GM[2] (Table 
2-3) and cells were cultured for up to 120hr without replacing the growth medium. 
Details of the procedure are described in Chapter 2. Cell confluency increased under 
different growth media and was different after 72hr of culture and this difference 
became more obvious at 120hr of culture (Figure 3-1).
After 72hr of culture, cells at six locations of each 25cm2 flask were counted. Cells 
in GM[0] displayed a significant reduction which was ~36.8% of the cell number 
compared to GM[1] and GM[2]. The cell number of N9 cells cultured in GM[1] and 
GM[2] displayed no difference with each other (Figure 3-2).
3.2.2 Morphology of N9 cells in three different growth media
Activated microglia display  amoeboid morphology while resting microglia display 
ramified morphology. To determine the status of microglia in these growth media, the 
morphology of cells was analyzed first.
To avoid cell contact which can influence cell morphology, the measurement was 
performed at 24hr of culture. No latter than this stage, cells in each growth medium 
began to form long processes while part of them still displayed round soma with 
short processes (Figure 3-3A). The mean diameter of soma and length of the longest 
process of each cell were them measured (Figure 3-3). The result indicated that cells 
in GM[0] and GM[1] displayed similar diameter of soma which were 17.5±0.2µm 
and 17.2±0.2µm. Cells in GM[2] growth medium displayed significantly smaller 
soma at  16.7±0.2µm compared to GM[0]. For the length of process, cells in GM[1] 
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Figure 3-1. Representative photographs of N9 cells cultured in different 
growth media for 24hr~120hr. Same amount (2.5×105 cells/flask) of N9 
cells were seeded into three 25cm2 flask cultured in same volume of GM[0], 
GM[1] and GM[2] for up to 120hr without replacing the growth medium. The 














Figure 3-2. Quantification of cell number at 72hr after seeding. On day  3 
(72hr) cell density of each culture condition was: GM[0] 515±63.9/mm2, 
GM[1] 1381±150.8/mm2 and GM[2] 1416±133.0/mm2. N9 cells in GM[0] 
proliferated slower than GM[1] and GM[2] while GM[1] and GM[2] had no 
difference on the N9 microglial proliferation rate. Data are given as mean

















Figure 3-3. Microglial morphology in different growth media. (A) Images 
of N9 cells at 24hr of culture in three different growth media. Cells began to 
expand by extending their processes no latter than this stage. (B) At this 
stage, the diameter of soma and length of the longest process of each cells 
were measured. The diameters of cell soma in each growth medium were: 
GM[0]=17.5±0.2μm, GM[1]=17.2±0.2μm and GM[2]=16.7±0.2μm. The 
lengths of the of process were: GM[0] 30.3±1.1μm, GM[1]: 34.7±1.3μm and 
GM[2]: 32.5±1.0μm. Cells in GM[0] had the larger soma and shorter process 
while there was no difference between cell morphology  in GM[1] and GM[2]. 
Data are given as mean±SEM. *p<0.05, **p<0.01, by ANOVA with Tukey post 
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and GM[2] had similar length processes at  34.7±1.3µm and 32.5±1.0µm while cells 
in GM[0] had significantly shorter processes at 30.3±1.1µm compared to GM[1] 
(Figure 3-3B).
As the proportion of ramified microglia may be different in each growth medium, the 
ratio between the length of the longest process and the diameter of soma of each cell 
was then determined. Cells in GM[0] displayed the smallest ratio while GM[1] and 
GM[2] were similar (Figure 3-4). To obtain a more direct understanding on the 
proportion of ramified microglia in the culture, the proportion whose process was 
two times longer than or equal to the diameter of the soma were calculated 
(Kozlowski & Weimer, 2012) of which cells in GM[1] displayed the highest value of 
38.5% and cells in GM[0] displayed the lowest at 30.0% (Figure 3-4).
3.2.3 The microglial NO release in three different growth media
Besides the morphological examination, microglial resting status in different growth 
media was also compared through the microglial NO release. At 120hr of culture, the 
supernatant was collected for Griess reagent assay. None of the supernatant had 
detectable NO2- level which meant N9 cells in any growth medium did not release 
significant NO during the whole culture process (data not shown).
3.2.4 Seeding amount and microglial NO release
Cells in GM[0] displayed most larger cell soma and most shorter process (Figure 
3-3), GM[0] was not  suitable for N9 microglial maintenance. GM[1] and GM[2] did 
not display much difference from each other. Because GM[1] was more commonly 
used in previous publications (Table 2-2) (Meng et al., 2008; Wu et al., 2007; Hou et 
al., 2006; Bi et al., 2005; Cavaliere et al., 2005), it was used for the subsequent 
assays. The relationship between cell number and LPS-induced microglial NO 
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Figure 3-4. The ratio of process/soma and the proportion of ramified 
cells in three growth media. At 24hr after plating, the ratios of process vs. 
diameter of soma for cells in different growth medium were: GM[0]=1.7±0.1, 
GM[1]=2.0±0.1 and GM[2]=2.0±0.1. The proportion of cells whose process 
were not less than twice the diameter of soma were: GM[0]=30%, 
GM[1]=39% and GM[2]=37%. Data are given as mean±SEM. *p<0.05, 
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release was first  examined. Serial dilutions of N9 cells (0~2×105 cells/well; 24 well 
plate) were seeded and cells were cultured for 24hr before LPS was applied (1µg/ml; 
24hr). NO release increased dramatically  above the seeding density of 2.5×104 cells/
well after which the NO release and the cell density  displayed a near linear 
relationship  (Figure 3-5). Thus the seeding density in the range from 2.5×104 cells/
well to 2×105 cells/well on 24 well plate was suitable for the N9 microglial NO 
release. The detail of seeding density on different culture vessels is indicated in Table 
2-1.
3.2.5 Time course and dose response of LPS-induced NO release
The cells were cultured for up  to 48hr. At 0hr, 12hr, 24hr, 36hr, 48hr after seeding, 
LPS with different concentrations (0ng/ml, 10ng/ml, 100ng/ml, 1µg/ml) were 
applied.
The results indicated that following LPS application, the NO2- concentration in the 
supernatant increased in the first 12hr, reached a plateau within 12hr~36hr, and 
displayed a dropping phase after 36hr of LPS challenge until 48hr (Figure 3-6).
In addition, NO was released in a dose-dependent manner by  LPS. Under any LPS 
challenge duration, 1µg/ml LPS always triggered the most NO released while 10ng/
ml of LPS always induced the least NO release (Figure 3-6 and Figure 3-7). Using 
1µg/ml of LPS, the peak value appeared between 24hr or 36hr (Figure 3-7). There 
was no significant difference between these two values, (Figure 3-6), thus 1µg/ml for 
24hr of LPS was chosen for N9 microglial activation.
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Figure 3-5. The seeding density of N9 cells and LPS-induced microglial 
NO release. Cells were cultured in 24 well plate for 24hr before the 
application of 1μg/ml LPS for another 24hr. There was a threshold of 2.5×104 
cells/well before the detectable nitric oxide (NO) release. When seeding 
density was over this threshold the nitrite (NO2-) concentration, they 
displayed a near linear relationship  with seeding density. Data are given as 
mean±SEM. ***p<0.001 vs. the preceding value, by ANOVA with Tukey post 
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Figure 3-6. Time course of LPS challenge on N9 microglial NO release. 
Same amount of cells were challenged with different concentrations of LPS 
(0~1μg/ml) and duration (0~48hr). Nitrite began to accumulate in the 
supernatant during the first 12hr of LPS challenge (left dotted rectangle). The 
application of 1μg/ml LPS always induced the most abundant nitrite in the 
supernatant and there was a plateau at around 24hr to 36hr culture duration. 
The nitrite concentration began to decrease after around 36hr of culture (right 
dot rectangle). Data are given as mean±SEM. **p<0.01, ***p<0.001, by 
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Figure 3-7. Dose-dependent effect of LPS on microglial NO release. Data 
presented in Figure 3-6 are re-plotted to reveal the dose-dependent effect of 
LPS-induced microglial NO release. 24hr and 36hr of 1μg/ml LPS stimulation 
induced peak nitrite concentration in the supernatant (dotted circle). Data are 
given as mean±SEM. Error bars are within the symbol unless otherwise 
shown. (n=3)
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3.3 Discussion
3.3.1 N9 cells displayed higher proliferation rate in IMDM than 
DMEM
As indicated by the result the cells in GM[0] proliferate slower than ones cultured in 
either GM[1] or GM[2] while cells in GM[1] and GM[2] have the same growth rate. 
The main difference between GM[0], GM[1] and GM[2] is the basal medium. As 
indicated in the introduction, the basal medium used was DMEM  (excl. GLX) for 
GM[0], and IMDM (incl. GLX) for GM[1] and GM[2]. Thus the difference probably 
results from the basal medium.
IMDM was originally designed for the culture of lymphocytes (Iscove & Melchers, 
1978) which in addition was suitable for cell proliferation in in vitro cultures. 
Compared to DMEM, IMDM contains extra selenium, sodium pyruvate and other 
components like amino acids and vitamins. Here selenium may provide an essential 
trace element to N9 cells and incorporate into enzymes which then display 
antioxidant functions and protect cells against harmful oxidative damage from 
peroxides such as organic hydroperoxides and peroxynitrites in the growth medium. 
Sodium pyruvate is commonly used as an energy source in the culture medium and 
similar to selenium it also provides an antioxidant  effect (Giandomenico et al., 
1997). GLX included in the IMDM  medium is one non-essential amino acid (Fürst & 
Stehle, 2004) and it is also the only amino acid which can directly cross the blood-
brain barrier (BBB) (Reeds, 2000). Including GLX in the medium may thus mimic 
the CNS environment to the microglia culture in vitro. In addition, GLX also 
participates in DNA synthesis, protein synthesis, division of immune cells and energy 
support to the brain. The advantage of IMDM compared to DMEM for N9 cell 
proliferation may thus come from these elements which protected and facilitated the 
microglial growth in the culture.
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3.3.2 N9 cells in DMEM displayed reduced ramified morphology
Cells in DMEM  not only displayed a low proliferation rate but also a less ramified 
morphology  with larger soma and shorter processes. Only  30% cells in GM[0] 
displayed long process as twice the diameter of soma compared to 39% in GM[1] 
and 37% in GM[2]. As indicate above, the extra components in IMDM, such as 
selenium protected cells from reactive oxygen species (ROS) damage. Cells cultured 
in medium without such protected mechanism may display  a more activated status, 
but this was not a fully  activated status due to there was no NO2- detected in any 
growth medium. Microglial status is associated with their morphology and this may 
explain why there were fewer ramified cells cultured in DMEM than the ones in 
IMDM. As keeping microglia in a resting status during in vitro culture was the aim 
of the experiment, the medium GM[0] and GM[1] may be the most optimal medium.
3.3.3 β-MET did not affect cell proliferation and morphology in the 
IMDM based growth medium
Cells cultured in GM[1] and GM[2] did not display  significant difference in 
proliferation rate, diameter of soma, length of process or the ratio of process/soma. 
As indicated above β-MET was the only the difference between GM[1] and GM[2] 
(Table 2-3). Functionally β-MET provides a similar antioxidant effect as selenium to 
cells. However, as IMDM already included the antioxidant components, the effect of 
β-MET may not induce a sufficient influence to the cells. However, besides the 
antioxidant effect β-MET also promotes the uptake of cysteine from the medium and 
facilitates immune system function, like T lymphocyte-dependent immune response 
(Heidrick et al., 1984). As microglia belong to the monocytes/macrophages lineage 
and in previous studies the GM[1] was the most commonly used recipe for N9 cell 
culture in vitro (Table 2-2) (Meng et al., 2008; Wu et al., 2007; Hou et al., 2006; Bi 
et al., 2005; Cavaliere et al., 2005), GM[1] was used as our growth medium for N9 
murine microglia.
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3.3.4 There was a minimum seeding density of N9 to trigger 
abundant NO release
Results indicated that when the seeding density  was over 2.5×104 cells/well on a 24 
well plate NO2- concentration in the supernatant was significantly increased (Figure 
3-5). This means there was a threshold of cell density over which abundant NO will 
be released and detected in our assay. Such density-dependent LPS-induced 
microglial activation may be due to cell to cell communication through gap  junctions 
(Newman, 2001). Microglia form gap junctions (Dobrenis et al., 2005) and inositol 
trisphosphate (InsP3) may pass through to induce the release of Ca2+ from 
endoplasmic reticulum (ER) stores (Newman, 2001; Scemes & Giaume, 2006). The 
elevated intracellular Ca2+ concentration ([Ca2+]i) may then regulate Ca2+-dependent 
phosphorylation pathways, regulate activity of nuclear factor kappa-light-chain-
enhancer of activated B cells (NFκB), produce inducible nitric oxide synthase 
(iNOS) and NO.
Above the threshold density  it was a near linear relationship between NO release and 
cell density  at least in the range between 2.5×104~2×105 cells/well on 24 well plate. 
By normalizing cell amount to the area of 24 well which is 1.9cm2 (Table 2-1), the 
suitable seeding density for LPS-induced microglial NO release was from 1.3×104/
cm2 to 1.1×105/cm2.
3.3.5 Time- and dose-dependent effect of LPS-induced NO release
Activated microglial NO release displayed a time- (Figure 3-6) and dose-dependent 
(Figure 3-7) manner to LPS treatment. The time course of LPS-induced NO release 
did not display  a linear relationship. However, there was an increasing phase at 
around 12hr of culture, a plateau at around 24~36hr before a decreasing phase 
beginning at around 36hr of culture (Figure 3-6). The mechanism why the NO2- 
concentration began to drop at longer culture durations with LPS was not clear. 
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Similar phenomenon indicated that LPS-induced pro-inflammatory mRNA 
expression, including iNOS mRNA, decreased at around 48hr (Nikodemova & 
Watters, 2011) and NFκB has a time-dependent inactivation phenomenon which was 
supposed to the decreased binding activity of the transcription factor (Granado-
Serrano et al., 2010). In addition, LPS-induced microglial activation may desensitize 
over a long periods (Nörenberg et al., 1992).
Microglial activation displayed a dose-dependent of LPS application at  least within 
the range of 10ng/ml~1µg/ml. Similar phenomenon was observed in previous studies 
as well (Chang et al., 2008). Here 1µg/ml for either 24hr or 36hr of LPS induced 
most abundant NO release. As 36hr may  be included in the decreasing phase (Figure 
3-6), 1µg/ml for 24hr was chosen as the LPS activation for the subsequent N9 
microglial in vitro studies here.
3.3.6 Conclusion
Here the optimal growth medium for N9 cell in vitro culture was determined which 
consists of IMDM (including 4mM  GLX), 5% FCS, 100µg/ml STREP, 100U/ml 
PEN, and 50µM β-MET. In addition, the optimal cell seeding density, LPS 
concentration and LPS challenge duration for N9 cell activation were systematically 
examined. Thus the activation protocol for subsequent assays on N9 cells was: 
Seeding density was 1.3×104~1.1×105/cm2 for 24hr before the application of 1µg/ml 
LPS and culture with LPS for another 24hr. This provided a reliable and efficient 
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4.1 Chapter introduction
4.1.1 Ion channels expressed in microglia
Microglia have been reported to express a variety of ion channels including calcium 
(Ca2+) channels, potassium (K+) channels, proton (H+) channels, sodium (Na+) 
channels, chloride (Cl-) channels as well as a variety  of ion pumps (Färber & 
Kettenmann, 2005; Eder, 2005; Kettenmann et al., 2011). Ions play  important roles 
in regulating cellular functions like maintaining the resting membrane potential, 
cellular migration, proliferation, intracellular phosphorylation pathways and 
intercellular signal transduction. The expression of ion channels was believed to be 
associating with the microglial status (Kotecha & Schlichter, 1999; Boucsein et al., 
2000; Kettenmann et al., 1990; Nörenberg et al., 1992; Nörenberg et al., 1994; 
Chung et al., 1999; Boucsein et al., 2003; Schilling & Eder, 2007; Boucsein et al., 
2003; Kettenmann et al., 1990; Ducharme et al., 2007; X. Jiang et al., 2003) which 
can be modulated by exposure to various agents like lipopolysaccharide (LPS), 
lysophosphatidylcholine (LPC), tumor necrosis factor alpha (TNFα) or adenosine 
triphosphate (ATP). Thus studies on the expression pattern of ion channels may 
provide insight into microglial activation.
4.1.2 K+ channels play important roles in regulating cellular 
properties
As one of the largest families of ion channels, K+ channels include four major types 
including calcium-activated K+ channels (KCa), inwardly rectifying K+ channels (Kir), 
tandem pore domain K+ channels (K2p) and voltage-gated K+ channels (Kv). K+ 
channels set the resting membrane potential, regulate neuronal action potentials, 
modulate physiological functions of cardiac muscle, maintain vascular tone and 
regulate the secretion of hormone. They also play important  roles in the immune 
system (Mullen et al., 2006; Cahalan et al., 2001; Koo et al., 1997; Ahluwalia et al., 
2004), central nervous system (CNS) inflammation and neuronal degenerative 
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diseases (Judge et al., 2006). Thus investigation of microglial K+ channel functions 
may provide new pathways for treatment of CNS-related diseases.
4.1.3 Microglial K+ channel expression in the published data
Microglia are very sensitive to the extracellular K+ (Gehrmann et al., 1995) as they 
express K+ channels which regulate homeostasis of the intracellular and extracellular 
K+. K+ channels found in microglia include Kv1.1 (Wu et al., 2009), Kv1.2 (Li et al., 
2008b; Fordyce et al., 2005; Kotecha & Schlichter, 1999), Kv1.3 (Küst et al., 1999; 
Kotecha & Schlichter, 1999; Khanna et al., 2001; Fordyce et al., 2005; Pannasch et 
al., 2006), Kv1.5 (Pannasch et al., 2006; Khanna et al., 2001; Fordyce et al., 2005; 
Kotecha & Schlichter, 1999), Kv1.6 (Kotecha & Schlichter, 1999), G protein-coupled 
inwardly-rectifying K+ channels (GIRKs) (Ilschner et al., 1996; Ilschner et al., 
1995), human ether-a-go-go-related gene (HERG) channels (Zhou et al., 1998), large 
conductance Ca2+-sensitive and voltage-activated K+ channels (BK) (McLarnon et 
al., 1997; McLarnon et al., 1995; Schilling et al., 2002), small conductance Ca2+-
activated K+ channels (SK) family members (Khanna et al., 2001; Kaushal et al., 
2007; Eder, Klee & Heinemann, 1997b; Khanna et al., 2001), intermediate 
conductance Ca2+-activated K+ channels (IK) (Kaushal et al., 2007; Khanna et al., 
2001; Schilling et al., 2002; Schilling, Stock, et al., 2004b; Schilling, Lehmann, et 
al., 2004a; Eder, Klee & Heinemann, 1997a), Kir1.1 (Küst et al., 1999), Kir2.1 
(Schilling et al., 2000), Kir6.1 (Ortega et al., 2012) and Kir6.2 (Ortega et al., 2012). 
The expression of these K+ channels was based on analysis at gene level, protein 
level or functional characterization of ionic currents (Table 4-1). The ionic currents 
of both Kv1.5 and Kv1.3 can be enhanced by LPS treatment (Pannasch et al., 2006) 
while Kv1.3 expression, but not Kv1.5 was increased by  external TGFβ (Schilling et 
al., 2000). Change in gene expression may not link to the expression change of 
protein for example mRNA of Kv1.3 was upregulated by  external LPS which did not 
change the protein expression (Fordyce et al., 2005). Findings on gene expression of 
K+ channels were controversial. For example, expression of Kv1.1 was found in 
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Channels Species preparation Reference
Kv1.1 mice:& BV-2 cell line
rat:& brain slice
(Wu et al., 2009)
Kv1.2 mice:& BV-2 cell line
rat:& cultured primary cells
& brain slice
(Li et al., 2008a; Fordyce et al., 2005; 
Kotecha & Schlichter, 1999)
Kv1.3 rat:& cultured primary cells
mice:& brain slice
& cultured primary cells
& BV-2 cell line
(Cayabyab  et al., 2000; Visentin et al., 2001; 
Chung et al., 2001a; Schilling & Eder, 2007; 
Kotecha & Schlichter, 1999; Fordyce et al., 
2005; Khanna et al., 2001; Pannasch et al., 
2006; Küst et al., 1999; Schilling et al., 2000)
Kv1.5 mice:& cultured primary cells
rat:& cultured primary cells
(Pannasch et al., 2006; Jou et al., 1998; 
Khanna et al., 2001; Chung et al., 2001a; 
Fordyce et al., 2005; Kotecha & Schlichter, 
1999)
Kv1.6 rat:& cultured primary cells (Kotecha & Schlichter, 1999)
Kv11.1 rat:& MSL-9 cell line (Zhou et al., 1998)
BK human: cultured primary cells
bovine:&cultured primary cells
mice:& brain slice
& BV-2 cell line
& cultured primary cells
(McLarnon et al., 1995; Schilling & Eder, 
2007; McLarnon et al., 1997; Schilling et al., 
2002)
SK2 rat:& cultured primary cells (Khanna et al., 2001)
SK3 rat:& cultured primary cells (Khanna et al., 2001; Schlichter et al., 2010)
SK1~3 mice:& cultured primary cells
rat:& cultured primary cells
(Eder, Klee & Heinemann, 1997b; Khanna et 
al., 2001)
SK4 rat:& cultured primary cells
mice:& cultured primary cells
(Khanna et al., 2001; Schilling et al., 2002; 
Schilling, Stock, et al., 2004b; Schilling, 
Lehmann, et al., 2004a; Kaushal et al., 2007)
Kir1.1 rat:& cultured primary cells (Küst et al., 1999)
Kir2.1 mice:& BV-2 cell line (Schilling et al., 2000)
GIRKs mice:& cultured primary cells (Ilschner et al., 1996; Ilschner et al., 1995)
Kir6.1 mice:& BV-2 cell line (Ortega et al., 2012)
Kir6.2 mice:& BV-2 cell line
rat:& brain slice
(Ortega et al., 2012)
SUR1 mice:& BV-2 cell line
rat:& brain slice
(Ortega et al., 2012)
SUR2B rat:& brain slice (Ortega et al., 2012)
Table 4-1
Table 4-1. Microglial K+ channel expression in previous studies. 
Evidence for K+ channel expression in primary or microglial cell lines. Data 
are based on gene, protein or current detection of K+ channels. Kv: voltage-
gated potassium channel; Kir: inwardly rectifying potassium channel; SK: 
small-conductance calcium-activated K+ channels; BK: large conductance 
calcium-sensitive and voltage-activated K+ channels; GIRKs: G protein-
coupled inwardly-rectifying potassium channels; SUR: sulfonylurea receptor.
microglia in brain slices from rat of postnatal day  (P)1~P10 (Wu et al., 2009), but in 
cultured rat primary microglia from P5~P14, the Kv1.1 mRNA was not detectable 
(Kotecha & Schlichter, 1999).
4.1.4 K+ channel expression in microglia needs systematic 
examination
As shown before, expression of several K+ channels has been found in microglia, but 
a systematic screen of all K+ channels, which includes four families and >80 
members, has not been addressed. In addition the expression of several K+ channels 
remains controversial such as Kv1.1, Kv1.3 which were described previously. The 
discrepancies may  result from the differences of cellular preparation as microglia are 
very sensitive to their environment which lead to changes in trafficking and 
expression of channels (Kotecha & Schlichter, 1999). Thus, to investigate K+ 
channels in microglia, it becomes necessary and important to screen the expression 
of K+ channels using a systematic and unified cellular preparation method. This will 
offer a huge benefit on the understanding of K+ expression in microglia and facilitate 
the investigation in the future.
4.1.5 Working hypothesis
In this chapter, the mRNA expression pattern of K+ channels in the N9 microglial 
cell line will be examined under control conditions and the LPS treatment.
94
4.1.6 Aims to be addressed in this chapter
4.1.6.1 What  is the expression pattern of K+ channels in resting 
microglia?
Based on the optimized cellular preparation described in Chapter 3, mRNA 
expression of >80 K+ channel subunits in resting N9 microglia were examined using 
quantitative reverse transcription polymerase chain reaction (qRT-PCR). Subunits 
included the pore-forming subunits and regulatory subunits of four K+ families. The 
four families included Kv, Kir, KCa and K2p. Primers for qRT-PCR were listed in 
Chapter 2 (Table 2-4 to Table 2-9).
4.1.6.2 The effect of LPS on K+ channel expression.
Beside the K+ channel expression in resting N9 microglia, changes in mRNA 
expression in activated microglia by LPS (1µg/ml, 24hr) were examined as well. The 
cellular preparation was identical to resting microglia in an attempt to have a 
standardized experiment model to generate comparable conditions for the expression 
of different K+ channels in resting and activated microglia.
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4.2 Results
4.2.1 Stability of β-actin expression in microglia
Due to the MIQE guidelines regarding the general procedure of qRT-PCR 
experiments (Bustin et al., 2009), use of a housekeeping gene for normalization in 
the experiment requires that its expression is not influenced by the condition of the 
experiments.
Thus before detecting the K+ channel expression, it was necessary to make sure the 
housekeeping gene, β-actin, did not change before and after LPS treatment. Its 
mRNA expression was tested in the resting N9 cells and LPS-activated N9 cells. Ct 
value of β-actin of each sample was normalised to the relative input cDNA 
concentration. The expression of β-actin was not influenced by LPS stimulation 
(Figure 4-1A) and during every  round of qRT-PCR experiments the stability of β-
actin expression was confirmed as well.
4.2.2 Confirmation of LPS-induced N9 microglial activation
For every  qRT-PCR experiment, microglial activation and control (resting) condition 
was confirmed using Griess reagent assay. It was confirmed that cells treated with 
LPS (1µg/ml, 24hr) were activated as nitrite (NO2-) was detected in the supernatant 
while cells without LPS treatment did not release detectable nitric oxide (NO) 
(Figure 4-1B).
4.2.3 Overview of K+ channel expression in microglia
As the expression of β-actin was stable with or without LPS treatment, the K+ 
channel expression in both resting microglia and LPS-activated microglia was 
96
97
Figure 4-1. Effect of LPS on the expression of β-actin and N9 microglial 
activation. During each qRT-PCR assay, N9 cells were either activated by 
lipopolysaccharide (LPS) or treated by vehicle as a control. (A) β-actin 
expression was not significantly regulated by LPS treatment. The data 
presented is the Ct value of β-actin normalised to input cDNA concentration. 
There was no significant difference between the expression of β-actin in LPS 
treated microglia and resting microglia. (B) With Griess reagent assay, it was 
confirmed that LPS is able to activate N9 microglia while resting microglia 






























normalised to the relative β-actin expression.
4.2.3.1 Expression pattern of K+ channels in N9 cells
Totally 82 subunits were examined including the pore-forming subunits of the Kv 
family, K2p family, KCa family, K2p family and the regulatory subunits of K+ channels 
(Figure 4-2). There were 17 out of the 82 subunits whose mRNA expression was not 
detectable. These subunits included Kcna2 (Kv1.2), Kcnb2 (Kv2.2), Kcnq2 (Kv7.2), 
Kcnq4 (Kv7.4), Kcnq5 (Kv7.5), Kcns1 (Kv9.1), Kcnh2 (Kv11.1), Kcnk13 (K2p13.1), 
Kcnj5 (Kir3.4), Kcnj10 (Kir4.1), Kcnj16 (Kir5.1), Kcnj8 (Kir6.1), Kcnj11 (Kir6.2), 
Kcnn2 (KCa2.2), Kcnt1 (KCa4.1), Kcnmb3 (sloβ3) and Abcc9 (SUR2) (Table 4-2). 
Among the 65 expressed subunits, only  Kcnk6 (K2p6.1) was significantly  decreased 
to 68.8% of control by LPS treatment. The detail of expression for each K+ family is 
described in the following sections.
4.2.3.2 Most abundantly expressed K+ channel subunits mRNAs
Among the 82 subunits, the mRNA encoding Kcnma1 (KCa1.1), Kcnk6 (K2p6.1), 
Kcnc3 (Kv3.3), Abcc8 (SUR1), Kcnj2 (Kir2.1), Kcnn4 (KCa3.1) were the most 
abundantly expressed in resting microglia. Expression of Kcnk6 (K2p6.1) was 
significantly reduced by LPS treatment (Figure 4-3). 
4.2.4. mRNA expression of Kv pore-forming subunits in N9 cells
In total 33 pore-forming subunits of this Kv family were examined which included 
members of Kv1.x, Kv2.x, Kv3.x, Kv4.x, Kv5.x, Kv7.x, Kv8.x, Kv9.x, Kv10.x, Kv11.x 
and Kv12.x excepted for subunits of Kv1.8, Kv6.x, Kv10.2 and Kv12.3 (Figure 4-4). 


































































































































































































































Figure 4-2. The expression pattern of K+ channel subunit mRNAs in N9 
cells before and after LPS treatment. X axis represents the K+ channel 
expression in resting N9 cells while Y axis represents the K+ channel 
expression in LPS activated N9 cells. Totally 82 subunits including pore-
forming subunits and regulatory subunits tested. 65 subunits were detectable 
which were represented in the chart. 17 subunits were not detectable (Table 
4-2). Data are given as mean. (n≥3)
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Table 4-2. Subunits that were not detectable. Totally  17 subunits were not 
detectable which are from all four K+ families.
Pore-forming subunits Regulatory 
subunitsKv family K2p family Kir family KCa family
Kcna2 (Kv1.2) Kcnk13 (K2p13.1) Kcnj5 (Kir3.4) Kcnn2 (KCa2.2) Kcnmb3 (sloβ3)
Kcnb2 (Kv2.2) Kcnj10 (Kir4.1) Kcnt1 (KCa4.1) Abcc9 (SUR2)
Kcnq2 (Kv7.2) Kcnj16 (Kir5.1)
Kcnq4 (Kv7.4) Kcnj8 (Kir6.1)










































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4-4. mRNA expression of pore-forming subunits of Kv family 
before and after LPS treatment. Seven subunits were not detectable which 
were Kcna2 (Kv1.2), Kcnb2 (Kv2.2), Kcnq2 (Kv7.2), Kcnq4 (Kv7.4), Kcnq5 
(Kv7.5), Kcns1 (Kv9.1) and Kcnh2 (Kv11.1). The most abundantly expressed 
subunits in the resting N9 microglia included Kcnc3 (Kv3.3), Kcnh6 (Kv11.2), 
Kcna3 (Kv1.3), Kcna5 (Kv1.5) and Kcnh7 (Kv11.3). Data are given as mean
±SEM. (n≥3)
Kcnb2 (Kv2.2), Kcnq2 (Kv7.2), Kcnq4 (Kv7.4), Kcnq5 (Kv7.5), Kcns1 (Kv9.1) and 
Kcnh2 (Kv11.1). In the resting N9 microglia, the most abundantly expressed subunits 
of this family included Kcnc3 (Kv3.3), Kcnh6 (Kv11.2), Kcna3 (Kv1.3), Kcna5 
(Kv1.5) and Kcnh7 (Kv11.3).
For the fold change of Kv pore-forming subunits, there was no subunit  significantly 
regulated by LPS treatment (Figure 4-5).
4.2.5 mRNA expression of Kir pore-forming subunits in N9 cells
Totally 13 pore-forming subunits of this Kir family  were examined which included 
members of Kir1.x, Kir2.x, Kir3.x, Kir4.x, Kir5.x and Kir6.x except for subunits of 
Kir2.2 and Kir7.1 (Figure 4-6). Five of the examined subunits were not detectable and 
they  were Kcnj5 (Kir3.4), Kcnj10 (Kir4.1), Kcnj16 (Kir5.1), Kcnj8 (Kir6.1) and 
Kcnj11 (Kir6.2). In the resting N9 microglia, the most abundantly  expressed subunits 
of this family included Kcnj2 (Kir2.1), Kcnj4 (Kir2.3), Kcnj1 (Kir1.1), Kvnj14 
(Kir2.4) and Kcnj3 (Kir3.1).
For the fold change of Kir pore-forming subunits, there was no subunit  significantly 
regulated by LPS treatment (Figure 4-7).
4.2.6 mRNA expression of K2p pore-forming subunits in N9 cells
Totally 11 pore-forming subunits of this K2p family  were examined which included 
members of K2p1.x, K2p2.x, K2p3.x, K2p4.x, K2p5.x, K2p6.x, K2p7.x, K2p9.x, K2p12.x, 
K2p13.x and K2p18.x except for subunits of K2p10.1, K2p15.1, K2p16.1 and K2p17.1 
(Figure 4-8). One of the examined subunits was not detectable and it was Kcnk13 
(K2p13.1). In the resting N9 microglia, the most abundantly expressed subunits of 
this family  included Kcnk6 (K2p6.1), Kcnk7 (K2p7.1), Kcnk18 (K2p18.1), Kcnk9 
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Figure 4-5. Fold change of Kv pore-forming subunits after LPS 
treatment. For the fold change of Kv pore-forming subunits, there was no 
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Figure 4-7. Fold change of Kir pore-forming subunits after LPS 
treatment. For the fold change of Kir pore-forming subunits, there was no 
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(K2p9.1) and Kcnk3 (K2p3.1).
For the fold change of K2p pore-forming subunits, Kcnk6 (K2p6.1) was significantly 
decreased by 31.2% by LPS treatment (Figure 4-9).
4.2.7 mRNA expression of KCa pore-forming subunits in N9 cells
Totally eight pore-forming subunits of this KCa family were examined which 
included members of KCa1.x, KCa2.x, KCa3.x, KCa4.x and KCa5.x (Figure 4-10). Two 
of the examined subunits were not detectable and they were Kcnn2 (KCa2.2) and 
Kcnt1 (KCa4.1). In the resting N9 microglia, the most abundantly expressed subunits 
of this family included Kcnma1 (KCa1.1), Kcnn4 (KCa3.1) and Kcnn1 (KCa2.1).
For the fold change of KCa pore-forming subunits, there was no subunit significantly 
regulated by LPS treatment (Figure 4-11).
4.2.8 mRNA expression of regulatory subunits in N9 cells
Totally 17 regulatory  subunits for Kv, Kir and KCa channels were examined which 
included members of Kvβ, MiRP, KChIP, SUR and sloβ families (Figure 4-12). Two 
subunits were not detectable and they were Abcc9 (SUR2) and Kcnmb3 (sloβ3). In 
the resting N9 microglia, the most abundantly expressed subunits of this family 
included Abcc8 (SUR1), Kcnmb4 (sloβ4), Kcne3 (MiRP2), Kcnmb2 (sloβ2) and 
Kcnab3 (Kvβ3).
For the fold change of regulatory subunits, there was no subunit significantly 
regulated by LPS treatment (Figure 4-13).
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Figure 4-9. Fold change of K2p pore-forming subunits after LPS 
treatment. For the fold change of K2p pore-forming subunits the expression 
of Kcnk6 (K2p6.1) was significantly  decreased to 68.8% by LPS treatment. 
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Figure 4-11. Fold change of KCa pore-forming subunits after LPS 
treatment. For the fold change of KCa pore-forming subunits, there was no 
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Figure 4-13. Fold change of regulatory subunits after LPS treatment. For 
the fold change of regulatory subunits, there was no subunit significantly 
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4.3.1 General conclusion of the result
In this chapter, the mRNA expression pattern of K+ channels was examined in resting 
N9 microglial cell line and their change in expression after microglial activation by 
LPS treatment was examined. This is the first time systematic screening of K+ 
channel gene expression using the qRT-PCR technique in N9 cells by comparing the 
expression in both resting and LPS-activated status. Based on the limited numbers 
(around 15~20) of K+ channel members previously reported in microglia (Table 4-1), 
the detection of >60 subunits dramatically expands the understanding of K+ 
expression in microglia.
The expression of K+ channel subunits displayed a low level compared to the 
reference gene as only 14% (9 out of 65 detected) of subunit expression was over 
0.01% of β-actin with the most abundant subunit mRNA expressed at less than 1% of 
β-actin. The reason may be that β-actin in N9 cells is expressed at a high level. As 
microglia have the ability  to change their morphology according to cellular status or 
to keep moving their processes to survey the environment, it may require high β-
actin expression.
As described in section 4.2.3.1, 65 subunits were expressed, but only the expression 
of Kcnk6 (K2p6.1) was significantly reduced by LPS treatment. The different effects 
of LPS on K+ channel expression may result from the different gene regulating 
pathways activated by  LPS. As described in section 1.2.4, LPS binds to the Toll-like 
receptor (TLR)4/cluster of differentiation molecule (CD)14 receptor which leads to 
the activation of various transcription factors including ETS-like transcription factor 
1 (Elk1), cAMP response element-binding protein (CREB), c-jun, nuclear factor 
kappa-light-chain-enhancer of activated B cells (NFκB), interferon regulatory factor 
(IRF)5 and IRF3 (Lu et al., 2008; Bjørkøy et al., 1995; Mas et al., 2003; Dauphinee 
& Karsan, 2006; Fenton & Golenbock, 1998; Tamemoto et al., 1992; Cobb & 
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Goldsmith, 1995; Meja et al., 2000; Chan et al., 2001). Thus K+ channel expression 
by LPS may be controlled by a complex rather than an unified pathway. In addition, 
in pituitary cells the mRNA expression of Kv1.5 was downregulated by  membrane 
depolarization which was Ca2+- and Na+-independent (Levitan et al., 1995). Thus, it 
may  be possible the transcription level of K+ channels is regulated by membrane 
potential (Lee et al., 2007; Kiefer & Schulze, 1982) and may be independent of the 
Ca2+-dependent phosphorylation pathways, such as Ca2+/calmodulin-dependent 
protein kinase II (CaMKII) or calcineurin.
4.3.2 Integration of results with published data
4.3.2.1 Kir channels
Kcnj1 (Kir1.1) was detected in our study which supported the finding in previous 
work (Küst et al., 1999). Kcnj1 (Kir1.1) was not significantly  regulated by LPS 
treatment. In isolated rat microglia, study investigating the relationship  between 
cyclic adenosine monophosphate (cAMP) and Kcnj1 (Kir1.1) gene expression 
indicated the elevation of cAMP decreased Kcnj1 (Kir1.1) gene expression (Küst et 
al., 1999). It  was known that elevation of cAMP can be induced by  LPS in human 
monocytes (Mengozzi et al., 1993). Perhaps the regulation of Kir1.1 channel mRNA 
expression may not only be through the LPS-induced cAMP pathway. For example, 
protein kinase C (PKC) has been postulated playing a role in expression of Kir1.1 
channels (Küst et al., 1999).
From the same Kir family, Kcnj2 (Kir2.1) was abundantly expressed in resting N9 
cells compared to most other channels. Here the finding of Kcnj2 (Kir2.1) in N9 cell 
line is inline with previous studies in BV-2 cells (Schilling et al., 2000). In addition, 
it was further discovered that mRNA expression of Kcnj2 (Kir2.1) was not 
significantly affected by LPS stimulation.
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In previous studies, the gene of Kcnj8 (Kir6.1), Kcnj11 (Kir6.2) and Abcc8 (SUR1) 
have been found expressed in BV-2 cells but at a very low level. Their expression 
was increased after microglial activation by  LPS+interferon gama (IFN-γ) (100ng/ml
+0.05ng/ml, 48hr) (Ortega et al., 2012) despite that the elevated gene expression was 
still low. Of these subunits only Abcc8 (SUR1) was expressed in N9 microglia 
suggesting that N9 and BV-2 share different expression properties on these type of 
channel subunits. The reason may be: (1) The difference expression pattern of these 
two cell lines as well as the difference between other cell lines (Horvath et al., 2008). 
(2) The different cell preparation and stimulation used to induce different microglial 
responses. In the previous study, BV-2 cells were treated by LPS+IFN-γ while here 
N9 was treated by LPS only. In addition, the concentration and duration of LPS 
treatment was different either 100ng/ml for 48hr for BV-2 cells or 1µg/ml for 24hr 
here. Neither N9 nor BV-2 cells express high level of Abcc9 (SUR2) subunit mRNA 
(Ortega et al., 2012).
4.3.2.2 Kv channels
The changes in mRNA expression of Kv channels between resting and activated N9 
microglia were compared to the previous studies. N9 cells express Kcna1 (Kv1.1) but 
this was not significantly  influenced by LPS activation. This was similar to BV-2 
cells in which both mRNA and protein of Kcna1 (Kv1.1) were discovered (Wu et al., 
2009). However, in BV-2 cells LPS elevated both its gene and protein expression 
(Wu et al., 2009). Such discrepancy may result from: (1) BV-2 was treated by 1µg/ml 
of LPS for 6hr but here 1µg/ml of LPS for 24hr was applied. LPS-regulated 
microglial current expression was indicated a time-dependent manner (Nörenberg et 
al., 1992). It may be possible the duration of LPS challenge played a role in the 
transcription of K+ channels. (2) In previous studies the protein expression of Kcna1 
(Kv1.1) was found in microglia in rat brain slices (C. Y. Wu et al., 2009) while Kcna1 
(Kv1.1) was not detected in isolated primary  microglia of the same species (Kotecha 
& Schlichter, 1999). This suggested that the culture environment may  play a role in 
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regulating the expression of microglial Kv1.1 channels. (3) For both microglia 
prepared in in vitro culture, BV-2 cells expressed Kcna1 (Kv1.1) (Wu et al., 2009) 
while primary rat  microglia did not (Kotecha & Schlichter, 1999). This suggested 
that different cell types may display different properties (Horvath et al., 2008).
Kcna2 (Kv1.2) channel mRNA was not detectable in N9 cells. This may go some 
way towards explaining the different phenomenon with previous studies. There was 
one previous study indicating Kcna2 (Kv1.2) expression in rat microglia in brain 
slices (Li et al., 2008a), one study detecting Kcna2 (Kv1.2) expression in BV-2 
murine microglia cell line (Li et al., 2008a) and two studies detecting Kcna2 (Kv1.2) 
expression in cultured primary rat microglia (Kotecha & Schlichter, 1999; Fordyce et 
al., 2005). However, comparing the details of these studies may give an explanation 
for the different results: (1) The study on microglia in brain slices indicated the 
expression of Kcna2 (Kv1.2) is an age-dependent phenomenon during which Kcna2 
(Kv1.2) expression disappeared when rats were older than P21 (Li et al., 2008a). 
Thus it was possible that  N9 cells represent a similar expression property on Kcna2 
(Kv1.2) to more mature primary microglia. (2) Another study using cultured primary 
rat microglia indicated that Kcna2 (Kv1.2) gene expression was not changed in 
activated microglia by LPS or phorbol 12-myristate 13-acetate (PMA) (Fordyce et 
al., 2005) while Kcna2 (Kv1.2) expression in activated microglia in brain slices of 
same species increased under hypoxia exposure. These different responses may be 
due to the different activation and maintenance methods which may change Kcna2 
(Kv1.2) expression. (3) It was indicated that different microglial cell lines had 
different physiological properties (Horvath et al., 2008). It  may be possible the N9 
microglial cell line differs from other cell types in the expression of Kcna2 (Kv1.2).
In primary rat microglia, Kcna3 (Kv1.3) gene was increased to 2~2.5 fold by  LPS 
(Fordyce et al., 2005). In addition, increasing cAMP, one of the downstream 
mediators of LPS, elevated gene expression of Kv1.3 by about 50%~100% (Küst et 
al., 1999). mRNA expression of Kcna3 (Kv1.3) in N9 cells here was not significantly 
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increased by LPS (1µg/ml, 24hr) although there was a trend to increase after 
activation which was about a 2.6 fold change. This was similar to the 2~2.5 fold 
change in cultured rat  microglia (Fordyce et al., 2005). Such discrepancies may be 
from the different activation methods in which 10ng/ml of LPS for overnight was 
used previously (Fordyce et al., 2005) and 1µg/ml of LPS for 24hr was applied here. 
As the LPS-induced microglial activation is a dose- and time-dependent process 
which was confirmed in Chapter 3, it is reasonable to assume different concentration 
and duration of LPS application may affect on Kcna3 (Kv1.3) gene expression.
In vivo work in rat brain indicated Kv1.5 protein expression in microglia and its 
upregulation by LPS (2µg) injection in the hippocampus (Jou et al., 1998). 
Expression of Kcna5 (Kv1.5) was detected in N9 here although its expression was 
not significantly  regulated by  LPS. The expression of Kv1.5 channels is still 
controversial. Besides the upregulation of Kv1.5 protein by  LPS in in vivo study, 
neither the gene nor protein was changed in isolated primary rat microglia in vitro 
culture by LPS (10ng/ml, overnight) treatment (Fordyce et al., 2005). What is more 
interesting, gene expression of Kv1.5 was decreased by LPS (10ng/ml, 24hr) in 
isolated primary  mouse microglia in vitro culture (Pannasch et al., 2006). The reason 
for the different results may be due to species differences and it also can not be 
neglected that the LPS activation method was different in each study. For example, 
the LPS injection to the brain may generate a very  high concentration of LPS at the 
injection point. In addition, as shown in Chapter 3, microglial response to LPS 
treatment was time- and dose-dependent, 10ng/ml of LPS may lead to a different 
channel expression pattern compared to the 1µg/ml used here.
One more Kv channel published before was Kcna6 (Kv1.6) (Kotecha & Schlichter, 
1999). Our work confirmed its expression in N9 microglia and indicated no 
significant influence by LPS treatment on its gene expression.
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4.3.2.3 KCa channels
BK-type current was recorded in the human, fetal and mouse microglia (McLarnon 
et al., 1997; McLarnon et al., 1995; Schilling & Eder, 2007). In addition, the 
expression of BK channel mRNA was found in the BV-2 microglial cell line 
(Schilling et al., 2002). However, whether BK mRNA expression changes under 
microglial activation by LPS has not been determined yet. It was shown here that 
Kcnma1 (KCa1.1) subunit mRNA was abundantly  expressed compared to other 
subunits in N9 microglia and its expression was not significantly influenced by  LPS. 
In addition, its β subunit mRNA was also examined in which Kcnmb3 (sloβ3) was 
not detectable and the gene of Kcnmb4 (sloβ4) was higher than Kcnmb1 (sloβ1) and 
Kcnmb2 (sloβ2). The work here extended the knowledge regarding BK gene 
expression in microglia. However as a complete BK channel is a tetramer of α 
subunits and may include four different β subunits, the distribution, proportion and 
function of both pore-forming subunits and β subunits in microglia still need to be 
further studied.
The mRNA of Kcnn1 (KCa2.1), Kcnn3 (KCa2.3), Kcnn4 (KCa3.1) were all expressed 
in N9 cells as well as other rodent microglia in previous studies (Kaushal et al., 
2007; Schlichter et al., 2010; Khanna et al., 2001) except for Kcnn2 (KCa2.2) which 
was not detectable in N9 cells. In previous studies, two publications (Khanna et al., 
2001; Schlichter et al., 2010) identifying Kcnn2 (KCa2.2) were both from cultured 
primary rat microglia, thus Kcnn2 (KCa2.2) expression may  be species-dependent. 
Gene expression of Kcnn1 (KCa2.1) and Kcnn4 (KCa3.1) were decreased while gene 
of Kcnn3 (KCa2.3) was increased by LPS (100ng/ml, 24hr) in rat microglia. Here 
LPS (1µg/ml, 24hr) did not significantly influence the expression of these subunits in 
N9 cells. The reason for such discrepancy may be from either the difference of 
species or that LPS-induced gene expression of KCa channels occurs in a dose-
dependent manner.
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4.3.2.4 Kcnk6 (K2p6.1) channels
Kcnk6 (K2p6.1) is one of the most abundantly expressed subunits in N9 microglia 
cell line (Figure 4-3). However, in previous studies there was very  limited 
understanding on microglial K2p6.1, including both its expression and function. In 
addition, Kcnk6 (K2p6.1) was the only subunit significantly downregulated by LPS 
treatment in N9 microglia. It  is then questioned whether its activity may in turn 
regulate LPS-induced microglial activation.
4.3.3 Conclusion and future work
Here screening for the mRNAs encoding of most K+ channel subunits was performed 
in the resting N9 microglial cell line. In addition, using the optimized LPS activation 
method, the expression pattern of K+ channel mRNA was also examined in the 
activated microglia. The generated expression pattern extends the understanding of K
+ channels in microglia which may facilitate the research in the future.
Most K+ channel mRNA expression was not significantly affected by LPS treatment. 
As there was evidence indicating that whole cell current expression induced by LPS 
is time-dependent (Nörenberg et al., 1992), it may be possible that at shorter or 
longer culture exposure to 1µg/ml LPS the K+ channel mRNA may  display a 
different expression pattern.
From previous studies, it is clear that the change of gene expression may not be 
associated with change of protein. For example, Kv1.3 gene expression in the 
isolated rat primary  microglia was upregulated by extracellular PMA or LPS 
treatment but their protein was not affected by either of these two stimulations 
(Fordyce et al., 2005). Thus it will be important to screen the protein and current 
expression of K+ channels and their change following the LPS application. This 
would facilitate the understanding of how LPS-induced gene and protein expression 
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was associated in microglia. In addition, investigations should also examine K+ 
channel mRNA expression in different species as mice and rats may potentially 
display  different expression properties. What is more, an important question is to ask 
what role K+ channels play  in microglia. For example, the blockade of IK channels 
attenuated microglial respiratory burst and neuronal toxicity (Khanna et al., 2001). 
As channels are sensitive the to various blockers, a pharmacological approach would 
be a good way to detect channel function in N9 cells.
Finally, in this thesis most of the 65 subunits detected were expressed at  low level 
(Figure 4-2). Thus it  is reasonable to focus on the most abundantly expressed 
subunits (Figure 4-3) which included Kcnma1 (KCa1.1), Kcnk6 (K2p6.1), Kcnc3 
(Kv3.3), Abcc8 (SUR1), Kcnj2 (Kir2.1) and Kcnn4 (KCa3.1) with K2p6.1 significantly 
decreased by LPS treatment. For these channels, roles of K2p6.1, Kv3.3 and Kir2.1 in 
microglia have not been extensively examined. In addition, it is also important to 
examine ion channels like BK whose current and gene were discovered before but 
not their function. Besides abundantly expressed channels, further research on the 
channels, such as Kv1.3 and Kv1.5 which were well examined in other types of 
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5.1 Chapter introduction
Activated microglia release nitric oxide (NO) that plays an important role in neuronal 
death. As described in Chapter 1, blocking potassium (K+) channel currents either 
attenuated (Fordyce et al., 2005) or facilitated (Ortega et al., 2012) microglial 
activation which further regulated microglial neuronal toxicity. Thus, based on the 
mRNA expression pattern of K+ channels examined in Chapter 4, it is aimed to 
determine how the functional role of K+ channels is in N9 microglial NO release. In 
addition, examination of expression of K+ current would facilitate the understanding 
of their role in microglial NO release. However, although the N9 microglial cell line 
has been commonly used for investigation of microglial activation and microglial 
NO release (Zhao et al., 2011; Chang et al., 2008; Meng et al., 2008; Wu et al., 
2007; Hou et al., 2006; Bi et al., 2005; Suuronen et al., 2006; Nuutinen et al., 2005; 
Suuronen et al., 2003), little electrophysiological work has been done on it. In 
addition, it was reported the expression of K+ current varies depending on microglial 
activation (Boucsein et al., 2000; Kettenmann et al., 1990; Nörenberg et al., 1992; 
Draheim et al., 1999). Thus, electrophysiological analysis will not only facilitate the 
investigation of the role of K+ channels in microglial NO release but also extend the 
understanding of N9 microglial current properties.
5.1.1 Channels and subunits to be examined
N9 microglia expressed a variety of K+ channel mRNAs as examined in Chapter 4. 
Because the majority of their expression was at low level, the focus was then on the 
most abundantly expressed channels and subunits which included: large conductance 
Ca2+-sensitive and voltage-activated K+ channels (BK), tandem pore domain K+ 
channel (K2p)6.1 channels, voltage-gated K+ channel (Kv)3.3 channels, sulfonylurea 
receptor (SUR)1 subunit, inwardly  rectifying K+ channel (Kir)2.1 channels and 
intermediate conductance Ca2+-activated of K+ ions channels (IK) (Figure 4-3). 
However, considering the availability of pharmacology, Kv3.3 can not be examined 
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at this step as there was no specific activator or blocker for it. Besides these 
abundantly expressed K+ channel subunits, Kv1.3 and Kv1.5 channels which are 
expressed in N9 cell and play important roles in microglia in previous studies were 
also examined here.
5.1.2 Pharmacological blockers and activators
For BK channels, IK channels, Kv1.3 and SUR1 subunits, the well characterized 
antagonists paxilline, Tram34, margatoxin (MgTX) and glibenclamide (GBC) 
(Gutman et al., 2005; Kubo et al., 2005; Wei et al., 2005; Lovasz et al., 2011; Ortega 
et al., 2012) were used. Agonists for BK and IK, NS1619 and NS309, were also used 
(Wei et al., 2005). NS309 is an activator for both small conductance Ca2+-activated 
K+ channels (SK) (half maximal effective concentration (EC50)=30nM) and IK 
(EC50=10nM) channels (Wei et al., 2005; Mannhold et al., 2006; Strøbaek et al., 
2004). Due to the lack of an IK channel selective activator, NS309 was applied 
during the experiment. GBC blocks ATP-sensitive K+ channel (KATP) current via 
binding to either SUR1 or SUR2 subunits (Lovasz et al., 2011). However, as SUR2 
was not detectable in N9 cells (Table 4-2), GBC may reveal a role for SUR1 in N9 
cells. For Kv1.5 channels, the inhibitor propafenone (PPF) was used. Although 
extracellular PPF is not a potent selective blocker for Kv1.5 channels as it is able to 
block Kv1.5, KATP and human ether-a-go-go-related gene (HERG) currents (Grissmer 
et al., 1994; Franqueza et al., 1997; Malayev et al., 1995; Franqueza et al., 1998; 
Seki et al., 1999; Christé et al., 1999; Arias et al., 2003), based on the gene 
expression described in Chapter 4 the pore-forming subunits of Kcnj8 (Kir6.1), 
Kcnj11 (Kir6.2) and Kcnh2 (Kv11.1) were not detectable in N9 cells. In addition, 
previous reports also indicated that Kv1.2 current is sensitive to PPF as well, but this 
was only  seen with intracellular application of PPF (Madeja et al., 2003) and Kcna2 
(Kv1.2) was not  detectable in N9 cells, either (Table 4-2). Thus the effect of PPF may 
be mainly through the Kv1.5 in N9 cells. Similar to Kv1.5 channels, there was no 
selective blocker for K2p6.1 and Kir2.1 channels, but they are both sensitive to 
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external barium (Ba2+). Kir2.1 has half-maximal inhibition concentration (IC50) of 
15.9±2.5µM at -120mV or IC50 of <45µM at -90mV for external Ba2+ (Schram et al., 
2002). Its IC50 value decreased dramatically  if Kir2.1 was co-expressed with Kir2.3 
(about 6.3µM) (Kubo et al., 2005) or Kir2.4 (about 3.7µM) (Schram et al., 2002). 
K2p6.1 has IC50 of 100µM for external Ba2+ (Patel et al., 2000; Goldstein et al., 
2005). What is more important, based on the K+ channel mRNAs expressed in 
resting N9 microglia, there were potentially >10 channels that are sensitive to 
external Ba2+ (100µM) (Figure 5-1A) (Kubo et al., 2005; Goldstein et al., 2005; 
Gutman et al., 2005). Kcnk6 (K2p6.1) and Kcnj2 (Kir2.1) were abundantly expressed 
which represented over 80% of these channels (Figure 5-1B). Thus effect of low B2+ 
may mainly  represent the function of K2p6.1 and Kir2.1 channels. The applied 
blockers and activators with commonly used concentrations are listed in Table 5-1.
5.1.3 Working hypothesis
In this chapter, the hypothesis that N9 microglia express multiple K+ current and the 
blockade of K+ channel current regulates N9 microglial NO release will be 
examined.
5.1.4 Aims to be addressed in this chapter
5.1.4.1 Do the selected K+ channels regulate LPS-induced microglial NO 
release?
Under the application of PPF, MgTX, Tram34, paxilline, BaCl2, NS1619 and NS309, 
their effect on lipopolysaccharide (LPS)-induced N9 microglial NO release will be 
examined. Because LPS-induced NO release is also dependent on cellular viability, 









































Figure 5-1. K+ channels expressed in N9 cells that can be blocked by 
extracellular Ba2+. (A) Based on the gene expression described in Chapter 
4, in resting N9 microglia there were >10 potassium (K+) channels reported 
sensitive to extracellular barium (Ba2+). Kcnj1 (Kir1.1): IC50=NE [10]; Kcnj2 
(Kir2.1): IC50<50μM, if co-expressed with either Kir2.4 or Kir2.3 IC50<10μM [1]
[4]; Kcnj4 (Kir2.3): IC50=10.3μM [1]; Kcnj14 (Kir2.4): IC50≤116μM [1][4]; Kcnj3 
(Kir3.1): IC50=~3.5nM [5]; Kcnj6 (Kir3.2): IC50=NE [1][10]; Kcnj15 (Kir4.2): 
IC50=NE [10]; Kcnk12 (K2p2.1): IC50=1mM [2]; Kcnk3 (K2p3.1): IC50=500mM 
[2]; Kcnk6 (K2p6.1): IC50=100μM [2][6]; Kcnk18 (K2p18.1): IC50=3mM [2]; 
Kcna3 (Kv1.3): IC50=NE, pH-dependent [9][10]; Kcna5 (Kv1.5): IC50=~20μM 
(0.003Hz), or IC50=~1mM (0.7Hz), depolarization from -80mV to +50mV 
(ph7.4), frequency- & pH-dependent [8]; Kcnb1 (Kv2.1): IC50=30mM [3]; 
Kcnh8 (Kv12.1): IC50=180μM [7]. (B) Of these K+ channels, Kcnk6 (K2P6.1) 
channels occupied 52.6% and Kcnj2 (Kir2.1) occupied 28.1% of these K+ 
channel mRNAs expression. Kir: inwardly rectifying K+ channel; K2p: tandem 
pore domain K+ channel; Kv: voltage-gated K+ channel; IC50: half-maximal 
inhibition concentration; NE: not established.
References: [1]: (Kubo et al., 2005); [2]: (Goldstein et al., 2005); [3]: (Gutman 
et al., 2005); [4]: (Schram et al., 2002); [5]: (Ehrlich et al., 2004; Jin & Z. Lu, 
1999); [6]: (Patel et al., 2000); [7]: (Zou et al., 2003); [8]: (Cheng et al., 2008); 
[9]: (Somodi et al., 2004); [10]: (Wulff & Zhorov, 2008).
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Table 5-1. Pharmacological blockers and activators used in this thesis 
and their regular concentrations used in previous studies. Here includes 
six K+ channel blockers (PPF, MgTX, GBC, BaCl2, Tram34 and paxilline) and 
two K+ channels activator (NS309 and NS1619). Their target (channels or 
subunit), regular pharmacological concentration or IC50 value are indicated in 
the table. PPF: propafenone; MgTX: margatoxin; GBC: glibenclamide; BK: 
large conductance Ca2+-sensitive and voltage-activated K+ channels; SK: 
small conductance Ca2+-activated K+ channels; IK: intermediate conductance 
Ca2+-activated K+ channels; SUR: sulfonylurea receptor; IC50: half-maximal 








(1) (Gutman et al., 2005)




Kv1.3 (1) (Gutman et al., 2005)
(2) (Carrisoza-Gaytán et al., 2010)
GBC (1) 10-5nM to 10μM 
(2) IC50=5μM (SUR1+Kir6.1)
IC50=8nM (SUR1+Kir6.2)
SUR (1) (Lovasz et al., 2011; Ortega et al., 2012; 
Mikhailov et al., 2001; Tan et al., 2007)
(2) (Kew & Davies, 2009)
BaCl2 0.1~1mM see
Figure 5-1
(Goldstein et al., 2005; Preisig-Müller et al., 
2002; Young et al., 2009; Patel et al., 2000)
Tram34 (1) 1μM
(2) IC50=18nM
IK (1) (Wei et al., 2005)
(2) (Toyama et al., 2008)
NS1619 EC50=1μM BK (Skalska et al., 2008)
paxilline (1) 1μM
(2) IC50=17nM
BK (1) (Wei et al., 2005)




SK/IK (1) (Sones et al., 2009)
(2) (Mannhold et al., 2006; Strøbaek et al., 
2004)
5.1.4.2 Do N9 microglia express K+ channel current?
Using whole-cell voltage clamp and current clamp, the electrophysiological 
properties of resting N9 microglia will be examined including: (1) The membrane 
potential. (2) Cell capacitance. (3) The whole-cell current of N9 microglia. (4) The 
sensitivity of N9 microglial whole-cell current  to K+ channels blockers. Both 1µM 
intracellular Ca2+ concentration ([Ca2+]i) and 10nM [Ca2+]i would be applied to 
examine any potential calcium-activated K+ channel (KCa)-type current. As it was 
reported microglia in vitro express large inward K+ current with low outward K+ 
current, the hypothesis is N9 microglia may display similar phenomenon.
5.1.4.3 Is N9 microglial whole-cell current regulated by LPS treatment?
After activation, N9 microglial whole-cell current may be regulated by LPS 
treatment. The difference between LPS-induced and resting microglial whole-cell 
current will be compared including current density, membrane potential and cell 
capacitance. As LPS was reported to regulate the expression of K+ channel current 
(Kettenmann et al., 1990; Draheim et al., 1999), whether in N9 microglia different  K
+ current will be induced by LPS was examined. The morphology of all activated 




5.2.1 Role of K+ channels in LPS-induced NO release
The roles of K+ channels in N9 microglial NO release was examined by culturing N9 
microglia with the respective pharmacological blockers or activators. Some channels 
play  a role in regulating LPS-induced NO release while some did not. Here, how 
each channel regulates N9 microglial activation is introduced below.
5.2.1.1 The effect of Kv1.3 channel inhibition on N9 microglial viability 
and NO release
MgTX, a commonly used Kv1.3 blocker (Kazama et al., 2012; Jang et al., 2011), was 
used to test the role of Kv1.3 in LPS-induced NO release. N9 cells were either treated 
using LPS with MgTX or using LPS with vehicle as control following the optimized 
activation method generated in Chapter 3. The NO2- concentration in the supernatant 
was normalised to cell number to avoid pharmacological effect on cell viability. 
Application of MgTX (0.1nM  to 10nM) had no significant effect on either cell 
viability or LPS-induced NO release (Figure 5-2).
5.2.1.2 The effect of Kv1.5 channel inhibition on N9 microglial viability 
and NO release
As described in section 5.1.2, PPF was applied to investigate the function of Kv1.5 
channels in N9 microglia. PPF at concentrations from 0.1µM  to 10µM  displayed no 
significant effect on cellular viability, but at 100µM  PPF was toxic to N9 cells 
(Figure 5-3A). Thus the NO2- in the supernatant was not detectable in the sample 
treated by 100µM  PPF. PPF at 0.1µM  and 1µM did not regulate LPS-induced 
microglial NO release, but 10µM PPF significantly attenuated the NO release by 
about 13.4% (Figure 5-3B).
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Figure 5-2. Dose-dependence of MgTX on N9 microglial viability and 
LPS-induced microglial NO. MgTX is a commonly  used blocker for Kv1.3 
channels. N9 cells were activated following the optimized method described 
in section 2.1.1.5.2 in the presence of MgTX. Nitrite (NO2-) concentrations 
were normalised by cell number and data are presented as percentage of 
control, lipopolysaccharide (LPS) with respective vehicle (dotted line). (A) 
MgTX ranging from 0.1nM to 10nM did not display any cytotoxicity to N9 
cells. Cell number was determined by  measuring the absorbance in the MTS 
assay as described in section 2.1.1.7. (B) MgTX ranging form 0.1nM to 10nM 










































Figure 5-3. Dose-dependence of PPF on N9 microglial viability and LPS-
induced microglial NO. NO2- concentrations were normalised by cell 
number and data are presented as percentage of control, LPS with 
respective vehicle (dotted line). (A) PPF at 100μM displayed cytotoxicity to 
N9 cells which killed 100% of the cells in the sample. (B) At 10μM, PPF 
significantly decreased LPS-induced microglial NO release to about 86.6% of 
control. No nitrite was detectable in the presence of 100μM PPF. Data are 











































5.2.1.3 The effect of Ba2+ on N9 microglial viability and NO release
As indicated at the beginning of this chapter there are no selective blockers for 
K2p6.1 or Kir2.1 channels. However, as their mRNA expression represents >80% of 
the mRNA expression of channels that  can be blocked by external Ba2+ (Figure 5-1). 
Thus Ba2+ was applied to examine the function of these two channels.
BaCl2 at  concentration from 10µM to 1mM was not toxic to N9 cells, but 10mM of 
BaCl2 reduced cell number by about 8.1% (Figure 5-4A). Ba2+ at 10µM and 100µM 
had no effect on LPS-induced NO release. However, at 1mM and 10mM it 
significantly attenuated LPS-induced NO release by  by about 21.6% and 34.4% 
respectively (Figure 5-4B).
5.2.1.4 The effect of SUR1-associated channels inhibition on N9 
microglial viability and NO release
N9 cells were cultured with LPS and GBC (0.1nM  to 10µM) which blocks KATP 
current by binding to their SUR subunits. As SUR2 mRNA was not  detectable in N9 
cells (Table 4-2), GBC was assumed to only  bind to SUR1 in N9 microglia. 
However, GBC had no effect on cell viability or LPS-induced NO release (Figure 
5-5).
5.2.1.5 The role of IK channels on N9 microglial viability and NO release
To investigate the role of IK channels in microglia, the IK channel selective blocker, 
Tram34, and activator, NS309, were applied to N9 cells. Tram34 (0.01µM  to 10µM) 
was not toxic to N9 cells (Figure 5-6A). However, Tram34 at 0.01µM and 1µM 
attenuated LPS-induced microglial NO release by about 9.4% while 10µM  Tram34 
attenuated microglial NO release by about 50.6% (Figure 5-6B). At the latter 
concentration Tram34 may  nonspecifically block K+ current (Wei et al., 2005; 
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Figure 5-4. Dose-dependence of BaCl2 on N9 microglial viability and 
LPS-induced microglial NO. BaCl2 is supposed mainly blocking Kir2.1 and 
K2p6.1 channels in N9 microglia. NO2- concentrations were normalised by  cell 
number and data are presented as percentage of control, LPS with 
respective vehicle (dotted line). (A) BaCl2 only at 10mM displayed cytotoxicity 
to N9 cells which killed 8.1% of the N9 cells in the sample. (B) At 1mM, BaCl2 
significantly decreased LPS-induced microglial NO release to about 78.4% of 
control. At 10mM, BaCl2 significantly decreased microglial NO release to 
about 65.6%. Data are given as mean±SEM. ***p<0.001 vs. control, by 











































Figure 5-5. Dose-dependence of GBC  on N9 microglial viability and 
LPS-induced microglial NO. GBC is a selective blocker for KATP current and 
it was supposed to mainly bind SUR1 subunit in N9 cells. NO2- 
concentrations were normalised by cell number and data are presented as 
percentage of control, LPS with respective vehicle (dotted line). (A) GBC 
ranging from 0.1nM to 10μM did not display any cytotoxicity  to N9 cells. (B) 










































Figure 5-6. Dose-dependence of Tram34 on N9 microglial viability and 
LPS-induced microglial NO. Tram34 is a selective blocker for IK channels. 
NO2- concentrations were normalised by  cell number and data are presented 
as percentage of control, LPS with respective vehicle (dotted line). (A) 
Tram34 (0.1μM to 10μM) did not display any cytotoxicity to N9 cells. (B) At 
0.01μM, 1μM and 10μM, Tram34 significantly  decreased LPS-induced 
microglial NO release. Data are given as mean±SEM. **p<0.01, ***p<0.001 









































Toyama et al., 2008).
In addition, the activator of IK channels, NS309, (0.1µM to 10µM) had no effect on 
N9 cell proliferation (Figure 5-7A) or LPS-induced N9 microglial NO release 
(Figure 5-7B).
5.2.1.6 The role of BK channels on N9 microglial viability and NO 
release
The BK channel blocker, paxilline, at concentrations from 0.01µM  to 10µM (Yaghi 
et al., 2002; Raffaelli et al., 2004) did not display  toxicity to N9 cells (Figure 5-8A) 
only at 10µM did paxilline significantly decrease LPS-induced NO release by about 
43.0% (Figure 5-8B) at which concentration paxilline may nonspecifically block K+ 
channels (Wei et al., 2005; Ahluwalia et al., 2004). Meanwhile, the BK activator 
NS1619 at concentration 1µM and 10µM did not influence N9 cell proliferation but 
100µM of NS1619 reduced N9 cells number by  about 33.8% (Figure 5-9A). In 
addition, 100µM  NS1619 significantly reduced LPS-induced NO release by about 
81.8% while 1µM and 10µM of NS1619 had no effect (Figure 5-9B).
5.2.1.7 Role of BK channels on LPS-induced NO release in the presence 
of another channel blocker
Paxilline and NS1619 at  concentrations 1µM  or less (Table 5-1) that  are specific for 
BK channels had no significant effect on LPS-induced NO release. However, BK 
channels may interact with other K+ channels, such as IK channels (Thompson & 
Begenisich, 2009). Thus, it was questioned whether either paxilline or NS1619 may 
affect the inhibitory effect of Tram34, PPF or BaCl2 on LPS-induced NO release.
Interestingly, paxilline prevented the inhibitory effect of Tram34, BaCl2 and PPF on 
LPS-induced microglial NO release (Figure 5-10).
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Figure 5-7. Dose-dependence of NS309 on N9 microglial viability and 
LPS-induced microglial NO.  NS309 is able to activate IK channels. NO2- 
concentrations were normalised by cell number and data are presented as 
percentage of control, LPS with respective vehicle (dotted line). (A) NS309 
ranging from 0.1μM to 10μM did not display any cytotoxicity  to N9 cells. (B) 
NS309 ranging from 0.1μM to 10μM did not affect the LPS-induced microglial 









































Figure 5-8. Dose-dependence of paxilline on N9 microglial viability and 
LPS-induced microglial NO.  Paxilline is the selective blocker for BK 
channels. NO2- concentrations were normalised by cell number and data are 
presented as percentage of control, LPS with respective vehicle (dotted line). 
(A) Paxilline ranging from 0.01μM to 10μM did not display any cytotoxicity to 
N9 cells. (B) At 10μM, paxilline significantly decreased LPS-induced 
microglial NO release to about 57.0%. Data are given as mean±SEM. 










































Figure 5-9. Dose-dependence of NS1619 on N9 microglial viability and 
LPS-induced microglial NO.  NS1619 is a selective activator for BK 
channels. NO2- concentrations were normalised by cell number and data are 
presented as percentage of control, LPS with respective vehicle (dotted line). 
(A) NS1619 only  at 100μM inhibited N9 microglial proliferation rate to about 
66.2%. (B) At 100μM, NS1619 significantly decreased LPS-induced 
microglial NO release to about 18.2%. Data are given as mean±SEM. 











































Figure 5-10. Paxilline attenuated the effect of Tram34, BaCl2 and PPF on 
LPS-induced NO release. Paxilline (1μM), Tram34 (1μM), BaCl2 (1mM) and 
PPF (10μM) were applied. All NO2- concentrations were normalised by cell 
number and data are presented as percentage of control, LPS with 
respective vehicle (dotted line). Paxilline attenuated the inhibition effect of 
Tram34, BaCl2 and PPF on LPS-induced NO release. Data are given as 



























As inhibiting BK channel attenuated the effect  of other K+ channel blockers, it was 
hypothesized that activating BK using NS1619 might have an opposite effect. 
NS1619 facilitated the effect of Tram34 and PPF, but not BaCl2, on the N9 
microglial NO release by about 5.9% and 13.4% respectively (Figure 5-11).
5.2.1.8 Tram34 is additive with PPF to inhibit LPS-induced NO release
As the examination on BK channels indicated the interaction between channels, it 
was questioned whether combination of other channel blockers had an additive effect 
or not. Tram34 was additive with PPF to inhibit LPS-induced N9 microglial NO 
release (Figure 5-12A). However, BaCl2 had no additive effect with either Tram34 or 
PPF on LPS-induced NO release (Figure 5-12B&C).
5.2.2 Electrophysiological characterization of N9 cells
It was questioned (1) Whether paxilline, Tram34, PPF, BaCl2 affects N9 microglial 
whole-cell current. (2) Whether and how LPS affects the whole-cell current and K+ 
current expression in N9 microglia. As MgTX (Pannasch et al., 2006; Fordyce et al., 
2005) and GBC did not have effect on N9 microglial NO release, they were not 
examined in these experiments.
5.2.2.1 The whole-cell current of resting N9 cells
By using conventional whole-cell voltage clamp, the whole-cell current of resting N9 
cells was examined. Cells were voltage clamped at -50mV and whole-cell current 
was evoked (200ms) by steps from -140mV to +100mV in 10mV increments (Figure 
5-13A) in the physiological K+ gradient as described in section 2.1.3.2. Intracellular 
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Figure 5-11. NS1619 facilitated the effect of Tram34 and PPF, but not 
BaCl2 on LPS-induced NO release. NS1619 (10μM), Tram34 (1μM), BaCl2 
(1mM) and PPF (10μM) were applied. All NO2- concentrations were 
normalised by cell number and data are presented as percentage of control, 
LPS with respective vehicle (dotted line). NS1619 facilitated the inhibiting 
effect of Tram34 and PPF on LPS-induced NO release. However, the effect 
of BaCl2 on NO release was not significantly regulated by NS1619 treatment. 




























Figure 5-12. Tram34 was additive with the effect of PPF, but not BaCl2 
on LPS-induced NO release.  Tram34 (1μM), BaCl2 (1mM) and PPF (10μM) 
were applied. All NO2- concentrations were normalised by cell number and 
data are presented as percentage of control, LPS with respective vehicle 
(dotted line). (A) Only Tram34 with PPF displayed an accumulative effect on 
the microglial NO release which facilitated their inhibiting effect from 91.3% 
(Tram34) and 91.9% (PPF) to 81.8%. (B) & (C) However, BaCl2 was not 
addictive with the effect of Tram34 or PPF. Data are given as mean±SEM. 






























































Figure 5-13. N9 microglial whole-cell current with 10nM and 1μM [Ca2+]i. 
The holding potential was -50mV. Currents were evoked by voltage steps 
from -140mV to +100mV in 20mV increments (200ms). (A) Representative 
traces of N9 microglial whole-cell current conditioned in physiological ion 
gradients with intracellular free Ca2+ buffered to 10nM and 1μM. On the right 
side it is the stimulation protocol associating with the traces. (B) The current 
density (pA/pF) vs. voltage (mV) plots for untreated N9 cells with 10nM 
[Ca2+]i and 1μM [Ca2+]i. There was no significant difference in the outward 
current density  but 1μM [Ca2+]i displayed a higher inward current density than 
10nM [Ca2+]i. Data are given as mean±SEM. *p<0.05, **p<0.01 vs. 10nM 
[Ca2+]i, by ANOVA with Bonferroni post hoc test. Error bars are within the 
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free Ca2+ was buffered to 10nM or 1µM to allow examination of the Ca2+-sensitive 
current. Resting N9 microglia displayed inward current at negative potential but with 
very low outward current  at  positive potential (Figure 5-13A). The I-V curve of 
resting N9 cells with different [Ca2+]i revealed no significant difference in the 
outward current density  (Figure 5-13B). This suggested there was very  little outward 
KCa-type current expressed in the resting N9 microglia. However, the inward current 
density  in 1µM  [Ca2+]i was increased compared to 10nM [Ca2+]i (Figure 5-13B) 
suggesting a Ca2+-sensitive inward current was generated.
5.2.2.2 The sensitivity of resting N9 microglial whole-cell current to 
paxilline, Tram34, PPF and Ba2+.
The effects of pharmacological blockers paxilline, Tram34, PPF and Ba2+ on N9 
microglial whole-cell currents were examined. Each blocker was applied to the cell 
for >5min before recordings. To reveal a possible KCa current, 1µM [Ca2+]i was used 
in the pipette solution through out this experiment. Compared to the control, there 
was no significant effect  of paxilline (1µM), Tram34 (1µM) or PPF (10µM) on the 
outward current density (Figure 5-14). However, surprisingly Tram34 attenuated the 
inward current density significantly  compared to the control (Figure 5-14A). BaCl2 
(100µM) did not affect the outward current density  (data not shown), but it 
dramatically blocked the inward current (Figure 5-15A) from -16.4±2.9pA/pF to 
-1.5±0.7pA/pF recorded at -140mV (Figure 5-15B).
5.2.2.3 LPS triggered a Ca2+-sensitive outward current in N9 cells
As LPS has been reported to modify K+ currents in some microglia, the effect  of LPS 
(1µg/ml, 24hr) on the whole-cell current  of N9 cells was examined. LPS significantly 
elevated the outward current with 1µM [Ca2+]i (Figure 5-16A). For example, at 
depolarization from -50 to 100mV the current density of resting microglia was 
9.0±3.7pA/pF while in activated microglia it was 23.9±7.0pA/pF. However, LPS-had 
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Figure 5-14. The effect of Tram34, paxilline and PPF on the whole-cell 
current of resting N9 microglia with 1μM [Ca2+]i. Cells were patched after 
being exposed to extracellular (A) Tram34 (1μM), (B) paxilline (1μM) or (C) 
PPF (10μM) for >5min. Cells in the absence of blockers were used as 
control. The holding potential was -50mV. Currents were evoked by voltage 
steps from -140mV to +100mV in 20mV increments (200ms). Whole cell 
current were recorded in the presence of 1μM [Ca2+]i. There was no 
significant effect of these drugs on the whole-cell current except for (A) 
Tram34 which significantly decreased the inward current density at negative 
potentials. Data are given as mean±SEM. *p<0.05, **p<0.01 vs. control, by 
ANOVA with Bonferroni post hoc test. Error bars are within the symbol unless 
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Figure 5-15. The effect of Ba2+ on the whole-cell inward current of 
resting N9 microglia with 1μM [Ca2+]i. Cells were patched after being 
exposed to extracellular Ba2+ (100μM) for >5min while cells in the absence of 
blocker were used as control. (A) Representative traces associated with the 
plots within the dotted rectangle. On the right side it is the stimulation 
protocol associating with the traces. (B) The current density (pA/pF) vs. 
voltage (mV) plots of the inward current. The inward current recorded at 
-140mV to -80mV was completely  blocked by extracellular Ba2+. Data are 
given as mean±SEM. ***p<0.001 vs. control, by ANOVA with Bonferroni post 
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Figure 5-16. LPS-induced whole-cell current of resting N9 microglia with 
1μM [Ca2+]i. Cells were treated with LPS (1mg/ml, 24hr) before being 
patched. The holding potential was -50mV. Currents were evoked by voltage 
steps from -140mV to +100mV in 20mV increments (200ms). (A) 
Representative traces of resting and LPS-activated N9 microglial whole-cell 
current under with [Ca2+]i buffered to 1μM. On the right side is the stimulation 
protocol associated with the traces. (B) The current density (pA/pF) vs. 
voltage (mV) plots indicated that LPS significantly elevated the outward 
current density. Data are given as mean±SEM. *p<0.05, ***p<0.001 vs. 
control, by ANOVA with Bonferroni post hoc test. Error bars are within the 
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no significant effect on the outward current with 10nM [Ca2+]i (Figure 5-17A). These 
results suggest that LPS induced a Ca2+-sensitive outward current.
Interestingly, LPS in 10nM [Ca2+]i promoted the inward current density significantly 
compared to control (Figure 5-17B). This inward current density was -21.3±3.1pA/
pF (at -140mV) which was very similar to control or LPS-treated microglia with 
1µM  [Ca2+]i which were -16.4±2.9pA/pF and -21.3±3.4pA/pF (at -140mV) 
respectively (Figure 5-16B).
5.2.2.4 The effect of paxilline and Tram34 on the LPS triggered outward 
current
As Tram34 and paxilline are selective blockers for KCa current and the previous 
results indicated LPS was able to trigger a Ca2+-sensitive outward current in N9 
microglia, the focus was on the LPS-induced microglial outward current to examine 
whether it was mediated by BK or IK channels.
LPS-induced outward current was significantly  inhibited by  paxilline (1µM) with 
current density reduced from 23.9±7.0pA/pF to 7.0±1.5pA/pF (at  100mV) (Figure 
5-18B). This suggests that LPS induced expression of BK channels on the N9 
microglial membrane at the time of current examination.
In contrast, application of Tram34 (1µM) had no significant effect on the LPS-
induced outward current (Figure 5-19). The current density of activated N9 microglia 
was 23.9±7.0pA/pF while it was 19.1±4.1pA/pF (at 100mV) after exposure to 
external Tram34 (Figure 5-19B).
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Figure 5-17. LPS-induced whole-cell current of resting N9 microglia with 
10nM [Ca2+]i. Cells were treated by LPS (1mg/ml, 24hr) before being 
patched. The holding potential was -50mV. Currents were evoked by voltage 
steps from -140mV to +100mV in 20mV increments (200ms). (A) 
Representative traces of resting and activated N9 microglial whole-cell 
current with [Ca2+]i buffered to 10nM. On the right side is the stimulation 
protocol associated with the traces. (B) The current density (pA/pF) vs. 
voltage (mV) plots indicated that LPS had no significant effect on the outward 
current density of N9 microglia but it significantly improved the inward current 
density at negative potentials which had no difference to the one of resting 
microglia with 1μM [Ca2+]i (Figure 5-16B). Data are given as mean±SEM. 
**p<0.01, ***p<0.001 vs. control, by ANOVA with Bonferroni post hoc test. 
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Figure 5-18. Paxilline reduced LPS-induced whole-cell outward current 
with 1μM [Ca2+]i. LPS-activated microglia were patched after being exposed 
to extracellular paxilline (1μM) for >5min. The holding potential was -50mV. 
Currents were evoked by voltage steps from -60mV to +100mV in 20mV 
increments (200ms). (A) Representative traces of whole-cell outward current 
of activated N9 cells with or without extracellular paxilline treatment. On the 
right side is the stimulation protocol associating with the traces. (B) The 
current density (pA/pF) vs. voltage (mV) plots revealed that the outward 
current density  was significantly  decreased by paxilline. Data are given as 
mean±SEM. *p<0.01, ***p<0.001 vs. +LPS+paxilline, by ANOVA with 
Bonferroni post hoc test. Error bars are within the symbol unless otherwise 
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Figure 5-19. Tram34 did not attenuate LPS-induced whole-cell outward 
current with 1μM [Ca2+]i. LPS-activated microglia were patched after being 
exposed to extracellular Tram34 (1μM) for >5min. The holding potential was 
-50mV. Currents were evoked by voltage steps from -60mV to +100mV in 
20mV increments (200ms). (A) Representative traces of whole-cell outward 
current of activated N9 cells with or without extracellular Tram34 treatment. 
On the right side is the stimulation protocol associating with the traces. (B) 
The current density (pA/pF) vs. voltage (mV) plots revealed that the outward 
current density  was not significantly  influenced by the Tram34 treatment. 
Data are given as mean±SEM. Error bars are within the symbol unless 
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5.2.2.5 Resting membrane potential and capacitance of N9 microglia
The resting membrane potential and capacitance of N9 cells under different 
conditions was also examined. Under the four different conditions: LPS-activated N9 
microglia with either 1µM  [Ca2+]i or 10nM [Ca2+]i and resting N9 microglia with 
either 1µM  [Ca2+]i or 10nM [Ca2+]i, there was no significant difference in resting 
membrane potential using current clamp (I=0). The mean resting membrane potential 
was within the range of -40mV to -60mV (Figure 5-20B). In addition, there was no 
action potential generation during the current clamp recording (Figure 5-20A).
LPS-activated microglia patched were all amoeboid while resting microglia patched 
were all ramified. This was to make sure N9 microglia recorded in the desired status. 




Figure 5-20. LPS had no significant effect on resting membrane 
potential or capacitance of N9 microglia. Cells were patched using whole-
cell current clamp  (I=0) and stabilized for >5min before the recording of 
membrane potential. (A) Representative trace of membrane potential from 
resting N9 microglia with [Ca2+]i buffered to 10nM. (B) Bar chart of resting 
membrane potential under control and LPS-activated conditions with [Ca2+]i 
buffered to 10nM or 1μM. There was no significant difference between any 
two conditions. (C) Activated and resting microglia had no significant 
difference in the cellular capacitance. Data are given as mean±SEM. (N 













































5.3.1 Whole-cell current of resting N9 microglia
The whole-cell current of resting N9 cells displayed a low outward current at 
positive potentials and large inward current at  negative potentials. This was similar to 
other microglial models in in vitro culture in previous studies (Boucsein et al., 2000; 
Kettenmann et al., 1990; Schilling et al., 2000).
The resting outward current was not significantly  different  with low or high [Ca2+]i 
suggesting little KCa-type current  was expressed. In addition, external PPF (10µM), 
Tram34 (1µM) or paxilline (1µM) did not significantly block the resting outward 
current, either (Figure 5-14).
However, the resting microglial whole-cell current displayed a [Ca2+]i-dependent 
increase of inward current density (Figure 5-13). The reason may be the inward 
current induced by the intracellular Ca2+ such as inward sodium (Na+)/Ca2+ 
exchanger current (Janvier et al., 1997), inward chloride (Cl-) current (Korn & 
Weight, 1987), Ca2+-activated non-specific cationic current (Kramer & Zucker, 1985; 
Yamashita & Isa, 2003a; Yamashita & Isa, 2003b). In addition, Tram34 (1µM) 
unexpectedly decreased the inward current density  of resting microglia (Figure 
5-14A) displaying no significant difference to resting inward whole-cell current with 
10nM [Ca2+]i. Previous evidence indicated that IK channels play  an important role in 
maintaining the entry  of Ca2+ into immune cells, such as in T cells (Fanger et al., 
2001; Jensen et al., 2001). Thus, blocking IK channels by Tram34 may lower [Ca2+]i 
but this needs to be tested by Ca2+ imaging. As the outward current was not 
significantly sensitive to external Tram34, this suggests that low membrane 
expression of IK channels was sufficient to regulate [Ca2+]i. A further 
immunostaining analysis is required to confirm IK protein expression and 
localization in the cells. Finally, the application of external Ba2+ (100µM) fully 
blocked the inward current as well as previously reported (Figure 5-15).
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5.3.2 Effect of LPS on the whole-cell current of N9 microglia
Compared to resting N9 microglia, LPS treatment (1µg/ml, 24hr) affected both the 
inward and outward whole-cell current.
LPS elevated outward current density at positive potentials (Figure 5-16) similar to 
previous findings (Boucsein et al., 2000; Nörenberg et al., 1992; Draheim et al., 
1999). Because the LPS-induced outward whole-cell current only occurred at  high 
(1µM) [Ca2+]i (Figure 5-16) but not low (10nM) [Ca2+]i (Figure 5-17), Tram34 and 
paxilline were applied to block it. Here, the LPS-induced outward current was 
significantly blocked by external paxilline (1µM) (Figure 5-18B) but not Tram34 
(Figure 5-19B). In addition, because after exposure to paxilline the remaining 
outward current density was still significantly higher than control (Figure 5-18B) and 
the LPS-induced outward current was not significantly sensitive to Tram34, it is 
possible the remaining [Ca2+]i sensitive outward current is composed of SK-type 
current. To examine this apamin should be applied which is a SK1~3 channel 
blocker.
In addition, LPS increased the inward current density at negative potentials (Figure 
5-17) as reported previously  (Nörenberg et al., 1992). This may be a [Ca2+]i-
dependent process, because the LPS-induced inward current density with 10nM 
[Ca2+]i had no significant difference to the resting inward current density of N9 
microglia with 1µM [Ca2+]i. Reasons may  be: (1) LPS can release the Ca2+ stores 
from the endoplasmic reticulum (ER) by  activating the inositol trisphosphate (InsP3)-
dependent channels (Wheeler & Thurman, 1999; Drysdale et al., 1987; Prpic et al., 
1987; Liu et al., 2008). This further induced Ca2+ influx through the Ca2+ release-
activated Ca2+ channels (Hoth & Penner, 1993). (2) LPS may also increase [Ca2+]i 
via the activation of protein kinase C (PKC) (Wen et al., 2011). PKC can activate the 
Na+/Ca2+ exchanger (Kettenmann et al., 2011) elevating the [Ca2+]i.
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Finally, as previously reported, a morphology-dependent outward Cl- current was 
activated by  microglial swelling (Schlichter et al., 2011). Thus, it was possible the 
LPS-regulated N9 microglial whole-cell current may depend on cell morphology.
5.3.3 LPS effect on capacitance and resting membrane potential of 
N9 microglia
LPS did not significantly affect the capacitance of N9 microglia (Figure 5-20C) as 
reported elsewhere (Kozlowski & Weimer, 2012). In addition, resting N9 microglia 
had a resting membrane potential with mean value at  about -55mV and they 
displayed no difference with either 10nM or 1µM  [Ca2+]i. LPS here did not 
significantly change microglial resting membrane potential, either (Figure 5-20B). 
Due to the low sealing success rate indicated in section 2.1.3.3, there was insufficient 
data to examine whether the resting membrane potential displayed a bimodal 
distribution or whether LPS hyperpolarized the higher peak value of the distribution 
as previously reported (Chung et al., 1999).
5.3.4 The functional role of outward K+ current in N9 microglia
5.3.4.1 The functional role of BK channels
Previous studies have revealed BK-type current in human, bovine and mouse 
microglia (McLarnon et al., 1995; McLarnon et al., 1997; Schilling et al., 2002; 
Schilling & Eder, 2007). In this thesis LPS induced a Ca2+-dependent and paxilline-
sensitive outward current (Figure 5-18B) while there was no significant BK current 
in resting N9 cells. This is similar to previous findings of a BK-type current in 
activated mouse microglia in brain slices and in vitro cultured cells (Schilling & 
Eder, 2007; Schilling et al., 2002).
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In Chapter 4 it was demonstrated that the mRNA expression of Kcnma1 (KCa1.1) 
was not significantly regulated by LPS treatment (Figure 4-10), but functional 
studies demonstrated that LPS elevated a BK-type current. There may be several 
reasons for this apparent discrepancy: (1) LPS elevated BK channel expression at a 
post-transcriptional level, as protein expression may not be associated with mRNA 
expression (Ortega et al., 2012). In addition, LPS may regulate BK current through 
the NO-regulated pathway, as NO was reported to upregulate the protein expression 
of BK channels (Kadekaro et al., 2006) and directly activate BK current (Zhu & 
Huizinga, 2008). (2) LPS may induce more BK channels to localize on the plasma 
membrane. In this case, total protein of BK channels may not be significantly 
changed, rather LPS may promote channel membrane expression. (3) In the case that 
membrane expression of BK channels is not changed by LPS, BK channel activity 
may be elevated by LPS-induced regulation of signaling pathways or [Ca2+]i. For 
example, the activity of BK channels can be regulated by phosphorylation (Widmer 
et al., 2003) and LPS is able to activate PKC, protein kinase A (PKA), Ca2+/
calmodulin-dependent protein kinase II (CaMKII) and calcineurin. Thus LPS may 
regulate BK activity  through phosphorylation pathways. To further confirm this 
hypothesis, it could be possible to examine the LPS-induced BK current after 
blocking the activity or knocking down the expression of these downstream 
mediators.
In this chapter, blocking BK channels using paxilline (≤1µM) or activating BK 
channels using NS1619 (≤10µM) on their own did not display any  significant effect 
on LPS-induced microglial NO release while at  higher concentration paxilline 
(10µM) or NS1619 (100µM) attenuated either microglial NO release or cell 
numbers. However, at these concentrations these compounds are not selective for BK 
channels. Although LPS-induced paxilline (1µM) sensitive outward current, blocking 
BK channels with paxilline (1µM) did not regulate LPS-induced microglial NO 
release. This suggested that the LPS-induced activation of BK channel current may 
not be required for NO release. Furthermore, activating BK channels with NS1619 
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alone or in the presence of LPS did not affect NO release. However, alternative 
mechanisms may explain the difference. For example, membrane expression of BK 
channels may be time-dependent as discovered for other types of K+ channels in 
microglia (Kotecha & Schlichter, 1999). Although LPS-induced NO release was 
measured at 24hr, the NO release was already  increasing before the time point while 
LPS-induced outward current was analyzed at 24hr. In this case the effect of LPS on 
NO release may  precede the expression of BK channel current. Thus, blocking BK 
channels alone may not be able to have an effect on NO release.
5.3.4.2 The functional role of IK channels
Tram34 decreased LPS-induced microglial NO release while it was not toxic to N9 
cells in the culture. These results were not only consistent with the previous studies 
on IK channel function in isolated primary rat microglia (Kaushal et al., 2007) but 
also extended the role of IK to mouse microglia. In previous work, LPS-induced 
microglial NO release was attenuated by the blockade of IK channels which was 
proposed to be via the p38 mitogen-activated protein kinases (MAPKs) pathway but 
not nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) (Kaushal 
et al., 2007). This could explain the role of IK blockade in N9 cells, but it has not 
been tested. In addition, as described before blocking IK inhibits Ca2+ influx (Fanger 
et al., 2001; Jensen et al., 2001) and in N9 microglia Tram34 induced a similar 
inward whole-cell current to the low [Ca2+]i conditions (Figure 5-14A). It is 
questioned whether the Tram34-induced inhibitory effect on LPS-induced NO 
release may rely on the Ca2+-dependent phosphorylation pathways, such as CaMKII, 
and further examinations are required. However, the IK activator NS309 did not 
display  any  effect on either N9 microglial viability or NO release after activation. It 
is postulated that under the experimental activation process most IK channels (or 
even SK channels) were activated, thus NS309 would not give any further effect.
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However, in the LPS-induced Ca2+-dependent outward current, there was no 
significant Tram34-sensitive outward current detected. In isolated rat  primary 
microglia, the whole-cell currents displayed only  a small current component which 
was sensitive to Tram34 (1µM) (Kaushal et al., 2007). It is possible the proportion of 
IK current in N9 cells was very small compared to the LPS-induced outward current 
(Figure 5-19) and then it was not detected by examining cell population data here. 
Thus, a discrete single cell recording before and after Tram34 exposure is required to 
examine the existence of a small IK-type current. In addition, in rat microglia the 
outward current induced by  100ng/ml LPS was time-dependent displaying a plateau 
at 24hr (Nörenberg et al., 1992). As we used 1µg/ml LPS, this time course may 
change and IK current  may  be evoked at different treatment duration. For example, 
IK channels may sufficiently express at the plasma membrane but internalize after 
24hr of culture. What is more, the activity of IK channels can be inhibited by PKA 
phosphorylation (Regenhard et al., 2001) and LPS is known to activate PKA. Thus 
this may  inhibit the activity of IK channels at the time the current was examined. 
Intriguingly, a recent study indicated that to fully  activate the IK current in microglia, 
riluzole, a neuroprotective drug, was a necessary modulator while the application of 
1µM [Ca2+]i on its own was not sufficient to trigger the KCa current (Liu et al., 2012).
5.3.4.3 The functional role of Kv1.3 or Kv1.5 channels
In previous studies Kv1.3 channels have been shown to regulate rat microglial 
neurotoxicity induced by LPS (Fordyce et al., 2005) which was proposed to be 
through regulation of the respiratory burst pathway (Fordyce et al., 2005; Khanna et 
al., 2001; Schilling & Eder, 2011). However, Kv1.3 channels did not regulate the 
LPS-induced NO release as antisense deoxyoligonucleotides knockdown of Kv1.3 
(Pannasch et al., 2006) or agitoxin-2 (AgTX-2) blockade (Fordyce et al., 2005) 
displayed no effect in rat  microglia. Here it confirmed a similar result that Kv1.3 
inhibition had no effect on LPS-induced N9 microglial NO release.
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In previous studies, LPS-induced NO release was almost abolished from the Kv1.5−/− 
mouse and it was decreased by around 50% by the AO knockdown of Kv1.5 
(Pannasch et al., 2006). Here, LPS-induced N9 microglial NO release was decreased 
by about 10~14% in the presence of PPF (10µM) (Figure 5-3 & Figure 5-11). This 
data suggests a role of Kv1.5 on N9 microglial NO release using a pharmacological 
approach. However, the attenuation effect (10~14%) by pharmacological blockade 
was much less than the 50~100% inhibition of NO release by genetic deletion of 
Kv1.5 (Pannasch et al., 2006). It  has been postulated previously that Kv1.5 may 
regulate microglial NO release through intracellular pathways rather than regulating 
ion transport (Pannasch et al., 2006). If this was true, pharmacological interference 
of Kv1.5 channels may  not fully abolish their functions in microglia. In addition, PPF 
at 100µM displayed a high toxicity to N9 cells. As the IC50 of PPF for Kv1.5 
channels is around 4.4µM  (Franqueza et al., 1998; Gutman et al., 2005), it is possible 
100µM of PPF began to block other channels rather than specifically blocking Kv1.5 
which led to an abnormal metabolism of N9 cells.
However, the mRNA expression of Kcna5 (Kv1.5) was not significantly regulated by 
LPS although the mean expression increased by 80% (Figure 4-5). In addition, there 
was no significant PPF (10µM)-sensitive current detected in resting microglia 
(Figure 5-14B) and the LPS-elevated outward current was shown mainly composed 
of KCa-type current as with 10nM [Ca2+]i LPS-induced outward current was not 
significantly different to control (Figure 5-17B). First it is questioned why mRNA of 
Kcna5 (Kv1.5) was detected while there was no PPF-sensitive current. Similar to 
explanations before, protein expression of Kv1.5 may not be associated with its 
mRNA expression. LPS may induce more Kv1.5 channels to localize in the cytosol. 
Besides these possibilities, the current of Kv1.5 channels can be inactivated by PKC-
phosphorylated intracellular Kvβ1.3 (Kwak et al., 1999; Sewing et al., 1996) whose 
mRNA (Kcnab1) expression was detected in N9 microglia (Figure 4-12). In addition, 
LPS was able to activate the PKC family (Comalada et al., 2003; Wen et al., 2011; 
Lee et al., 2008). Thus it is possible even if Kv1.5 channels were expressed on the 
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plasma membrane their current was inhibited by such mechanisms. Second it is 
questioned while there was no PPF-sensitive current detected why blockade of Kv1.5 
channels attenuated LPS-induced NO release. As previously  reported expression of 
Kv1.5 channels on microglial plasma membrane depended on the in vitro culture 
duration (Kotecha & Schlichter, 1999). Thus, it  is possible Kv1.5 channels may 
express sufficiently on the plasma membrane during the 24hr of culture but at the 
time of current analysis their membrane expression reduced dramatically  or even 
their activity is blocked by Kvβ1.3 subunit as described before.
5.3.5 The functional role of inward K+ current in N9 microglia
As discussed at the beginning of this chapter, the effect of Ba2+ in N9 cells is thought 
likely to be mainly through the blockade of K2p6.1 and Kir2.1 as mRNA expression 
of Kcnk6 (K2p6.1) together with Kcnj2 (Kir2.1) was over 80% among the detected K+ 
channel subunits which were sensitive to extracellular Ba2+ (Figure 5-1).
Kir2.1 has been supposed as the major component  of inward K+ current of microglia 
(Schilling et al., 2000). Here the N9 microglial inward current was completely 
blocked by 100µM Ba2+ (Figure 5-15B) which was similar to previous reports 
(Kettenmann et al., 1990; Schilling et al., 2000). Activated K2p6.1 channels generate 
both outward current at positive potentials and inward currents at negative potentials 
and they exhibit a weak outward rectification under physiological K+ gradients (Patel 
et al., 2000). Ba2+ can block both the inward and outward current generated by 
K2p6.1 (Patel et al., 2000) and as LPS significantly downregulated expression of 
Kcnk6 (K2p6.1), there would be more K2p6.1 current generated in resting N9 
microglia if its protein expression was associated with mRNA expression. However, 
as the current generated by K2p6.1 is inactivated by depolarization (Patel et al., 
2000), this may explain why  Ba2+ (100µM) did not  significantly decrease the whole-
cell outward current of resting N9 microglia. Thus immunostaining could be applied 
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to detect the expression of K2p6.1 channels and gene knockdown to examine the 
function.
Although Ba2+ (100µM) fully  blocked the whole-cell inward current  (Figure 5-15), it 
did not affect LPS-induced microglial NO release while higher concentrations 
(1mM) significantly decreased it  by 21.6% with out significant affect on cell viability 
(Figure 5-4). Based on the IC50 values of Kir2.1 for Ba2+, 100µM  Ba2+ is sufficient to 
fully  block current generated by Kir2.1 (Kubo et al., 2005; Schram et al., 2002). This 
suggests that the inward Ba2+-sensitive K+ current may not be involved in LPS-
induced NO release. In addition, 100µM Ba2+ is able to block about 50% current of 
K2p6.1 (Patel et al., 2000; Goldstein et al., 2005; Lloyd et al., 2009), thus 1mM Ba2+ 
may fully  block K2p6.1 current in N9 microglia. It  is then questioned whether K2p6.1 
play  a role in LPS-induced NO release. Alternative techniques are required to 
examine the role of K2p6.1 channels in LPS-induced NO release, such as siRNA 
knockdown. Besides K2p6.1 channels, 1mM  Ba2+ is able to block other outward K+ 
current (Shi et al., 2000), for example K2p2.1 (IC50=1mM for external Ba2+) or 
Kv12.1 (IC50=180µM for external Ba2+) (Figure 5-1) whose mRNAs were detected in 
N9 microglia. Thus, other K+ channels may be implicated in LPS-induced NO 
release even if expressed at a low level. In addition, external Ba2+ depolarizes the 
resting membrane potential (Chung et al., 1999). Depolarization is able to regulate 
activity of transcription factors via Ca2+ signaling pathways (Bernal-Mizrachi et al., 
2002). This provides a possible mechanism how K+ channels regulate the NO 
release. What is more, during the 24hr culture, Ba2+ may diffuse into the cytosol such 
as through the voltage-dependent Ca2+ channels (Heldman et al., 1989). Intracellular 
Ba2+ would either activate or block different K+ channels leading to a more complex 
interaction between K+ channels. Finally Ba2+ at 10mM  inhibited both N9 microglial 
proliferation by 8.1% and microglial NO release by 34.4% (Figure 5-4). The 
additional osmolarity  induced by 10mM of Ba2+ in the environment may be one 
reason leading to microglial cell death and attenuated NO release. In addition, there 
are several channels sensitive to such high concentration of external Ba2+, for 
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example Kv2.1 (IC50=30mM  for external Ba2+). Blockade of these channels may play 
a role in N9 microglia viability and LPS-induced NO release.
GBC blocks KATP channels by binding to sites on the SUR subunit (Ortega et al., 
2012; Mikhailov et al., 2001). In the presence of Kir6.1 the IC50 of SUR1 is 5µM  for 
GBC while in the presence of Kir6.2 the IC50 of SUR1 is 8nM  for GBC (Kew & 
Davies, 2009). Up to 10µM GBC was applied to N9 microglia here. However, no 
concentration affected either N9 microglial proliferation or NO release (Figure 5-5). 
As previously reported, GBC induced microglial activation and tumor necrosis factor 
alfa (TNFα) release preventing neuronal death in hypoxic conditions (Ortega et al., 
2012). Thus, similar to Kv1.3, GBC may participate in microglial activation but not 
regulate NO release. What is more, it may  be possible there was no pore-forming 
subunits expressed in N9 microglia, because the mRNA expression of Kcnj8 (Kir6.1) 
and Kcnj11 (Kir6.2) were not detectable in N9 microglia.
5.3.6 Functional role of interactions between K+ currents in N9 
microglia
5.3.6.1 BK channels regulate LPS-induced NO release in the presence 
of another K+ channel blocker
Although paxilline or NS1619 did not affect LPS-induced N9 microglial NO release 
on their own, interestingly  in the presence of other K+ channel blockers, paxilline 
significantly attenuated the inhibitory  effect  of Tram34, PPF and Ba2+ to inhibit  LPS-
induced NO release while NS1619 significantly facilitated the inhibitory effect of 
Tram34 and PPF (Figure 5-10 and Figure 5-11).
How might BK channel regulate the effect  of IK channels on LPS-induced NO 
release? As previously described in other immune cells, blocking IK depolarizes 
membrane potential and inhibits Ca2+ influx through nonselective cation channels 
(Fanger et al., 2001; Jensen et al., 2001) while blockade of BK channel induces 
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membrane depolarization (Semenov et al., 2011) and depolarization is able to 
activate voltage-dependent Ca2+ channels and induce Ca2+ influx (Fukushima & 
Hagiwara, 1983). In addition, microglia express both voltage-gated Ca2+ channels 
(Eder, 1998) and nonselective cation channels (Schilling & Eder, 2009). Thus, if in 
N9 microglia IK channels were colocalized with non-selective cation channels while 
BK channels were colocalized with voltage-dependent Ca2+ channels, the net effect 
of blocking BK and IK on [Ca2+]i may be cancelled out. Conversely, activating BK 
by NS1619 may  decrease the activity of voltage-dependent Ca2+ channels which is 
then additive to the effect of blocking IK channels. As described before, the change 
of [Ca2+]i may activate phosphorylation pathways, such as CaMKII and calcineurin. 
These pathways can further regulate the activity of transcription factors such as 
NFκB which induce the synthesis of inducible nitric oxide synthase (iNOS) and NO 
release. However, such an hypothesis is based on one precondition. Because Ca2+-
dependent phosphorylation pathways display  different sensitivity  to various Ca2+ 
stimulations (Dupont et al., 2003; Saucerman & Bers, 2008). It is thus supposed that 
in N9 microglia activity  of BK channel on its own can not induce a sufficient change 
of pattern of [Ca2+]i to further regulate these pathways. Finally, to examine this 
hypothesis immunostaining is required to localize the channels expression. Ca2+-
imaging is required to confirm the BK or IK channel-regulated change of [Ca2+]i. 
Blockade of Ca2+ channels can be applied to investigate the role of Ca2+ under this 
phenomenon. What is more, siRNA knockdown can be applied. Another mechanism 
may involve the activation of IK channels that blocked BK channels as reported in 
salivary gland acinar cells. Activated IK channels insert their N termini into the 
intracellular portals of BK channels and this process is voltage independent 
(Thompson & Begenisich, 2009). It is thus possible blocking IK by Tram34 changed 
the structure of IK channels and led to less BK channels blocked by IK N termini. 
The blockade of BK channels by  paxilline becomes a competitive process to the 
blockade of IK channels meanwhile the activation of BK by NS1619 assists it, but 
such mechanism would require BK and IK channels locate closely enough.
165
Secondly, the mechanisms underlying the interactions among BK and Kv1.5 channels 
are not clear. Kv1.5 is a voltage-activated K+ channels which is opened by membrane 
depolarization. Blocking BK can depolarize the membrane potential (Semenov et al., 
2011). Thus it is possible that blocking BK leads to activation of Kv1.5 channels and 
thus opposes the effect of blocking Kv1.5. The activation of BK using NS1619 may 
display an additive effect.
In addition, because neither the Tram34- nor PPF-sensitive current was observed in 
N9 microglia, it was assumed that channels of IK and Kv1.5 may have moved onto 
the membrane during the 24hr culture while at the time of whole-cell current 
examination, there were no or little channels left on the plasma membrane. In such 
case, one can not exclude that BK, IK and Kv1.5 channels may not simultaneously 
express on the plasma membrane during the 24hr of culture.
Thirdly, BK channels are Ca2+-sensitive and voltage-activated K+ channels which 
would be activated under this condition. External Ba2+ is able to depolarize cellular 
membrane potential (Pappas & Ransom, 1994). In addition, as described in section 
5.3.2 LPS is able to elevate [Ca2+]i by releasing Ca2+ from the ER (Wheeler & 
Thurman, 1999; Drysdale et al., 1987; Prpic et al., 1987; Liu et al., 2008) or by 
activating Na+/Ca2+ exchanger (Kettenmann et al., 2011) and the Ca2+ release-
activated Ca2+ channels (Hoth & Penner, 1993). However, external Ba2+ was also 
reported to decrease [Ca2+]i (Franchini et al., 2004). The net effect may  still lead to 
sufficient elevation of [Ca2+]i to activate BK channels. Thus, blockade of BK 
channels may oppose the effect of Ba2+. What is more, during the 24hr of culture, 
Ba2+ may enter the N9 microglia. Intracellular Ba2+ was recently reported to 
selectively activate BK channels by binding to the Ca2+ bowl at the regulator of 
conductance for K+ 2 (RCK2) domain (Zhou et al., 2012). However, NS1619 did not 
facilitate the inhibitory effect of Ba2+. After LPS treatment, BK channels may be 
mostly  activated so that further activation by NS1619 would not have any significant 
effect.
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5.3.6.2 The inhibitory effect of Tram34 and PPF, but  not Ba2+, on LPS-
induced NO release was additive
The inhibitory effect of Tram34 (1µM) was additive with PPF (10µM) displaying a 
further attenuation on NO release (Figure 5-12A). The mechanism is not clear yet. As 
indicated in the section 5.3.6.1, IK and Kv1.5 channels may not simultaneously 
express on the plasma membrane which may be one possibility  why their inhibitory 
effect on LPS-induced NO release is additive. In the case IK and Kv1.5 
simultaneously  express on the plasma membrane, blocking either of them may 
depolarize membrane potential. Although Kv1.5 can be activated by depolarization, 
the net effect of blocking both channels may still lead to more depolarization than 
blockade of either IK or Kv1.5 channels on its own.
However, Ba2+ did not display  any additive inhibitory effect on LPS-induced NO 
release with either Tram34 or PPF (Figure 5-12B&C). As described in before, the 
blockade of either inward K+ current (Pappas & Ransom, 1994) or outward K+ 
current (Chung et al., 1998) of microglia induced membrane depolarization, but 
blocking both of these currents at the same time may display  less regulation on ionic 
homeostasis. In this case the net effect may not induce more membrane 
depolarization. What is more, as described before, external Ba2+ decreases [Ca2+]i 
(Franchini et al., 2004). Although LPS is known to elevate [Ca2+]i, it is questioned 
during the period that IK channels express on the plasma membrane, whether the net 
effect of Ba2+ and LPS led to less [Ca2+]i which was not sufficient to activate IK. In 
such case, additional blocker of IK would not offer a significant effect. In addition, 
although the IC50 of Kv1.5 for extracellular Ba2+ varies depending on the different 
conditions, such as pH (Cheng et al., 2008), it can be in the range of 20µM~1mM 
(Figure 5-1). Thus, 1mM Ba2+ may block Kv1.5 current on its own, so additional 
application of PPF would not give any significant effect.
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5.3.7 Summary
The work presented here demonstrated the functional roles of selected K+ channels in 
the N9 microglia including their effect  on cell viability, LPS-induced NO release and 
the sensitivity  of whole-cell current to their pharmacological blockers. External PPF 
(10µM), Tram34 (1µM) and Ba2+ (1mM) inhibited LPS-induced N9 microglial NO 
release. What is more, LPS elevated a significant paxilline-sensitive outward current 
from N9 microglia. BK channels play a role in modulating the effect of other K+ 
channels on LPS-induced NO release.
It is hard to determine whether the effects of pharmacological manipulation are 
additive or display summation. Further study acquiring a wider range of combined 
pharmacological reagents is required to fix this issue. The membrane expression of K
+ channels during LPS challenge may be a time-dependent manner which plays an 
important role in modulating LPS-induced NO release. A time-course study on the 
localization of K+ channels is thus required. [Ca2+]i may play  an important role in 
mediating the K+ channel-regulated LPS-induced NO release. Investigations on the 
role of Ca2+ channels, cytosolic Ca2+, and Ca2+-dependent phosphorylation pathways 







6.1.1 Hypothesis and aims of the Thesis
The overall hypothesis to be tested was that: N9 murine microglia express multiple K
+ channels and that potassium (K+) channels regulate lipopolysaccharide (LPS)-
induced microglial nitric oxide (NO) release. The major aims to address these were: 
(1) Optimizing maintenance of N9 microglial cell line and LPS-induced N9 
microglial activation. (2) To investigate what K+ channel mRNAs express in resting 
N9 microglia and how they are regulated by LPS. (3) Functional role of K+ channels 
in N9 microglia including LPS-induced NO release and current expression.
6.1.2 Optimized maintenance of resting and LPS-activated N9 
microglia
By comparing morphology and proliferation of N9 microglia cultured in different 
growth media, microglia cultured in Iscove’s modified Dulbecco’s medium (IMDM) 
display  higher proliferation rate and increased ramified morphology than ones in 
Dulbecco’s Modified Eagle Medium (DMEM). Thus, as described in Chapter 3, the 
optimal growth media for N9 microglia maintenance in the resting state contains 
IMDM (including 4mM glutamine (GLX)) with 5% fetal calf serum (FCS), 100U/ml 
penicillin (PEN), 100µg/ml streptomycin (STREP) and 50µM β-mercaptoethanol (β-
MET).
What media components promote the resting state of N9 microglia? Compared to 
DMEM, IMDM contains extra antioxidant components, such as selenium and 
sodium pyruvate, which may protect cells from oxidative damage from peroxides in 
the growth medium (Giandomenico et al., 1997). In addition, this growth media 
provides components that  mimic the central nervous system (CNS) environment to 
the microglia culture in vitro, such as GLX (Reeds, 2000). Thus these may provide 
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N9 microglia an environment more similar to the one in vivo and with less oxidative 
stress.
As determined using the Griess assay, N9 microglia cultured at  the optimized 
seeding density (1.3×104~1.1×105/cm2) were able to release abundant NO in 
response to LPS (Figure 3-5). In addition, LPS-induced microglial NO release 
reached a plateau during 24~36hr with a decreasing phase beginning from around 
36hr (Figure 3-6) and displayed a dose-dependence of LPS application (10ng/
ml~1µg/ml) over this time course (Figure 3-7). Thus, LPS at 1µg/ml for 24hr was 
used as the activation method.
The optimized maintenance and activation methods for N9 microglia provided a 
reliable cell preparation and efficient  microglial activation model for the subsequent 
assays, including K+ channel expression and their functional role in resting and LPS-
activated microglia.
6.1.3 N9 microglia express a variety of K+ channel mRNAs
Using quantitative reverse transcription polymerase chain reaction (qRT-PCR), 
expression of 82 K+ channels subunits was systematically examined in resting and 
LPS-activated N9 microglia. There were 17 subunits not detected (Table 4-2) and 65 
subunits were detected. The most  abundantly  expressed subunits were Kcnma1 
(KCa1.1), Kcnk6 (K2p6.1), Kcnc3 (Kv3.3), Abcc8 (SUR1), Kcnj2 (Kir2.1), Kcnn4 
(KCa3.1) (Figure 4-3). Surprisingly, Kcnk6 (K2p6.1) was the only subunit mRNA 
significantly regulated by LPS treatment and was decreased to 68.8% compared to 
resting N9 cells. Further experiments need to be performed to investigate how LPS 
regulates the expression of Kcnk6 (K2p6.1).
The systematic examination extended the understanding of K+ channel gene 
expression in microglia and provided an important result for future investigations on 
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microglial K+ channels. Importantly, whether the LPS-regulated K+ channel 
expression in N9 microglia is temporally regulated needs to be determined. Thus, 
future experiments are required to address which K+ channel proteins are expressed, 
the time course of channel expression and the sub-cellular distribution of microglial 
K+ channels.
6.1.4 Functional role of K+ channels in N9 microglia
6.1.4.1 LPS elevated paxilline-sensitive outward current in N9 microglia
Using whole-cell voltage clamp, the whole-cell current of resting N9 microglia had a 
small outward current with a large inward current which is similar to previous reports 
on microglia in vitro. Importantly, LPS induced a calcium (Ca2+)-dependent outward 
current which was significantly blocked by paxilline suggesting a large conductance 
Ca2+-sensitive and voltage-activated K+ (BK) channel current was elevated by LPS. 
However, LPS did not change BK channel mRNA expression suggesting the effect of 
LPS is post-transcriptional. Future work needs to address whether the elevation of 
BK current results from increased protein expression or the activation of BK 
channels on the plasma membrane.
External barium (Ba2+) fully blocked the inward current as reported in previous 
studies. Tram34 and propafenone (PPF) did not significantly block the outward 
current in either resting or LPS-activated N9 microglia. In addition, paxilline had no 
effect on the outward current of resting N9 microglia. Due to the limitation of 
analysis on cell population data performed here, there could be a very small 
proportion of each relative type of current expressed. To confirm this hypothesis, 
discrete single cell recordings before and after blocker exposure is required. As 
previously  reported, both K+ channel expression on the microglial plasma membrane 
(Kotecha & Schlichter, 1999) and LPS-induced outward current  (Nörenberg et al., 
1992) may display  a time-dependence. Thus, a more systematic time course 
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examination of LPS-regulated K+ channel protein location and ionic current is 
required in N9 microglia.
6.1.4.2 BK channels modulate the effect of other K+ channels on LPS-
induced microglial NO release
The external application of K+ channel blockers, PPF (10µM), Tram34 (1µM) and 
Ba2+ (1mM), attenuated LPS-induced N9 microglial NO release. Inhibiting or 
activating BK channels on their own did not significantly affect LPS-induced NO 
release. However, blocking BK channel activity  attenuated the inhibitory effect of 
PPF, Tram34 and Ba2+ while activating BK channels significantly  facilitated the 
effect of Tram34 and PPF on LPS-induced NO release.
Is there a common mechanism for how blocking K+ channels using PPF, Tram34 or 
Ba2+ may inhibit LPS-induced NO release? The mechanism is not clear yet. As 
described before, blocking K+ channels likely depolarizes the membrane potential 
which would decrease the driving force for Ca2+ influx through non-selective cation 
channels, such as transient receptor potential channel (TRP), in microglia. Decreased 
intracellular Ca2+ concentration ([Ca2+]i) may  result in reduced inducible nitric oxide 
synthase (iNOS)/NO synthesis (Figure 6-1).
How might BK channels modulate the effect of other K+ channels in LPS-induced 
NO release? A working hypothesis is that BK channels may potentially  locate with 
voltage-gated Ca2+ channels which are known to be expressed by microglia. Thus, 
blocking BK channels might induce depolarization which would activate voltage-
gated Ca2+ channels and increase [Ca2+]i. This increased [Ca2+]i would oppose the 
effect of blocking other K+ channels, which decrease [Ca2+]i through the interactions 
with non-selective cation channels. Thus, blocking BK may prevent the inhibitory 
effect of blocking other K+ channels on LPS-induced NO release.
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Figure 6-1. Working hypothesis to explain how BK channels may 
modulate the effect of blocking other K+ channels on [Ca2+]i and LPS-
induced NO release. The hypothesis is based on BK channels locating with 
voltage-gated Ca2+ channels while other K+ channels locating with non-
selective cation channels. Blockade of other K+ channels, such as IK, 
reduces the Ca2+ influx through the non-selective cation channels by 
decreasing the driving force for Ca2+ influx. However, blockade of BK channel 
induces membrane depolarization and activates voltage-gated Ca2+ channels 
inducing Ca2+ influx. The net effect may result in no significant change in 
[Ca2+]i and thus blocking BK prevents the inhibitory  effect of blocking other K+ 
channels on LPS-induced NO release. BK: large conductance Ca2+-sensitive 
and voltage-activated K+ channels; IK: intermediate conductance Ca2+-
activated K+ channels; K+: potassium; [Ca2+]i: intracellular Ca2+ concentration; 






















To address this hypothesis, experiments are required to examine the [Ca2+]i regulated 
by blocking these K+ channels, the colocalization of Ca2+ channels and K+ channels, 
the activity  of Ca2+-dependent phosphorylation pathways and iNOS/NO synthesis. 
Furthermore whether BK channel may  modulate LPS-induced NO release in native 
mouse microglia via similar mechanism needs to be investigated.
6.1.5 Final overview
The work here extends the understanding of K+ channel expression in resting and 
activated microglia and their role in LPS-induced NO release. Intriguingly  it 
provides the first evidence of the functional role of BK channels in modulating the 
effect of other K+ channels in LPS-induced N9 microglial NO release. However, the 
regulation of K+ channels and NO release by  LPS may involve a more complex 




Figure 6-2. Schematic of LPS-induced regulation of K+ channel function 
and NO release in microglia. LPS induces microglial NO release by 
activating TLR4/CD14 receptors which regulates the activity of downstream 
phosphorylation pathways and induction of iNOS expression via the 
regulation of transcription factors. Then iNOS produces NO from L-arginine 
(Hobbs et al., 1994). As Ca2+ is able to regulate the phosphorylation 
pathways, K+ channels may thus regulate LPS-induced NO release by 
regulating membrane potential and [Ca2+]i. This process includes interaction 
between K+ channels and other channels, such as Ca2+ channels, TRP 
channels and NCX which are expressed by  microglia (Eder, 1998). 
Additionally, expression and activities of K+ channels can be regulated by NO 
(Zhu & Huizinga, 2008) and membrane potential (Levitan et al., 1995). TRP: 
transient receptor potential channel; ER: endoplasmic reticulum; NCX: Na+/
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